# ::snt CAF-1 Is Essential for Heterochromatin Organization in Pluripotent Embryonic Cells .
# ::tok CAF-1 Is Essential for Heterochromatin Organization in Pluripotent Embryonic Cells .
# ::alignments 7-10|0.0.0.0.0.2+0.0.0.0.0.1+0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 4-6|0.0.1.1+0.0.1.0+0.0.1+0.0 2-3|0.0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:28:58.237
(b / be-01 
      :ARG1 (o2 / organization 
            :beneficiary-of (e / essential 
                  :location (o / organization 
                        :name (n / name 
                              :op1 "Pluripotent" 
                              :op2 "Embryonic" 
                              :op3 "Cells"))) 
            :name (n2 / name 
                  :op1 "Heterochromatin" 
                  :op2 "Organization")))

# ::snt During mammalian development , chromatin dynamics and epigenetic marking are important for genome reprogramming .
# ::tok During mammalian development , chromatin dynamics and epigenetic marking are important for genome reprogramming .
# ::alignments 13-14|0.0.4.0 12-13|0.0.4 10-11|0 8-9|0.0.0 7-8|0.0.3 6-7|0.0 5-6|0.0.2 4-5|0.0.2.0 2-3|0.0.1 1-2|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:28:59.006
(i / important 
      :domain (a / and 
            :ARG1-of (m / mark-01) 
            :op1 (d2 / develop-02 
                  :ARG1 (m2 / mammalian)) 
            :op2 (d / dynamic 
                  :mod (c / chromatin)) 
            :op3 (e / epigenetic) 
            :op4 (g / genome 
                  :mod-of (r / reprogramm))))

# ::snt Recent data suggest an important role for the chromatin assembly machinery in this process .
# ::tok Recent data suggest an important role for the chromatin assembly machinery in this process .
# ::alignments 13-14|0.0.0 12-13|0.0.0.0 10-11|0.1.0 9-10|0.1.0.0 8-9|0.1.0.1 5-6|0.1 4-5|0.1.1 2-3|0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:28:59.418
(s / suggest-01 
      :ARG0 (d / data 
            :ARG0-of (p / process-02 
                  :mod (t / this)) 
            :time (r2 / recent)) 
      :ARG1 (r / role 
            :beneficiary (m / machinery 
                  :mod (a / assembly) 
                  :mod (c / chromatin)) 
            :mod (i / important)))

# ::snt To analyze the role of chromatin assembly factor 1 ( CAF-1 ) during pre-implantation development , we generated a mouse line carrying a targeted mutation in the gene encoding its large subunit , p150CAF-1 .
# ::tok To analyze the role of chromatin assembly factor 1 ( CAF-1 ) during pre-implantation development , we generated a mouse line carrying a targeted mutation in the gene encoding its large subunit , p150CAF-1 .
# ::alignments 31-32|0.2.1 30-31|0.2.1.0 28-29|0.2 27-28|0.2.0 24-25|0.1.0.0 23-24|0.1.0.0.0 21-22|0.1.0 20-21|0.1 19-20|0.1.1 17-18|0 16-17|0.0 14-15|0.0.0 8-9|0.0.0.0 7-8|0.0.0.1.0.0 6-7|0.0.0.1.0.0.0 5-6|0.0.0.1.0.0.0.0 3-4|0.0.0.1.0 1-2|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:00.700
(g2 / generate-01 
      :ARG0 (w / we 
            :ARG0-of (d / develop-02 
                  :ARG1 1 
                  :time-of (a2 / analyze-01 
                        :ARG1 (r / role 
                              :poss (f / factor 
                                    :mod (a / assembly 
                                          :mod (c2 / chromatin))))))) 
      :ARG1 (l2 / line 
            :ARG0-of (c / carry-01 
                  :ARG1 (m / mutation 
                        :ARG1-of (t / target-01))) 
            :mod (m2 / mouse)) 
      :manner (e / encode-01 
            :ARG0 (g / gene) 
            :ARG1 (s / subunit 
                  :mod (l / large))))

# ::snt Loss of p150CAF-1 in homozygous mutants leads to developmental arrest at the 16-cell stage .
# ::tok Loss of p150CAF-1 in homozygous mutants leads to developmental arrest at the 16-cell stage .
# ::alignments 13-14|0.0.0.1 9-10|0.0.0 8-9|0.0.0.2 6-7|0 5-6|0.0.0.0.0 4-5|0.0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:00.794
(l / lead-03 
      :ARG0 (l2 / los 
            :ARG1-of (a / arrest-01 
                  :ARG0 (h / homozygou 
                        :mod-of (m / mutant)) 
                  :ARG2 (s / stage) 
                  :mod (d / developmental))))

# ::snt Absence of p150CAF-1 in these embryos results in severe alterations in the nuclear organization of constitutive heterochromatin .
# ::tok Absence of p150CAF-1 in these embryos results in severe alterations in the nuclear organization of constitutive heterochromatin .
# ::alignments 16-17|0.2.0.1 15-16|0.2.0.1.0 13-14|0.2.0 12-13|0.2.0.0 9-10|0.2 8-9|0.2.1 6-7|0 5-6|0.1 4-5|0.1.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:00.896
(r / result-01 
      :ARG0 (a2 / absence) 
      :ARG1 (e / embryo 
            :mod (t / this)) 
      :ARG2 (a / alteration 
            :location (o / organization 
                  :mod (n / nucleus) 
                  :quant-of (h / heterochromatin 
                        :mod (c / constitutive))) 
            :mod (s / severe)))

# ::snt We provide evidence that in wild-type embryos , heterochromatin domains are extensively reorganized between the two-cell and blastocyst stages .
# ::tok We provide evidence that in wild-type embryos , heterochromatin domains are extensively reorganized between the two-cell and blastocyst stages .
# ::alignments 18-19|0.2 17-18|0.1 16-17|0 12-13|0.0 11-12|0.0.2 9-10|0.0.0 8-9|0.0.0.0 6-7|0.0.1.0 2-3|0.0.1 1-2|0.0.1.1 0-1|0.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:00.997
(a / and 
      :ARG0-of (r / reorganize-01 
            :ARG1 (d / domain 
                  :mod (h / heterochromatin)) 
            :ARG1-of (e3 / evidence-01 
                  :ARG0 (e2 / embryo) 
                  :ARG1-of (p / provide-01 
                        :ARG0 (w / we))) 
            :degree (e / extensive)) 
      :op1 (b / blastocyst) 
      :op2 (s / stage))

# ::snt In p150CAF-1 mutant 16-cell stage embryos , the altered organization of heterochromatin displays similarities to the structure of heterochromatin in two - to four-cell stage wild-type embryos , suggesting that CAF-1 is required for the maturation of heterochromatin during preimplantation development .
# ::tok In p150CAF-1 mutant 16-cell stage embryos , the altered organization of heterochromatin displays similarities to the structure of heterochromatin in two - to four-cell stage wild-type embryos , suggesting that CAF-1 is required for the maturation of heterochromatin during preimplantation development .
# ::alignments 40-41|0.0 39-40|0.0.0 35-36|0.0.1.1.0 32-33|0.0.1.1 28-29|0.0.1 26-27|0 24-25|0.0.3 20-21|0.0.1.0.1.0 16-17|0.0.1.0.0.0.1 13-14|0.0.1.0.0.0 12-13|0.0.1.0.0 11-12|0.0.1.0.0.0.0 9-10|0.0.1.0 8-9|0.0.1.0.1 5-6|0.0.1.0.0.1 4-5|0.0.2 2-3|0.0.1.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:02.256
(e / embryo 
      :ARG0-of (d / develop-02 
            :ARG1 (p / preimplantation) 
            :ARG2-of (s / suggest-01 
                  :ARG0 (o / organization 
                        :ARG0-of (d2 / display-01 
                              :ARG1 (s4 / similar-00 
                                    :ARG0 (h / heterochromatin) 
                                    :ARG1 (s3 / structure)) 
                              :location (e2 / embryo 
                                    :mod (m2 / mutant))) 
                        :ARG1-of (a / alter-01 
                              :ARG0 2)) 
                  :ARG1 (r / require-01 
                        :ARG1 (m / maturation))) 
            :mod (s5 / stage) 
            :mod (s2 / stage)))

# ::snt In embryonic stem cells , depletion of p150CAF-1 using RNA interference results in the mislocalization , loss of clustering , and decondensation of pericentric heterochromatin domains .
# ::tok In embryonic stem cells , depletion of p150CAF-1 using RNA interference results in the mislocalization , loss of clustering , and decondensation of pericentric heterochromatin domains .
# ::alignments 25-26|0.3.2.0 24-25|0.3.2 21-22|0.1.2 20-21|0.1 18-19|0.1.1 16-17|0.1.0 14-15|0.2 11-12|0 10-11|0.3 9-10|0.3.0 8-9|0.3.1 5-6|0.0 3-4|0.1.1.0.0 2-3|0.1.1.0 1-2|0.1.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:02.895
(r / result-01 
      :ARG0 (d3 / depletion) 
      :ARG1 (a / and 
            :op1 (l / loss) 
            :op2 (c / cluster-01 
                  :ARG1 (s / stem 
                        :mod-of (c2 / cell 
                              :mod (e / embryonic)))) 
            :op3 (d2 / decondensation)) 
      :ARG2 (m / mislocalization) 
      :manner (i / interfere-01 
            :ARG1 (r2 / rna) 
            :ARG1-of (u / use-01) 
            :op1-of (h / heterochromatin 
                  :mod-of (d / domain))))

# ::snt Furthermore , loss of CAF-1 in these cells results in the alteration of epigenetic histone methylation marks at the level of pericentric heterochromatin .
# ::tok Furthermore , loss of CAF-1 in these cells results in the alteration of epigenetic histone methylation marks at the level of pericentric heterochromatin .
# ::alignments 22-23|0.1.1.0 19-20|0.1.1 16-17|0.1.0.0+0.1.0 15-16|0.1.0.1 14-15|0.1.0.2 11-12|0.1 8-9|0 7-8|0.0.0 6-7|0.0.0.0 2-3|0.0 0-1|0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:03.117
(r / result-01 
      :ARG1 (l2 / loss 
            :location (c / cell 
                  :mod (t2 / this))) 
      :ARG2 (a / alteration 
            :poss (t / thing 
                  :ARG0-of (m / mark-01 
                        :ARG1 (f / furthermore)) 
                  :mod (m2 / methylation) 
                  :mod (h2 / histone)) 
            :prep-at (l / level 
                  :mod (h / heterochromatin))))

# ::snt These alterations of heterochromatin are not found in p150CAF-1-depleted mouse embryonic fibroblasts , which are cells that are already lineage committed , suggesting that CAF-1 is specifically required for heterochromatin organization in pluripotent embryonic cells .
# ::tok These alterations of heterochromatin are not found in p150CAF-1-depleted mouse embryonic fibroblasts , which are cells that are already lineage committed , suggesting that CAF-1 is specifically required for heterochromatin organization in pluripotent embryonic cells .
# ::alignments 34-35|0.0.0.0.0.0 33-34|0.0.0.0.0.0.0 30-31|0.0.0.0.0 27-28|0.0.0.0 26-27|0.0.0.0.2 22-23|0.0.0 20-21|0 19-20|0.1 18-19|0.2 15-16|0.0 11-12|0.0.0.0.1.1 10-11|0.0.0.0.1.1.0 9-10|0.0.0.0.1.1.1 8-9|0.0.0.0.2.0 6-7|0.0.0.0.1 5-6|0.0.0.0.1.2 3-4|0.0.0.0.1.0.1 1-2|0.0.0.0.1.0 0-1|0.0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:03.424
(c2 / commit-01 
      :ARG0 (c3 / cell 
            :ARG0-of (s2 / suggest-01 
                  :ARG1 (r / require-01 
                        :ARG0 (o / organization 
                              :location (c / cell 
                                    :mod (e / embryonic))) 
                        :ARG1 (f2 / find-01 
                              :ARG1 (a2 / alteration 
                                    :mod (t / this) 
                                    :mod (h / heterochromatin)) 
                              :location (f / fibroblast 
                                    :mod (e2 / embryonic) 
                                    :mod (m / mouse)) 
                              :polarity -) 
                        :manner (s / specific-02 
                              :ARG1 (p / p150caf-1-deplet))))) 
      :manner (l / lineage) 
      :time (a / already))

# ::snt Our findings underline the role of the chromatin assembly machinery in controlling the spatial organization and epigenetic marking of the genome in early embryos and embryonic stem cells .
# ::tok Our findings underline the role of the chromatin assembly machinery in controlling the spatial organization and epigenetic marking of the genome in early embryos and embryonic stem cells .
# ::alignments 27-28|0.1.0.0.0.0.1.1 26-27|0.1.0.0.0.0.1.1.0 25-26|0.1.0.0.0.0.1.1.1 24-25|0.1.0.0.0.0.1 23-24|0.1.0.0.0.0.1.0 22-23|0.1.0.0.0.0.1.0.0 20-21|0.1.0.0.0.0.0 17-18|0.1.0.0.0.0 16-17|0.1.0.0.0.2 15-16|0.1.0.0.0 14-15|0.1.0.0.0.1 13-14|0.1.0.0.0.1.0 11-12|0.1.0.0 9-10|0.1.0 8-9|0.1.0.1 7-8|0.1.0.2 4-5|0.1 2-3|0 1-2|0.0.0+0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:05.951
(u / underline-01 
      :ARG0 (t / thing 
            :ARG1-of (f / find-01 
                  :ARG0 (w / we))) 
      :ARG1 (r / role 
            :poss (m2 / machinery 
                  :ARG0-of (c2 / control-01 
                        :ARG1 (a2 / and 
                              :ARG0-of (m / mark-01 
                                    :ARG1 (g / genome) 
                                    :ARG2 (a / and 
                                          :op1 (e2 / embryo 
                                                :mod (e3 / early)) 
                                          :op2 (c / cell 
                                                :mod (s / stem) 
                                                :mod (e / embryonic)))) 
                              :op1 (o / organization 
                                    :mod (s2 / spatial)) 
                              :op2 (e4 / epigenetic))) 
                  :mod (a3 / assembly) 
                  :mod (c3 / chromatin))))

# ::snt Chromatin is the support of our genetic information .
# ::tok Chromatin is the support of our genetic information .
# ::alignments 7-8|0.0 6-7|0.0.0 5-6|0.0.1 3-4|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:05.990
(s / support-01 
      :ARG1 (i / information 
            :mod (g / gene) 
            :poss (w / we)) 
      :ARG2 (c / chromatin))

# ::snt It is composed of numerous repeated units called nucleosomes , in which DNA wraps around a core of histone proteins .
# ::tok It is composed of numerous repeated units called nucleosomes , in which DNA wraps around a core of histone proteins .
# ::alignments 19-20|0.1.1.0.0.0.0.0 18-19|0.1.1.0.0.0.0.0.0 16-17|0.1.1.0.0.0.0 14-15|0.1.1.0.0.0 13-14|0.1.1.0.0 12-13|0.1.1.0 8-9|0.1.1.1 7-8|0.1.1 6-7|0.1 5-6|0.1.0 4-5|0.1.2 2-3|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:06.154
(c3 / compose-01 
      :ARG1 (i / it) 
      :ARG2 (u / unit 
            :ARG1-of (r / repeat-01) 
            :ARG1-of (c2 / call-01 
                  :ARG0 (d / DNA 
                        :mod-of (w / wrap 
                              :location (a / around 
                                    :op1 (c / core 
                                          :poss (p / protein 
                                                :mod (h / histone)))))) 
                  :manner (n / nucleosom)) 
            :quant (n2 / numerous)))

# ::snt Modifications in the composition and biochemical properties of nucleosomes play major roles in the regulation of genome function .
# ::tok Modifications in the composition and biochemical properties of nucleosomes play major roles in the regulation of genome function .
# ::alignments 17-18|0.0.2.0 16-17|0.0.2.0.0 14-15|0.0.2 11-12|0.0.1 10-11|0.0.1.0 9-10|0.0 8-9|0.3.0 6-7|0.3 5-6|0.2 4-5|0 3-4|0.1 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:06.676
(a / and 
      :ARG2-of (p / play-01 
            :ARG0 (m2 / modification) 
            :ARG1 (r2 / role 
                  :ARG1-of (m / major-02)) 
            :location (r / regulate-01 
                  :ARG1 (f / function-01 
                        :ARG1 (g / genome)))) 
      :op1 (c / compose-01) 
      :op2 (b / biochemical) 
      :poss-of (p2 / property 
            :mod (n / nucleosom)))

# ::snt Such modifications are termed `` epigenetic '' when they are inherited across cell divisions and confer new information to chromatin , in addition to the genetic information provided by DNA .
# ::tok Such modifications are termed `` epigenetic '' when they are inherited across cell divisions and confer new information to chromatin , in addition to the genetic information provided by DNA .
# ::alignments 29-30|0.0.1.0.0 27-28|0.0.1.0 26-27|0.0.1.0.1 25-26|0.0.0 22-23|0.1.2 19-20|0.1.1 17-18|0.1.0 16-17|0.1.0.0 15-16|0.1 14-15|0 13-14|0.0.2.1.0 12-13|0.0.2.1.0.0 11-12|0.0.2.1 10-11|0.0.2 8-9|0.0.2.0 3-4|0.0 1-2|0.0.1 0-1|0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:07.475
(a2 / and 
      :op1 (t2 / term-01 
            :ARG0 (g / gene) 
            :ARG1 (m / modify-01 
                  :ARG1 (p / provide-01 
                        :ARG0 (d / DNA) 
                        :ARG1 (i / information)) 
                  :mod (s / such)) 
            :condition (i3 / inherit-01 
                  :ARG1 (t / they) 
                  :location (a3 / across 
                        :op1 (d2 / division 
                              :mod (c3 / cell))))) 
      :op2 (c2 / confer-01 
            :ARG1 (i2 / information 
                  :mod (n / new)) 
            :ARG2 (c / chromatin) 
            :location (a / addition)))

# ::snt It is usually believed that during genome replication , the basic chromatin assembly machinery builds up `` nave '' nucleosomes , and , in a subsequent step , nucleosomes are selectively modified by a series of enzymes to acquire epigenetic information .
# ::tok It is usually believed that during genome replication , the basic chromatin assembly machinery builds up `` nave '' nucleosomes , and , in a subsequent step , nucleosomes are selectively modified by a series of enzymes to acquire epigenetic information .
# ::alignments 40-41|0.0.2.1 38-39|0.0.2 36-37|0.0.0.0 34-35|0.0.0 31-32|0.0 30-31|0.0.3 28-29|0.0.2.0 26-27|0.0.1.0.1 25-26|0.0.1.0.1.0 21-22|0 19-20|0.0.1.0.0.1 17-18|0.0.1.0.0.1.0 14-15|0.0.1.0.0 13-14|0.0.1.0.0.0 12-13|0.0.1.0.0.0.0 11-12|0.0.1.0.0.0.0.0 10-11|0.0.1.0.0.0.0.0.0 7-8|0.0.1.0.0.2 6-7|0.0.1.0.0.2.0 3-4|0.0.1.0 2-3|0.0.1.0.2 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:09.249
(a2 / and 
      :op1 (m / modify-01 
            :ARG0 (s / series 
                  :quant-of (e / enzym)) 
            :ARG1 (i2 / it 
                  :ARG0-of (b3 / believe-01 
                        :ARG1 (b / build-01 
                              :ARG0 (m2 / machinery 
                                    :mod (a3 / assembly 
                                          :mod (c / chromatin 
                                                :mod (b2 / basic)))) 
                              :ARG1 (n2 / nucleosom 
                                    :mod (n3 / nave)) 
                              :time (r / replication 
                                    :mod (g / genome))) 
                        :location (s3 / step 
                              :mod (s4 / subsequent)) 
                        :time (u / usual))) 
            :ARG2 (a / acquire-01 
                  :ARG0 (n / nucleosom) 
                  :ARG1 (i / information)) 
            :manner (s2 / selectively)))

# ::snt Here , the authors studied the role of a basic chromatin assembly factor ( CAF-1 ) in mouse embryonic stem cells and early embryos .
# ::tok Here , the authors studied the role of a basic chromatin assembly factor ( CAF-1 ) in mouse embryonic stem cells and early embryos .
# ::alignments 23-24|0.2 22-23|0.1 21-22|0 20-21|0.0 19-20|0.0.1 18-19|0.0.3 17-18|0.0.2 12-13|0.0.0.1 11-12|0.0.0.1.0 10-11|0.0.0.1.1.0 9-10|0.0.0.1.1 6-7|0.0.0 4-5|0.0.0.0 3-4|0.0.0.0.0 0-1|0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:09.529
(a / and 
      :op1 (c / cell 
            :location-of (r / role 
                  :ARG1-of (s2 / study-01 
                        :ARG0 (a3 / author-01) 
                        :degree (h / here)) 
                  :poss (f / factor 
                        :mod (a2 / assembly) 
                        :mod (b / basic 
                              :mod-of (c2 / chromatin)))) 
            :mod (s / stem) 
            :mod (m / mouse) 
            :mod (e3 / embryonic)) 
      :op2 (e2 / early) 
      :op3 (e / embryo))

# ::snt Surprisingly , they show that CAF-1 confers epigenetic information to specific genomic regions .
# ::tok Surprisingly , they show that CAF-1 confers epigenetic information to specific genomic regions .
# ::alignments 12-13|0.1.1 10-11|0.1.1.0 8-9|0.1.0 6-7|0.1 3-4|0 2-3|0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:09.596
(s2 / show-01 
      :ARG0 (t / they) 
      :ARG1 (c / confer-01 
            :ARG1 (i / information) 
            :ARG2 (r / region 
                  :ARG1-of (s / specific-02))) 
      :mod (s3 / surprisingly))

# ::snt In addition , this study revealed that CAF-1 is required for the proper spatial organization of chromosomes in the nucleus .
# ::tok In addition , this study revealed that CAF-1 is required for the proper spatial organization of chromosomes in the nucleus .
# ::alignments 19-20|0.3 16-17|0.1.0.2 14-15|0.1.0 13-14|0.1.0.1 12-13|0.1.0.0 9-10|0.1 5-6|0 4-5|0.0 3-4|0.0.0 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:09.740
(r2 / reveal-01 
      :ARG0 (s2 / study-01 
            :mod (t / this)) 
      :ARG1 (r / require-01 
            :ARG2 (o / organization 
                  :mod (p / proper) 
                  :mod (s / spatial) 
                  :mod (c / chromosom))) 
      :location (a / addition) 
      :op1-of (n / nucleus))

# ::snt This new knowledge may contribute to better understanding the role of chromatin in the maintenance of embryonic stem cell identity and plasticity .
# ::tok This new knowledge may contribute to better understanding the role of chromatin in the maintenance of embryonic stem cell identity and plasticity .
# ::alignments 21-22|0.2 20-21|0 19-20|0.1.0 18-19|0.1.0.0 17-18|0.1.0.0.0 16-17|0.1.0.1 14-15|0.1 11-12|0.0.0.0 9-10|0.0.0 7-8|0.0 6-7|0.0.2 4-5|0.0.1 3-4|0.0.1.1 2-3|0.0.1.0 1-2|0.0.1.0.0 0-1|0.0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:09.922
(a / and 
      :op1 (u / understand-01 
            :ARG1 (r / role 
                  :poss (c2 / chromatin)) 
            :ARG2-of (c3 / contribute-01 
                  :ARG0 (k / knowledge 
                        :mod (n / new) 
                        :mod (t / this)) 
                  :ARG1-of (p2 / possible-01)) 
            :manner (g / good)) 
      :op2 (m / maintain-01 
            :ARG1 (i / identity 
                  :mod (c / cell 
                        :mod (s / stem)) 
                  :mod (e / embryonic))) 
      :op3 (p / plasticity))

# ::snt During mouse pre-implantation development , the genome undergoes a series of major epigenetic changes required for embryonic gene expression , the maintenance of totipotency , and the first differentiation events [ 1,2 ] .
# ::tok During mouse pre-implantation development , the genome undergoes a series of major epigenetic changes required for embryonic gene expression , the maintenance of totipotency , and the first differentiation events [ 1,2 ] .
# ::alignments 29-30|0.2 28-29|0.2.0 25-26|0 23-24|0.1.0 21-22|0.1 18-19|0.0.1.0 17-18|0.0.1.0.0 16-17|0.0.1.0.1 14-15|0.0.1 13-14|0.0 11-12|0.0.0 9-10|0.0.2 7-8|0.0.2.0 6-7|0.0.2.0.0 3-4|0.0.2.0.1 1-2|0.0.2.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:10.516
(a / and 
      :ARG0-of (c / change-01 
            :ARG1-of (m2 / major-02) 
            :ARG1-of (r / require-01 
                  :ARG2 (e2 / express-01 
                        :mod (g / gene) 
                        :mod (e3 / embryonic))) 
            :quant (s / series 
                  :ARG2-of (u / undergo-28 
                        :ARG1 (g2 / genome) 
                        :time (d2 / develop-02 
                              :ARG1 (m3 / mouse))))) 
      :op1 (m / maintain-01 
            :ARG1 (t / totipotency)) 
      :op2 (e / event 
            :mod (d / differentiation)))

# ::snt While many studies have established the importance of DNA methylation in epigenetic reprogramming , recent data point to a crucial role of chromatin in this process [ 3 -- 5 ] .
# ::tok While many studies have established the importance of DNA methylation in epigenetic reprogramming , recent data point to a crucial role of chromatin in this process [ 3 -- 5 ] .
# ::alignments 29-30|0.1.0.0 27-28|0.1.0.1 25-26|0.0.0 24-25|0.0.0.1 22-23|0.0.0.0.1 20-21|0.0.0.0 19-20|0.0.0.0.0 16-17|0 15-16|0.0 14-15|0.0.1 12-13|0.1.1.0.0 8-10|0.1.1.1.1+0.1.1.1.0+0.1.1.1+0.1.1 6-7|0.1.1.0 4-5|0.1 2-3|0.1.0 1-2|0.1.0.2 0-1|0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:12.267
(p2 / point 
      :mod (d / data 
            :ARG1-of (p / process-02 
                  :ARG2 (r / role 
                        :mod (c2 / crucial) 
                        :poss (c / chromatin)) 
                  :mod (t / this)) 
            :mod (r2 / recent)) 
      :purpose (e / establish-01 
            :ARG0 (s / study-01 
                  :ARG0 5 
                  :ARG1 3 
                  :quant (m2 / many)) 
            :ARG1 (t2 / thing 
                  :domain-of (i / important 
                        :location (r3 / reprogramm)) 
                  :name (n / name 
                        :op1 (d2 / DNA) 
                        :op2 (m / methylation))) 
            :ARG1-of (w / while-01)))

# ::snt Yet we know very little about the role of histone modifying enzymes , chromatin remodeling factors , and histone chaperones during pre-implantation development , or in stem cells derived from early embryos [ 6 ] .
# ::tok Yet we know very little about the role of histone modifying enzymes , chromatin remodeling factors , and histone chaperones during pre-implantation development , or in stem cells derived from early embryos [ 6 ] .
# ::alignments 33-34|0.1.0.0.0.0.0 31-32|0.1.2.2 30-31|0.1.2.2.1 28-29|0.1.2.2.0 27-28|0.1.2.2.0.0 26-27|0.1.2.2.0.0.0 24-25|0.1.2.0 22-23|0.1.0.0.0.0 19-20|0.1.2 18-19|0.1.2.1 17-18|0.1 15-16|0 14-15|0.0 13-14|0.0.0 11-12|0.1.1 10-11|0.1.1.0 9-10|0.1.1.1 7-8|0.1.0 4-5|0.1.0.0.1 3-4|0.1.0.0.1.0 2-3|0.1.0.0 1-2|0.1.0.0.0 0-1|0.1.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:12.793
(f / factor 
      :mod (r / remodel-01 
            :ARG1 (c3 / chromatin)) 
      :op3-of (a / and 
            :op1 (r2 / role 
                  :time-of (k / know-01 
                        :ARG0 (w / we 
                              :ARG0-of (d2 / develop-02 
                                    :ARG1 6)) 
                        :ARG1 (l / little 
                              :degree (v / very)) 
                        :mod (y / yet))) 
            :op2 (e3 / enzym 
                  :ARG1-of (m / modify-01) 
                  :mod (h2 / histone)) 
            :op4 (c2 / chaperone-01 
                  :ARG1 (o / or) 
                  :mod (h / histone) 
                  :op1-of (e / embryo 
                        :ARG2-of (d / derive-01 
                              :ARG1 (c / cell 
                                    :mod (s / stem))) 
                        :mod (e2 / early)))))

# ::snt A subset of identified histone chaperones and chromatin remodeling complexes can collaborate to promote nucleosome assembly in vitro and are therefore in a strategic position to control chromatin assembly and maturation during development [ 7,8 ] .
# ::tok A subset of identified histone chaperones and chromatin remodeling complexes can collaborate to promote nucleosome assembly in vitro and are therefore in a strategic position to control chromatin assembly and maturation during development [ 7,8 ] .
# ::alignments 32-33|0.0.1 30-31|0.3 29-30|0 28-29|0.2 27-28|0.2.0 26-27|0.0 24-25|0.0.0 23-24|0.0.0.0 18-19|0.1.0.1 15-16|0.1.0.0.1 13-14|0.1.0.0 11-12|0.1.0 10-11|0.1 9-10|0.1.1.0 8-9|0.1.1 7-8|0.1.1.0.0 6-7|0.1.1.0.1 5-6|0.1.1.0.1.0.0 4-5|0.1.1.0.1.0.0.0 3-4|0.1.1.0.1.0 1-2|0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:14.846
(a / and 
      :ARG1-of (c2 / control-01 
            :ARG0 (p / position 
                  :mod (s / strategy)) 
            :time (d / develop-02)) 
      :op1 (p3 / possible-01 
            :ARG1 (c3 / collaborate-01 
                  :ARG2 (p2 / promote-02 
                        :ARG0 (s2 / subset) 
                        :ARG1 (a4 / assembly)) 
                  :op1-of (a3 / and)) 
            :ARG1-of (r / remodel-01 
                  :ARG2 (c4 / complex 
                        :mod (c5 / chromatin) 
                        :op2-of (a5 / and 
                              :op1 (i / identify-01 
                                    :ARG1 (c6 / chaperone-01 
                                          :ARG1 (h / histone))))))) 
      :op2 (a2 / assembly 
            :mod (c / chromatin)) 
      :op3 (m / maturation))

# ::snt Among histone chaperones , chromatin assembly factor 1 ( CAF-1 ) is a three-subunit ( p150 , p60 , and p48 ) complex which promotes histone H3 and H4 deposition onto newly synthesized DNA during replication or DNA repair [ 9,10 ] .
# ::tok Among histone chaperones , chromatin assembly factor 1 ( CAF-1 ) is a three-subunit ( p150 , p60 , and p48 ) complex which promotes histone H3 and H4 deposition onto newly synthesized DNA during replication or DNA repair [ 9,10 ] .
# ::alignments 38-39|0.0.1.1.0 37-38|0.0.1.1 36-37|0.0.1 35-36|0.0.1.0 33-34|0.0.0.0.0.1.0 32-33|0.0.0.0.0.1.0.0 31-32|0.0.0.0.0.1.0.0.2 30-31|0.0.0.0.0.1 29-30|0.0.0.0.0.0 27-28|0 25-26|0.0.1.1.0.0 24-25|0.0.0.0.0 22-23|0.0.0.0 20-21|0.0.4 19-20|0.0 17-18|0.0.3 15-16|0.0.2 7-8|0.0.0.0.0.1.0.0.0 6-7|0.0.0 5-6|0.0.0.1 4-5|0.0.0.1.0 2-3|0.0.0.0.0.1.0.0.1 1-2|0.0.0.0.0.1.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:15.420
(a / and 
      :op5-of (a2 / and 
            :op1 (f / factor 
                  :domain-of (c / complex 
                        :ARG0-of (p / promote-02 
                              :ARG1 (d3 / deposition) 
                              :time (o2 / onto 
                                    :op1 (d2 / DNA 
                                          :ARG1-of (s / synthesize-01 
                                                :ARG0 1 
                                                :ARG1-of (c3 / chaperone-01 
                                                      :mod (h2 / histone)) 
                                                :degree (n / newly)))))) 
                  :mod (a3 / assembly 
                        :mod (c2 / chromatin))) 
            :op1-of (o / or 
                  :op2 (r2 / replication) 
                  :op3 (d / DNA 
                        :mod-of (r / repair-01 
                              :ARG1 (h / histone)))) 
            :op2 (p4 / p150) 
            :op3 (p3 / p60) 
            :op4 (p2 / p48)))

# ::snt Specifically , CAF-1 deposits the histone H3 variant H3 .1 into chromatin , in a pathway coupled to DNA synthesis , whereas a second histone chaperone , HIRA , is involved in the deposition of the H3 .3 variant in a DNA synthesis independent pathway [ 11,12 ] .
# ::tok Specifically , CAF-1 deposits the histone H3 variant H3 .1 into chromatin , in a pathway coupled to DNA synthesis , whereas a second histone chaperone , HIRA , is involved in the deposition of the H3 .3 variant in a DNA synthesis independent pathway [ 11,12 ] .
# ::alignments 44-45|0.0 43-44|0.2+0 41-42|0.1.1 38-39|0.1.2.0 33-34|0.1.2 30-31|0.1 25-26|0.1.0.0.1.1 24-25|0.1.0.0.1.1.0 21-22|0.1.3 19-20|0.1.0.0.1 18-19|0.1.0.0.1.0 16-17|0.1.0.0 15-16|0.1.0.0.0 11-12|0.1.0.2.0 7-8|0.1.0.2 6-7|0.1.0 5-6|0.1.0.1 3-4|0.1.0.3 0-1|0.1.0.0.1.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:16.575
(d / depend-01 
      :ARG0 (p / pathway) 
      :ARG1 (i / involve-01 
            :ARG0 (h2 / H3 
                  :ARG0-of (c2 / couple-01 
                        :ARG1 (p2 / pathway) 
                        :ARG2 (s / synthesi 
                              :mod (d4 / DNA) 
                              :op1 (c / chaperone-01 
                                    :ARG1 (h / histone) 
                                    :ARG1-of (s2 / specific-02)))) 
                  :mod (h3 / histone) 
                  :mod-of (v2 / variant 
                        :location (c3 / chromatin)) 
                  :poss (d5 / deposit)) 
            :ARG1 (d2 / DNA) 
            :ARG2 (d3 / deposition 
                  :mod (v / variant)) 
            :op1-of (w / whereas)) 
      :polarity -)

# ::snt In addition to this specific chromatin assembly activity , CAF-1 interacts with several proteins present in heterochromatin , including heterochromatin protein 1 ( HP1 ) and MBD1 , a methyl-CpG binding domain protein that recruits histone deacetylase and repressive histone methyltransferase activities [ 13 -- 15 ] .
# ::tok In addition to this specific chromatin assembly activity , CAF-1 interacts with several proteins present in heterochromatin , including heterochromatin protein 1 ( HP1 ) and MBD1 , a methyl-CpG binding domain protein that recruits histone deacetylase and repressive histone methyltransferase activities [ 13 -- 15 ] .
# ::alignments 45-46|0.0.3.0.0.0.1 43-44|0.0.3.0.1.0.4.0.0 41-42|0.0 39-40|0.0.1 38-39|0.0.0 37-38|0.0.3 36-37|0.0.3.1 35-36|0.0.3.1.0 34-35|0.0.3.0+0.0.3.0.1 32-33|0.0.3.0.0 31-32|0.0.3.0.0.0.0 30-31|0.0.3.0.0.0 25-26|0.0.3.0.1.0.4 21-22|0.0.2 20-21|0 16-17|0.0.0.0 14-15|0.0.3.0.1.0.4.0.2 13-14|0.0.3.0.1.0.4.0.1 12-13|0.0.3.0.1.0.4.0.1.0 10-11|0.0.3.0.1.0.4.0 7-8|0.0.3.0.1.0 6-7|0.0.3.0.1.0.0 5-6|0.0.3.0.1.0.1.0 4-5|0.0.3.0.1.0.1 3-4|0.0.3.0.1.0.3 1-2|0.0.3.0.1.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:19.610
(p3 / protein 
      :ARG2-of (a / activity-06 
            :ARG0-of (r / repress-01 
                  :op1-of (h3 / heterochromatin)) 
            :mod (h / histone) 
            :op1-of 1 
            :op2-of (a2 / and 
                  :ARG2-of (r2 / recruit-01 
                        :ARG0 (p2 / protein 
                              :ARG0-of (b / binding-07 
                                    :ARG1 (d2 / domain) 
                                    :ARG2 15)) 
                        :ARG1 (p / person 
                              :ARG0-of (a4 / activity-06 
                                    :ARG1 (a5 / assembly) 
                                    :ARG2-of (s2 / specific-02 
                                          :ARG1 (c / chromatin)) 
                                    :destination-of (a6 / addition) 
                                    :mod (t / this) 
                                    :op1-of (a3 / and 
                                          :op2 (i / interact-01 
                                                :ARG0 13 
                                                :ARG1 (p5 / protein 
                                                      :quant (s / several)) 
                                                :time (p4 / present)))))) 
                  :op1 (d / deacetylase 
                        :mod (h2 / histone)))))

# ::snt Furthermore , p150CAF-1 is required to ensure a replication-specific pool of HP1 molecules at replication sites in pericentric heterochromatin during mid-late S phase [ 16 ] .
# ::tok Furthermore , p150CAF-1 is required to ensure a replication-specific pool of HP1 molecules at replication sites in pericentric heterochromatin during mid-late S phase [ 16 ] .
# ::alignments 24-25|0.0.0.0.0.1.0.0 22-23|0.0.0.0.0.0 21-22|0.0.0.0.0.1.1+0.0.0.0.0.1 18-19|0.0.0.0.0 15-16|0.0.0.1 14-15|0.0.0.1.0 12-13|0.0.0.0 11-12|0.0.0.0.1 9-10|0.0.0 6-7|0.0 4-5|0 0-1|0.0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:19.835
(r2 / require-01 
      :ARG1 (e / ensure-01 
            :ARG1 (p2 / pool 
                  :consist-of (m / molecule 
                        :location (h / heterochromatin 
                              :purpose (p / phase) 
                              :source (n / name 
                                    :mod-of (f / furthermore 
                                          :mod-of 16) 
                                    :op1 "S-400")) 
                        :mod (h2 / HP1)) 
                  :location (s / site 
                        :location-of (r / replication)))))

# ::snt Taken together , these data suggest roles for CAF-1 in the formation of heterochromatin and in the heritability of epigenetic traits .
# ::tok Taken together , these data suggest roles for CAF-1 in the formation of heterochromatin and in the heritability of epigenetic traits .
# ::alignments 20-21|0.0.0.0 17-18|0.0.0 14-15|0.0 13-14|0.2.1.0 11-12|0.2.1 6-7|0.2.0 5-6|0 4-5|0.1 3-4|0.1.0 1-2|0.2.2 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:20.002
(s / suggest-01 
      :ARG0 (a / and 
            :op1 (h / heritability 
                  :mod (t / trait))) 
      :ARG1 (d / data 
            :mod (t2 / this)) 
      :purpose (t4 / take-01 
            :ARG0 (r / role) 
            :ARG2-of (f / form-01 
                  :ARG1 (h2 / heterochromatin)) 
            :mod (t3 / together)))

# ::snt While the function of this evolutionary conserved histone chaperone has been studied extensively biochemically , we still lack information concerning its importance during early development in mammals and in pluripotent cells such as embryonic stem ( ES ) cells .
# ::tok While the function of this evolutionary conserved histone chaperone has been studied extensively biochemically , we still lack information concerning its importance during early development in mammals and in pluripotent cells such as embryonic stem ( ES ) cells .
# ::alignments 38-39|0.0.0.0.1.0 36-37|0.0.2.0 34-35|0.0.2.2 33-34|0.0.2.2.0 31-32|0.0.0.0.1.1.0 30-31|0.0.0.0.1.2.0.0 27-28|0 26-27|0.0.2.1 24-25|0.0.2 23-24|0.0.3 21-22|0.0.1 19-20|0.0 18-19|0.0.0 17-18|0.0.0.0 15-17|0.0.0.0.0.1+0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 13-14|0.0.0.0.1.4 12-13|0.0.0.0.1.3 11-12|0.0.0.0.1 8-9|0.0.0.0.1.2.0 7-8|0.0.0.0.1.2.0.1 6-7|0.0.0.0.1.2.0.2 5-6|0.0.0.0.1.2.0.4 4-5|0.0.0.0.1.2.0.3 2-3|0.0.0.0.1.2 0-1|0.0.0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:21.691
(a / and 
      :ARG3-of (c3 / concern-02 
            :ARG0 (i2 / information 
                  :ARG1-of (l / lack-01 
                        :ARG0 (w / world-region 
                              :name (n / name 
                                    :op1 "West") 
                              :wiki "Western_world") 
                        :condition (s3 / study-01 
                              :ARG0 (c / cell) 
                              :ARG0-of (w2 / while-01 
                                    :ARG1 (s2 / such)) 
                              :ARG1 (f / function-01 
                                    :ARG1 (c4 / chaperone-01 
                                          :ARG0 (c2 / cell) 
                                          :ARG1 (h / histone) 
                                          :ARG1-of (c5 / conserve-01) 
                                          :mod (t / this) 
                                          :mod (e5 / evolutionary))) 
                              :degree (e4 / extensive) 
                              :mod (b / biochemically)))) 
            :ARG1 (i / important) 
            :time (d / develop-02 
                  :ARG0 (e / e) 
                  :ARG1 (m / mammal) 
                  :medium (s / stem 
                        :mod (e2 / embryonic))) 
            :time (e3 / early)))

# ::snt Here , we have analyzed the importance of CAF-1 during early mouse development by genetic ablation and in ES cells by depletion using RNA interference ( RNAi ) .
# ::tok Here , we have analyzed the importance of CAF-1 during early mouse development by genetic ablation and in ES cells by depletion using RNA interference ( RNAi ) .
# ::alignments 24-25|0.0 23-24|0.0.0 22-23|0.0.1 21-22|0.0.1.0 19-20|0.1 18-19|0 16-17|0.0.1.1.2.3 15-16|0.0.1.1.2.1 14-15|0.0.1.1.2.2 12-13|0.0.1.1.2 11-12|0.0.1.1.2.0 10-11|0.0.1.1.3 6-7|0.0.1.1.1 4-5|0.0.1.1 2-3|0.0.1.1.0 0-1|0.0.1.1.2.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:22.120
(e / e 
      :ARG2-of (i / interfere-01 
            :ARG1 (r / rna) 
            :ARG1-of (u / use-01 
                  :ARG0 (d / depletion) 
                  :manner-of (a3 / analyze-01 
                        :ARG0 (w / we) 
                        :ARG1 (i2 / important) 
                        :ARG2 (d2 / develop-02 
                              :ARG1 (m / mouse) 
                              :ARG2 (a2 / ablation) 
                              :location (g / gene) 
                              :op2-of (a / and 
                                    :op1 (h / here))) 
                        :time (e2 / early)))) 
      :mod-of (c / cell))

# ::snt We show that CAF-1 is essential for viability in early mouse embryos and ES cells .
# ::tok We show that CAF-1 is essential for viability in early mouse embryos and ES cells .
# ::alignments 14-15|0.2.2 13-14|0.2.2.0 12-13|0.2 11-12|0.2.1 10-11|0.2.1.0 9-10|0.2.1.1 7-8|0.2.0 5-6|0.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:22.514
(s / show-01 
      :ARG0 (w / we) 
      :ARG1 (e4 / essential) 
      :ARG2 (a / and 
            :consist (v / viability) 
            :op1 (e2 / embryo 
                  :mod (m / mouse) 
                  :mod (e3 / early)) 
            :op2 (c / cell 
                  :mod (e / e))))

# ::snt We provide evidence that CAF-1 is required for the spatial organization and epigenetic marking of heterochromatin domains in pluripotent embryonic cells .
# ::tok We provide evidence that CAF-1 is required for the spatial organization and epigenetic marking of heterochromatin domains in pluripotent embryonic cells .
# ::alignments 20-21|0.0.0 19-20|0.0.0.0 16-17|0.0 15-16|0.0.1 13-14|0 12-13|0.1.1 11-12|0.1 10-11|0.1.0.1 9-10|0.1.0.1.0 6-7|0.1.0 2-3|0.1.0.0 1-2|0.1.0.0.0 0-1|0.1.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:22.736
(m / mark-01 
      :ARG0 (d / domain 
            :location (c / cell 
                  :mod (e / embryonic)) 
            :mod (h / heterochromatin)) 
      :ARG1 (a / and 
            :ARG1-of (r / require-01 
                  :ARG1-of (e3 / evidence-01 
                        :ARG1-of (p / provide-01 
                              :ARG0 (w / we))) 
                  :ARG2 (o / organization 
                        :mod (s / spatial))) 
            :op1 (e2 / epigenetic)))

# ::snt We used gene targeting in ES cells to delete exon 3 in the Chaf1a gene , which encodes p150CAF-1 ( Figure 1A ) .
# ::tok We used gene targeting in ES cells to delete exon 3 in the Chaf1a gene , which encodes p150CAF-1 ( Figure 1A ) .
# ::alignments 20-21|0.2.0 17-18|0.2.1.0 14-15|0.2.1.0.0 13-14|0.2.1.0.0.0.0.0+0.2.1.0.0.0.0+0.2.1.0.0.0 10-11|0.1.0.1 9-10|0.2.1 8-9|0.2 6-7|0.1.0.0 5-6|0.1.0.0.0 3-4|0.1.0 2-3|0.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:23.083
(u / use-01 
      :ARG0 (w / we) 
      :ARG1 (g2 / gene 
            :ARG1-of (t / target-01 
                  :ARG0 (c2 / cell 
                        :mod (e3 / e)) 
                  :ARG2 3)) 
      :ARG2 (d / delete-01 
            :ARG0 (f / figure) 
            :ARG1 (e2 / exon 
                  :ARG0-of (e / encode-01 
                        :ARG1 (g / gene 
                              :mod (c / country 
                                    :name (n / name 
                                          :op1 "Chaf1a")))))))

# ::snt Chaf1a + /  mice were born at a Mendelian frequency , were of normal size and weight , displayed no obvious abnormalities , and were fertile .
# ::tok Chaf1a + /  mice were born at a Mendelian frequency , were of normal size and weight , displayed no obvious abnormalities , and were fertile .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:23.086
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Crossing heterozygous mice failed to generate viable newborn Chaf1a  /  mice .
# ::tok Crossing heterozygous mice failed to generate viable newborn Chaf1a  /  mice .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:23.096
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Furthermore , no homozygous Chaf1a  /  embryos were detected at any of the post-implantation stages .
# ::tok Furthermore , no homozygous Chaf1a  /  embryos were detected at any of the post-implantation stages .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:23.100
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt However , we could detect Chaf1a  /  embryos at embryonic day 4 ( E4 ) using a PCR strategy ( Figure 1B ) .
# ::tok However , we could detect Chaf1a  /  embryos at embryonic day 4 ( E4 ) using a PCR strategy ( Figure 1B ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:23.109
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt They represent only 10 % of E4 embryos obtained from Chaf1a + /  mice intercrosses , suggesting that more than half of the homozygous mutant embryos had degenerated before this stage .
# ::tok They represent only 10 % of E4 embryos obtained from Chaf1a + /  mice intercrosses , suggesting that more than half of the homozygous mutant embryos had degenerated before this stage .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:23.114
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Moreover , mutant embryos contained only eight to 16 cells at the E4 stage , instead of 32 cells observed for wild-type or heterozygous blastocysts ( Figure 1C and 1D ) .
# ::tok Moreover , mutant embryos contained only eight to 16 cells at the E4 stage , instead of 32 cells observed for wild-type or heterozygous blastocysts ( Figure 1C and 1D ) .
# ::alignments 28-29|0.2.1.0.0 26-27|0.2.1.0.0.0 24-25|0.2.1.0.1.1 23-24|0.2.1.0.1.0 22-23|0.2.1.0.1 19-20|0.2.1.0 18-19|0.2.1 17-18|0.0.0.0 15-16|0.2 13-14|0.1.0 9-10|0.1 8-9|0.2.1.0.3 6-7|0.2.1.0.4 5-6|0.2.1.0.2 4-5|0 3-4|0.0 2-3|0.0.0 0-1|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:24.009
(c3 / contain-01 
      :ARG0 (e / embryo 
            :mod (m / mutant 
                  :mod-of 32)) 
      :ARG1 (c2 / cell 
            :location (s / stage)) 
      :ARG1-of (i / instead-of-91 
            :ARG0 (m2 / moreover) 
            :ARG2 (c / cell 
                  :ARG1-of (o2 / observe-01 
                        :ARG0 (a / and 
                              :op1 (f / figure)) 
                        :ARG2 (o / or 
                              :op1 (h / heterozygou) 
                              :op2 (b / blastocyst)) 
                        :op1-of (o3 / only) 
                        :op1-of 16 
                        :op1-of 8))))

# ::snt Further analysis by light microscopy using immunofluorescence ( IF ) allowed us to compare wild-type and p150CAF-1-depleted embryos .
# ::tok Further analysis by light microscopy using immunofluorescence ( IF ) allowed us to compare wild-type and p150CAF-1-depleted embryos .
# ::alignments 17-18|0.0.2 16-17|0.0.1 15-16|0.0 13-14|0.0.0 10-11|0.0.0.1 8-9|0 6-7|0.0.0.0.0.0.0 5-6|0.0.0.0.0.0 4-5|0.0.0.0.0 3-4|0.0.0.0.0.1 1-2|0.0.0.0 0-1|0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:24.563
(c2 / cause-01 
      :ARG1 (a / and 
            :ARG1-of (c / compare-01 
                  :ARG0 (a3 / analyze-01 
                        :ARG1 (m / microscopy 
                              :ARG0-of (u / use-01 
                                    :ARG1 (i / immunofluorescence)) 
                              :ARG1-of (l / light-06)) 
                        :mod (f / further)) 
                  :ARG1-of (a2 / allow-01)) 
            :op1 (p / p150caf-1-deplet) 
            :op2 (e / embryo)))

# ::snt A loss of p150CAF-1 staining could not be detected before the eight-cell stage ( unpublished data ) suggesting that maternally contributed protein is present in the embryo up to the four-cell stage .
# ::tok A loss of p150CAF-1 staining could not be detected before the eight-cell stage ( unpublished data ) suggesting that maternally contributed protein is present in the embryo up to the four-cell stage .
# ::alignments 31-32|0.0.0.1.0.1.0 26-27|0.0.1 23-24|0.0 21-22|0 20-21|0.0.0 19-20|0.0.0.0 17-18|0.0.0.1 15-16|0.0.0.1.0.1.2.1 14-15|0.0.0.1.0.1.2.1.0 12-13|0.0.0.1.0.1.2.0 9-10|0.0.0.1.0.1.2 8-9|0.0.0.1.0.1 6-7|0.0.0.1.0.1.1.0 5-6|0.0.0.1.0.1.1 4-5|0.0.0.1.0.0 1-2|0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:24.846
(p2 / protein 
      :domain-of (p / present 
            :ARG1-of (c / contribute-01 
                  :ARG0 (m / maternally) 
                  :ARG1-of (s2 / suggest-01 
                        :ARG0 (l / loss 
                              :ARG1-of (s4 / stain-01) 
                              :ARG1-of (d2 / detect-01 
                                    :ARG0 (s / stage) 
                                    :ARG1-of (p3 / possible-01 
                                          :polarity -) 
                                    :time (b / before 
                                          :op1 (s3 / stage) 
                                          :op2 (d / data 
                                                :mod (u / unpublish))))))) 
            :location (e / embryo)))

# ::snt Thus , depletion of p150CAF-1 protein from this stage allows a maximum of two additional cell divisions before developmental arrest .
# ::tok Thus , depletion of p150CAF-1 protein from this stage allows a maximum of two additional cell divisions before developmental arrest .
# ::alignments 19-20|0.2.0 18-19|0.2.0.2 17-18|0.2 16-17|0.2.0.1 15-16|0.2.0.1.0 14-15|0.2.0.1.0.0 13-14|0.2.0.1.1 11-12|0.1 9-10|0 8-9|0.2.0.0.0 7-8|0.2.0.0 5-6|0.0.0 2-3|0.0 0-1|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:25.334
(a3 / allow-01 
      :ARG0 (d3 / depletion 
            :mod (p / protein)) 
      :ARG1 (m / maximum) 
      :time (b / before 
            :op1 (a / arrest-01 
                  :ARG0 (t / this 
                        :mod-of (s / stage)) 
                  :ARG1 (d2 / division 
                        :mod (c / cell 
                              :mod (a2 / additional)) 
                        :quant 2) 
                  :mod (d / developmental))) 
      :time (t2 / thu))

# ::snt Strikingly , we found that the nuclear organization of heterochromatin appeared abnormal in the nuclei of Chaf1a  /  embryos .
# ::tok Strikingly , we found that the nuclear organization of heterochromatin appeared abnormal in the nuclei of Chaf1a  /  embryos .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:25.336
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Pericentric heterochromatin , the major component of constitutive heterochromatin , can easily be visualized in interphase nuclei by the fluorochrome DAPI and by immunostaining with HP1 [ 16,17 -- 19 ] .
# ::tok Pericentric heterochromatin , the major component of constitutive heterochromatin , can easily be visualized in interphase nuclei by the fluorochrome DAPI and by immunostaining with HP1 [ 16,17 -- 19 ] .
# ::alignments 29-30|0.0.0.2.0.0 21-22|0.0.0.2 20-21|0.0.0.1.0+0.0.0.1+0.0.0 19-20|0.0.0.0 16-17|0.0.0.2.1 15-16|0.0.0.2.1.0 13-14|0.0 10-11|0 7-8|0.0.2 5-6|0.0.0.2.0.1 4-5|0.0.0.2.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:25.573
(p / possible-01 
      :ARG1 (v / visualize-01 
            :ARG0 (o / organization 
                  :mod (f / fluorochrome) 
                  :name (n / name 
                        :op1 "DAPI") 
                  :op2-of (a / and 
                        :op1 (m / major-02 
                              :ARG0 19 
                              :ARG1 (c2 / component)) 
                        :poss-of (n2 / nucleus 
                              :mod (i / interphase)))) 
            :ARG1 (h / heterochromatin) 
            :ARG2 (c / constitutive)))

# ::snt In wild-type blastocysts and in mouse somatic cells , pericentric heterochromatin domains cluster together and form higher-order chromatin structures called chromocenters [ 20 ] , which are visualized as DAPI-dense foci ( Figure 1C ) .
# ::tok In wild-type blastocysts and in mouse somatic cells , pericentric heterochromatin domains cluster together and form higher-order chromatin structures called chromocenters [ 20 ] , which are visualized as DAPI-dense foci ( Figure 1C ) .
# ::alignments 32-33|0.3.3.2 30-31|0.3.2.0.0 27-28|0.3.2.0 22-23|0.3.2.0.0.1 20-21|0.3.2 19-20|0.3 18-19|0.3.0 17-18|0.3.0.0 16-17|0.0 15-16|0.2 14-15|0 13-14|0.1.0 12-13|0.1 11-12|0.3.1 10-11|0.3.1.0 7-8|0.3.3.1 6-7|0.3.3.1.0 5-6|0.3.2.0.0.0 3-4|0.3.3 2-3|0.3.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:26.312
(a / and 
      :mod (h / higher-ord) 
      :op1 (c4 / cluster 
            :mod (t / together)) 
      :op2 (f3 / form) 
      :op3 (c2 / call-01 
            :ARG0 (s / structure 
                  :mod (c3 / chromatin)) 
            :ARG1 (d / domain 
                  :mod (h2 / heterochromatin)) 
            :ARG2 (c / chromocenter 
                  :ARG0-of (v / visualize-01 
                        :ARG2 (f2 / focus-01 
                              :ARG0 (m / mouse) 
                              :ARG1 20))) 
            :ARG3 (a2 / and 
                  :op1 (b / blastocyst) 
                  :op2 (c5 / cell 
                        :mod (s2 / somatic)) 
                  :op3 (f / figure))))

# ::snt These structures were not detected in Chaf1a  /  embryos ( Figure 1D ) .
# ::tok These structures were not detected in Chaf1a  /  embryos ( Figure 1D ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:26.314
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Since chromatin architecture and higher-order structures are important for genome function [ 21 ] , we decided to characterize this phenotype in more detail .
# ::tok Since chromatin architecture and higher-order structures are important for genome function [ 21 ] , we decided to characterize this phenotype in more detail .
# ::alignments 23-24|0.0.0.0.2 22-23|0.0.0.0.2.2 20-21|0.0.0.0.0 19-20|0.0.0.0.0.0 18-19|0.0.0.0 16-17|0.0.0.0.1 15-16|0.0.0.0.1.0 12-13|0.0.0.0.2.1 10-11|0.0.0.3 9-10|0.0.0.3.0 7-8|0.0.0.1 5-6|0.0 4-5|0 3-4|0.0.0 2-3|0.0.0.2 1-2|0.0.0.2.0 0-1|0.0.0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:27.143
(h / higher-ord 
      :mod-of (s / structure 
            :op2-of (a / and 
                  :ARG0-of (c / characterize-01 
                        :ARG1 (p / phenotype 
                              :mod (t / this)) 
                        :ARG1-of (d2 / decide-01 
                              :ARG0 (w / we)) 
                        :purpose (d / detail-01 
                              :ARG0 (s2 / since) 
                              :ARG1 21 
                              :degree (m / more))) 
                  :domain-of (i / important) 
                  :op1 (a2 / architecture 
                        :mod (c2 / chromatin)) 
                  :op3 (f / function-01 
                        :ARG1 (g / genome)))))

# ::snt For this purpose , we examined the status of heterochromatin organization between the two-cell and blastocyst stages .
# ::tok For this purpose , we examined the status of heterochromatin organization between the two-cell and blastocyst stages .
# ::alignments 16-17|0.0.1 15-16|0 14-15|0.0 10-11|0.0.0.1 9-10|0.0.0.1.0 7-8|0.0.0 5-6|0.0.0.0 4-5|0.0.0.0.0 2-3|0.0.0.0.1 1-2|0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:27.312
(b / blastocyst 
      :op2-of (a / and 
            :op1 (s2 / status 
                  :ARG1-of (e / examine-01 
                        :ARG0 (w / we) 
                        :prep-in (p / purpose 
                              :mod (t / this))) 
                  :poss (o / organization 
                        :mod (h / heterochromatin))) 
            :op3 (s / stage)))

# ::snt In two-cell stage wild-type embryos , DAPI staining is diffuse and fibrillar , with regions of higher density around the nucleolar precursor bodies ( Figure 1E ) .
# ::tok In two-cell stage wild-type embryos , DAPI staining is diffuse and fibrillar , with regions of higher density around the nucleolar precursor bodies ( Figure 1E ) .
# ::alignments 24-25|0.1.0 22-23|0.1.1.1.0.1 21-22|0.1.1.1.0.1.0 20-21|0.1.1.1.0.1.1 18-19|0.1.1.1.0 17-18|0.1.1.1.0.0 16-17|0.1.1.1 14-15|0.2 10-11|0 9-10|0.1 7-8|0.1.1 6-7|0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 4-5|0.1.2 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:27.727
(a2 / and 
      :op1 (s2 / stage) 
      :op2 (d2 / diffuse-01 
            :ARG0 (f / figure) 
            :ARG1 (s / stain-01 
                  :ARG0 (o / organization 
                        :name (n2 / name 
                              :op1 "DAPI")) 
                  :ARG1 (h / high-02 
                        :ARG1 (a / around 
                              :location-of (d / density) 
                              :op1 (b / body 
                                    :mod (p / precursor) 
                                    :mod (n / nucleolar))))) 
            :location (e / embryo)) 
      :op3 (r / region))

# ::snt Heterochromatin domains are progressively assembled into DAPI-dense foci between the four-cell and 32-cell blastocyst stages ( Figure 1F ) .
# ::tok Heterochromatin domains are progressively assembled into DAPI-dense foci between the four-cell and 32-cell blastocyst stages ( Figure 1F ) .
# ::alignments 16-17|0.0.0.0.0 14-15|0.0 13-14|0.0.0 11-12|0 7-8|0.0.0.0 4-5|0.0.0.0.1 3-4|0.0.0.0.1.1 1-2|0.0.0.0.1.0 0-1|0.0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:27.808
(a / and 
      :op1 (s / stage 
            :mod (b / blastocyst 
                  :ARG2-of (f2 / focus-01 
                        :ARG1 (f / figure) 
                        :ARG2-of (a2 / assemble-01 
                              :ARG1 (d / domain 
                                    :mod (h / Heterochromatin)) 
                              :manner (p / progressive))))))

# ::snt Localization of HP1 confirmed that the structures visualized by DAPI staining correspond to constitutive heterochromatin ( Figure 1E ) .
# ::tok Localization of HP1 confirmed that the structures visualized by DAPI staining correspond to constitutive heterochromatin ( Figure 1E ) .
# ::alignments 16-17|0.0.1 14-15|0.1 13-14|0.1.0 11-12|0 10-11|0.0 9-10|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 7-8|0.0.0.0 6-7|0.0.0 3-4|0.0.0.0.1 0-1|0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:28.016
(c2 / correspond-02 
      :ARG1 (s / stain-01 
            :ARG0 (s2 / structure 
                  :ARG1-of (v / visualize-01 
                        :ARG0 (o / organization 
                              :name (n / name 
                                    :op1 "DAPI")) 
                        :ARG1-of (c3 / confirm-01 
                              :ARG0 (l / localization)))) 
            :ARG1 (f / figure)) 
      :ARG2 (h / heterochromatin 
            :mod (c / constitutive)))

# ::snt Thus , the nuclear organization of heterochromatin is dramatically modified during pre-implantation development , between the two-cell and blastocyst stages .
# ::tok Thus , the nuclear organization of heterochromatin is dramatically modified during pre-implantation development , between the two-cell and blastocyst stages .
# ::alignments 19-20|0.1.1 18-19|0.1.1.0.1 17-18|0.1.1.0 12-13|0.1 9-10|0 8-9|0.2 6-7|0.1.0 4-5|0.0 3-4|0.0.0 0-1|0.1.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:28.146
(m / modify-01 
      :ARG1 (o / organization 
            :mod (n / nucleus)) 
      :ARG2 (d / develop-02 
            :ARG0 (h / heterochromatin) 
            :ARG1 (s / stage 
                  :op2-of (a / and 
                        :mod (t / thu) 
                        :op1 (b / blastocyst)))) 
      :manner (d2 / dramatic))

# ::snt In Chaf1a  /  E4 embryos , which are arrested between the eight - and 16-cell stage , DAPI-dense foci were barely detectable ( Figure 1D ) .
# ::tok In Chaf1a  /  E4 embryos , which are arrested between the eight - and 16-cell stage , DAPI-dense foci were barely detectable ( Figure 1D ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:28.148
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Instead , DAPI staining was diffuse within the nucleus , with regions of higher density around the nucleoli and at the periphery of the nuclei ( Figure 1D ) .
# ::tok Instead , DAPI staining was diffuse within the nucleus , with regions of higher density around the nucleoli and at the periphery of the nuclei ( Figure 1D ) .
# ::alignments 26-27|0.0.0.0.2.0 24-25|0.1.0 21-22|0.1 18-19|0 17-18|0.0.2 15-16|0.0 14-15|0.0.1 13-14|0.0.0 11-12|0.0.0.0.1.0 8-9|0.0.0.0.1.1 5-6|0.0.0.0.1 3-4|0.0.0.0 2-3|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 0-1|0.0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:28.528
(a / and 
      :op1 (a2 / around 
            :ARG1-of (h / high-02 
                  :ARG1-of (s / stain-01 
                        :ARG0 (o / organization 
                              :name (n4 / name 
                                    :op1 "DAPI")) 
                        :ARG1-of (d2 / diffuse-01 
                              :ARG0 (r / region) 
                              :ARG2 (n3 / nucleus)) 
                        :ARG1-of (i / instead-of-91 
                              :ARG0 (f / figure)))) 
            :location-of (d / density) 
            :op1 (n2 / nucleolus)) 
      :op2 (p / periphery 
            :poss (n / nucleus)))

# ::snt Localization of HP1 showed a diffuse pattern similar to the DAPI , with some enrichment at the nuclear periphery , and around the nucleoli ( Figure 1D ) .
# ::tok Localization of HP1 showed a diffuse pattern similar to the DAPI , with some enrichment at the nuclear periphery , and around the nucleoli ( Figure 1D ) .
# ::alignments 25-26|0.1.1.0 23-24|0.2.1.0.0 21-22|0.2.1.0 20-21|0.2.1 18-19|0.2.0 17-18|0.2.0.0 14-15|0.2 13-14|0.2.2 10-11|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 7-8|0.1.0 6-7|0.1 5-6|0.1.1 3-4|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:28.737
(s2 / show-01 
      :ARG0 (l / localization) 
      :ARG1 (p2 / pattern 
            :ARG1-of (r / resemble-01 
                  :ARG2 (o / organization 
                        :name (n3 / name 
                              :op1 "DAPI"))) 
            :mod (d / diffuse-01 
                  :ARG1 (f / figure))) 
      :ARG2 (e / enrich-01 
            :ARG0 (p / periphery 
                  :mod (n2 / nucleus)) 
            :ARG1 (a2 / and 
                  :op1 (a / around 
                        :op1 (n / nucleolus))) 
            :mod (s / some)))

# ::snt This abnormal organization of heterochromatin in Chaf1a  /  embryos is reminiscent of the heterochromatin organization found in two - to four-cell stage wild-type embryos ( compare Figure 1D and 1F ) .
# ::tok This abnormal organization of heterochromatin in Chaf1a  /  embryos is reminiscent of the heterochromatin organization found in two - to four-cell stage wild-type embryos ( compare Figure 1D and 1F ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:28.740
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt These data evidence a key role for p150CAF-1 during pre-implantation development , and reveal that this protein is required for the proper 3-D organization of heterochromatin within embryonic cell nuclei .
# ::tok These data evidence a key role for p150CAF-1 during pre-implantation development , and reveal that this protein is required for the proper 3-D organization of heterochromatin within embryonic cell nuclei .
# ::alignments 29-30|0.2.0.0 28-29|0.2.0 27-28|0.2.0.0.0 25-26|0.0 23-24|0.3.0.1.1 22-23|0.3.0.1.1.1 21-22|0.3.0.1.1.0 18-19|0.3.0.1 16-17|0.3.0.1.0 15-16|0.3.0.1.0.0 13-14|0.3.0 12-13|0.3 10-11|0.2 5-6|0.1 4-5|0.1.0 2-3|0 1-2|0.3.0.0 0-1|0.3.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:29.098
(e2 / evidence-01 
      :ARG0 (h / heterochromatin) 
      :ARG1 (r3 / role 
            :ARG1-of (k / key-02)) 
      :ARG3 (d / develop-02 
            :ARG1 (c / cell 
                  :mod-of (n / nucleus 
                        :mod (e / embryonic)))) 
      :op1-of (a / and 
            :op2 (r2 / reveal-01 
                  :ARG0 (d2 / data 
                        :mod (t2 / this)) 
                  :ARG1 (r / require-01 
                        :ARG1 (p2 / protein 
                              :mod (t / this)) 
                        :ARG2 (o / organization 
                              :mod (p / proper) 
                              :mod 3-d)))))

# ::snt Next , we wondered whether a similar requirement for CAF-1 could also be observed in ES cells , which are derived from the blastocyst inner cell mass .
# ::tok Next , we wondered whether a similar requirement for CAF-1 could also be observed in ES cells , which are derived from the blastocyst inner cell mass .
# ::alignments 26-27|0.1.0.0.0.0 25-26|0.1.0.0.0.0.0 24-25|0.1.0.0.0.0.0.0 23-24|0.1.0.0.0.0.1 20-21|0.1.0.0.0 16-17|0.1.0.0 15-16|0.1.0.0.1 13-14|0.1.0 11-12|0.1.0.2 10-11|0.1 7-8|0.1.0.1 6-7|0.1.0.1.1 3-4|0 2-3|0.0 0-1|0.1.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:29.249
(w / wonder-01 
      :ARG0 (w2 / we) 
      :ARG1 (p / possible-01 
            :ARG1 (o / observe-01 
                  :ARG0 (c2 / cell 
                        :ARG1-of (d / derive-01 
                              :ARG2 (m / mass 
                                    :mod (c / cell 
                                          :mod (i / inner)) 
                                    :mod (b / blastocyst))) 
                        :mod (e / e)) 
                  :ARG1 (r / require-01 
                        :ARG1 (n / next) 
                        :ARG1-of (r2 / resemble-01)) 
                  :mod (a / also))))

# ::snt Given the early developmental arrest observed in Chaf1a  /  embryos , such cells could not be derived directly from null embryos , and we thus used an RNAi strategy ( Figure 2A ) .
# ::tok Given the early developmental arrest observed in Chaf1a  /  embryos , such cells could not be derived directly from null embryos , and we thus used an RNAi strategy ( Figure 2A ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:29.251
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt p150CAF-1 knockdown in ES cells was quantified by Western blot analysis and IF .
# ::tok p150CAF-1 knockdown in ES cells was quantified by Western blot analysis and IF .
# ::alignments 12-13|0.0.0 11-12|0.0 10-11|0.1 9-10|0.1.1 8-9|0.1.2.1+0.1.2.0.0+0.1.2.0+0.1.2 6-7|0 4-5|0.1.0.0 3-4|0.1.0 1-2|0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:29.555
(q / quantify-01 
      :ARG0 (a / and 
            :op1 (c / cause-01)) 
      :ARG1 (a2 / analyze-01 
            :ARG1 (e / e 
                  :mod-of (c2 / cell 
                        :location-of (k / knockdown))) 
            :ARG1-of (b / blot-01) 
            :mod (w / world-region 
                  :name (n / name 
                        :op1 "West") 
                  :wiki "Western_world")))

# ::snt ( Figure S1 ) .
# ::tok ( Figure S1 ) .
# ::alignments 2-3|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:29.563
(s / S1 
      :mod (f / figure))

# ::snt p150CAF-1 RNAi-depleted ES cells displayed a phenotype very similar to the cells of Chaf1a  /  E4 mice .
# ::tok p150CAF-1 RNAi-depleted ES cells displayed a phenotype very similar to the cells of Chaf1a  /  E4 mice .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:29.569
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt DAPI-dense foci were lost , and we observed diffuse HP1 and DAPI staining around the nucleoli and at the periphery of the nucleus ( Figure 2B ) .
# ::tok DAPI-dense foci were lost , and we observed diffuse HP1 and DAPI staining around the nucleoli and at the periphery of the nucleus ( Figure 2B ) .
# ::alignments 24-25|0.0.0.0.0.0.0.1.0 22-23|0.1.0 19-20|0.1 16-17|0 15-16|0.0.1 13-14|0.0 12-13|0.0.0 11-12|0.0.0.0.1.0.0+0.0.0.0.1.0+0.0.0.0.1 10-11|0.0.0.0 8-9|0.0.0.0.0 7-8|0.0.0.0.0.0.0 6-7|0.0.0.0.0.0.0.0 5-6|0.0.0.0.0.0 3-4|0.0.0.0.0.0.0.1.1 1-2|0.0.0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:29.701
(a / and 
      :op1 (a2 / around 
            :location-of (s / stain-01 
                  :ARG1 (a3 / and 
                        :ARG1-of (d / diffuse-01 
                              :op2-of (a4 / and 
                                    :op1 (o2 / observe-01 
                                          :ARG0 (w / we) 
                                          :ARG1 (f2 / focus-01 
                                                :ARG1 (f / figure) 
                                                :ARG1-of (l / lose-02))))) 
                        :op1 (o / organization 
                              :name (n3 / name 
                                    :op1 "DAPI")))) 
            :op1 (n2 / nucleolus)) 
      :op2 (p / periphery 
            :poss (n / nucleus)))

# ::snt This result indicates that p150CAF-1 is essential for nuclear organization of heterochromatin in ES cells in a similar way to early pre-implantation embryos .
# ::tok This result indicates that p150CAF-1 is essential for nuclear organization of heterochromatin in ES cells in a similar way to early pre-implantation embryos .
# ::alignments 22-23|0.0.0 20-21|0.0.0.0 18-19|0.0.2.0.0 17-18|0.0.2.0 14-15|0.1.0.0 13-14|0.1.0.0.0 11-12|0.1.0.0.0.0 9-10|0.1.0 8-9|0.0.1 6-7|0.1 2-3|0 1-2|0.0 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:29.870
(i / indicate-01 
      :ARG0 (r2 / result-01 
            :ARG0 (e / embryo 
                  :mod (e2 / early)) 
            :ARG1 (n / nucleus) 
            :mod (t / this 
                  :ARG2-of (r / resemble-01 
                        :ARG1 (w / way)))) 
      :ARG1 (e4 / essential 
            :beneficiary (o / organization 
                  :location (c / cell 
                        :mod (e3 / e 
                              :location-of (h / heterochromatin))))))

# ::snt Surprisingly , we did not observe this severe alteration in heterochromatin organization in primary mouse embryonic fibroblasts ( MEFs ) following p150CAF-1 depletion by RNAi .
# ::tok Surprisingly , we did not observe this severe alteration in heterochromatin organization in primary mouse embryonic fibroblasts ( MEFs ) following p150CAF-1 depletion by RNAi .
# ::alignments 22-23|0.2.1 20-21|0.2 18-19|0.3 16-17|0.2.0 15-16|0.2.0.0 14-15|0.1.1 13-14|0.1.1.0 11-12|0.1.0 10-11|0.1.0.0 8-9|0.1 7-8|0.1.2 6-7|0.1.3 5-6|0 4-5|0.5 2-3|0.0 0-1|0.4 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:30.169
(o2 / observe-01 
      :ARG0 (w / we) 
      :ARG1 (a / alteration 
            :location (o / organization 
                  :mod (h / heterochromatin)) 
            :location (m2 / mouse 
                  :mod (p / primary)) 
            :mod (s / severe) 
            :mod (t / this)) 
      :ARG1-of (f / follow-01 
            :ARG0 (f2 / fibroblast 
                  :mod (e / embryonic)) 
            :ARG2 (d / depletion)) 
      :ARG2 (m / mef) 
      :mod (s2 / surprisingly) 
      :polarity -)

# ::snt p150CAF-1 depletion in MEFs resulted in a strong inhibition of cell proliferation ( unpublished data ) , but did not alter the clustering of heterochromatin domains ( Figures 2C and S2 ) .
# ::tok p150CAF-1 depletion in MEFs resulted in a strong inhibition of cell proliferation ( unpublished data ) , but did not alter the clustering of heterochromatin domains ( Figures 2C and S2 ) .
# ::alignments 30-31|0.1.1.2.1 29-30|0.1.1.2 28-29|0.1.1.2.0 27-28|0.1.1.2.0.0 25-26|0.1.1.1 24-25|0.1.1.1.0 22-23|0.1.1 20-21|0.1 19-20|0.1.2 17-18|0 14-15|0.1.1.0 13-14|0.1.1.0.0 11-12|0.0.1.1 10-11|0.0.1.1.0 8-9|0.0.1 7-8|0.0.1.0 4-5|0.0 3-4|0.0.0 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:31.233
(c2 / contrast-01 
      :ARG1 (r / result-01 
            :ARG0 (m / mef) 
            :ARG2 (i / inhibition 
                  :ARG1-of (s2 / strong-02) 
                  :topic (p / proliferate-01 
                        :mod (c3 / cell)))) 
      :ARG2 (a2 / alter-01 
            :ARG0 (d3 / depletion) 
            :ARG1 (c / cluster-01 
                  :ARG0 (d2 / data 
                        :mod (u / unpublish)) 
                  :ARG1 (d / domain 
                        :mod (h / heterochromatin)) 
                  :op1-of (a / and 
                        :op2 (2 / 2C 
                              :mod (f / figure)) 
                        :op3 (s / S2))) 
            :polarity -))

# ::snt Similarly , p150CAF-1 depletion in 3T3 cells did not affect heterochromatin organization [ 16 ] .
# ::tok Similarly , p150CAF-1 depletion in 3T3 cells did not affect heterochromatin organization [ 16 ] .
# ::alignments 13-14|0.0.0.0 11-12|0.1 9-10|0 8-9|0.3 6-7|0.0.0 3-4|0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:31.274
(a / affect-01 
      :ARG0 (d / depletion 
            :location (c / cell 
                  :mod-of 16)) 
      :ARG1 (o / organization) 
      :manner (s / similarly) 
      :polarity -)

# ::snt These observations reveal a specific function for CAF-1 in the early embryo and ES cells .
# ::tok These observations reveal a specific function for CAF-1 in the early embryo and ES cells .
# ::alignments 14-15|0.2.1 13-14|0.2.1.0 12-13|0.2 11-12|0.2.0 10-11|0.2.0.0 5-6|0.1 4-5|0.1.0 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:31.428
(r / reveal-01 
      :ARG0 (o / observation 
            :mod (t / this)) 
      :ARG1 (f / function-01 
            :ARG1 (s / specific-02)) 
      :location (a / and 
            :op1 (e2 / embryo 
                  :mod (e3 / early)) 
            :op2 (c / cell 
                  :mod (e / e))))

# ::snt We also wondered whether loss of p150CAF-1 in ES cells specifically affects the heterochromatin nuclear subcompartment , or whether it might result in a more global loss of nuclear organization and architecture .
# ::tok We also wondered whether loss of p150CAF-1 in ES cells specifically affects the heterochromatin nuclear subcompartment , or whether it might result in a more global loss of nuclear organization and architecture .
# ::alignments 31-32|0.3.1 30-31|0.3 29-30|0.3.0 28-29|0.3.1.0 25-26|0.1.3.0.0.0 24-25|0.1.3.0.0.0.0 21-22|0.1.3.0.0 20-21|0.1.3.0 17-18|0.1.3 15-16|0.1.1 14-15|0.1.1.0 11-12|0.1 10-11|0.1.2 9-10|0.1.0.0 8-9|0.1.0.0.0 4-5|0.1.0 2-3|0 1-2|0.2 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:31.677
(w / wonder-01 
      :ARG0 (w2 / we) 
      :ARG1 (a3 / affect-01 
            :ARG0 (l / loss 
                  :location (c / cell 
                        :mod (e / e))) 
            :ARG1 (s / subcompartment 
                  :mod (n2 / nucleus)) 
            :manner (s2 / specific-02) 
            :op1-of (o2 / or 
                  :op2 (p / possible-01 
                        :ARG1 (r / result-01 
                              :ARG1 (g / globe 
                                    :degree (m / more)))))) 
      :mod (a4 / also) 
      :op1-of (a2 / and 
            :op2 (o / organization) 
            :op3 (a / architecture 
                  :mod (n / nucleus))))

# ::snt We used a specific antibody against the promyelocytic leukemia ( PML ) protein to study the fate of the PML nuclear bodies , which are well-characterized subnuclear structures [ 22 ] .
# ::tok We used a specific antibody against the promyelocytic leukemia ( PML ) protein to study the fate of the PML nuclear bodies , which are well-characterized subnuclear structures [ 22 ] .
# ::alignments 29-30|0.1.3 27-28|0.0 26-27|0 25-26|0.1.2 21-22|0.1.0.0.1.1.0 20-21|0.1.0.0.1.1.0.0 16-17|0.1.0.0.1.1 14-15|0.1.0.0.1 12-13|0.1.0.0.1.0 10-11|0.1.1.0.0+0.1.1.0+0.1.1 8-9|0.1.0.0.1.0.0.1+0.1.0.0.1.0.0.0.0+0.1.0.0.1.0.0.0+0.1.0.0.1.0.0 4-5|0.1.0 3-4|0.1 1-2|0.1.0.0 0-1|0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:32.030
(s2 / subnuclear 
      :mod-of (s / structure) 
      :op1 (s4 / specific-02 
            :ARG1 (a / antibody 
                  :ARG1-of (u / use-01 
                        :ARG0 (w2 / we) 
                        :ARG2 (s3 / study-01 
                              :ARG0 (p / protein 
                                    :mod (d / disease 
                                          :name (n3 / name 
                                                :op1 "Leukemia") 
                                          :wiki "Leukemia")) 
                              :ARG1 (f / fate 
                                    :mod (b / body 
                                          :mod (n / nucleus)))))) 
            :ARG2 (o / organization 
                  :name (n2 / name 
                        :op1 "PML")) 
            :op1-of (w / well-characteriz) 
            :op1-of 22))

# ::snt We could not detect any significant difference in the distribution and aspect of PML nuclear bodies between control and p150CAF-1-depleted ES cells ( Figure 2D ) .
# ::tok We could not detect any significant difference in the distribution and aspect of PML nuclear bodies between control and p150CAF-1-depleted ES cells ( Figure 2D ) .
# ::alignments 24-25|0.1.1.0 23-24|0.0 21-22|0.1.1.3.0.0.2 20-21|0.1.1.3.0.0.2.0 19-20|0.1.1.3.0.0.2.1 18-19|0.1.1.3.0.0 17-18|0.1.1.3.0.0.1 15-16|0.1.1.3.0.1 14-15|0.1.1.1.0 13-14|0.1.1.3.0.1.0.0.0+0.1.1.3.0.1.0.0+0.1.1.3.0.1.0 11-12|0.1.1.3.0.0.0 10-11|0.1.1.3 9-10|0.1.1.3.0 6-7|0.1.1 5-6|0.1.1.1 4-5|0.1.1.2 3-4|0.1 2-3|0.2 1-2|0 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:32.379
(p2 / possible-01 
      :ARG0 (f / figure) 
      :ARG1 (d3 / detect-01 
            :ARG0 (w / we) 
            :ARG1 (d2 / differ-02 
                  :ARG1 2d 
                  :ARG1-of (s / significant-02 
                        :ARG0 (n / nucleus)) 
                  :mod (a4 / any) 
                  :op1-of (a3 / and 
                        :op2 (d / distribute-01 
                              :ARG0 (a / and 
                                    :example-of (a2 / aspect) 
                                    :op1 (c2 / control-01) 
                                    :op2 (c / cell 
                                          :mod (e / e) 
                                          :mod (p / p150caf-1-deplet))) 
                              :ARG1 (b / body 
                                    :mod (o / organization 
                                          :name (n2 / name 
                                                :op1 "PML"))))))) 
      :polarity -)

# ::snt These data show that nuclear architecture is not globally altered following CAF-1 loss-of-function .
# ::tok These data show that nuclear architecture is not globally altered following CAF-1 loss-of-function .
# ::alignments 10-11|0.1.1 9-10|0.1 8-9|0.1.1.1 7-8|0.1.1.0 5-6|0.1.0 4-5|0.1.0.0 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:32.588
(s / show-01 
      :ARG0 (d / data 
            :mod (t / this)) 
      :ARG1 (a / alter-01 
            :ARG1 (a2 / architecture 
                  :mod (n / nucleus)) 
            :time (f / follow-01 
                  :ARG1 - 
                  :time (g / globe))))

# ::snt In addition , Western blot analysis revealed that CAF-1 depletion did not result in altered levels of chromatin architectural proteins such as histone H3 and HP1 ( Figure S1 ) .
# ::tok In addition , Western blot analysis revealed that CAF-1 depletion did not result in altered levels of chromatin architectural proteins such as histone H3 and HP1 ( Figure S1 ) .
# ::alignments 27-29|0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 24-25|0.1.0 23-24|0.1.0.0 22-23|0.1.0.0.0 20-21|0.0.1.0 19-20|0.1.2.1 18-19|0.1.2.1.0 17-18|0.1.2.1.1 15-16|0.1.2 14-15|0.1.2.0 12-13|0.1 11-12|0.1.3 9-10|0.1.1 6-7|0 5-6|0.0 4-5|0.0.1 3-4|0.0.2.1+0.0.2.0.0+0.0.2.0+0.0.2 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:33.189
(r2 / reveal-01 
      :ARG0 (a4 / analyze-01 
            :ARG0 (t / thing 
                  :name (n / name 
                        :op1 (f / Figure) 
                        :op2 (s / S1))) 
            :ARG1 (b / blot-01 
                  :ARG1 (s2 / such)) 
            :manner (w / world-region 
                  :name (n2 / name 
                        :op1 "West") 
                  :wiki "Western_world")) 
      :ARG1 (r / result-01 
            :ARG0 (a / and 
                  :op1 (h / H3 
                        :mod (h2 / histone))) 
            :ARG1 (d / depletion) 
            :ARG2 (l / level 
                  :ARG1-of (a3 / alter-01) 
                  :poss (p / protein 
                        :mod (a2 / architectural) 
                        :mod (c / chromatin))) 
            :polarity -) 
      :location (a5 / addition))

# ::snt Thus , CAF-1 is specifically required in early embryos and in ES cells for the proper organization of the heterochromatin subnuclear compartment .
# ::tok Thus , CAF-1 is specifically required in early embryos and in ES cells for the proper organization of the heterochromatin subnuclear compartment .
# ::alignments 21-22|0.1.1.0.1.1 20-21|0.1.1.0.1 19-20|0.1.1.0.1.0 16-17|0.1.1.0 15-16|0.1.1.0.0 12-13|0.1.1 11-12|0.1.1.1 9-10|0.1 8-9|0.0 7-8|0.3 5-6|0 4-5|0.2 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:33.298
(r / require-01 
      :ARG1 (e2 / embryo) 
      :ARG2 (a / and 
            :op1 (t / thu) 
            :op2 (c2 / cell 
                  :beneficiary (o / organization 
                        :mod (p / proper) 
                        :poss (s / subnuclear 
                              :mod (h / heterochromatin) 
                              :mod-of (c / compartment))) 
                  :mod (e / e))) 
      :manner (s2 / specific-02) 
      :time (e3 / early))

# ::snt Previous studies performed in mammalian cell lines showed that CAF-1 activity is required for S phase progression [ 16,23,24 ] .
# ::tok Previous studies performed in mammalian cell lines showed that CAF-1 activity is required for S phase progression [ 16,23,24 ] .
# ::alignments 16-17|0.0.2 15-16|0.0.2.0 14-15|0.0.1.1.0+0.0.1.1 12-13|0.1 10-11|0.1.0 7-8|0 6-7|0.0.1.0 5-6|0.0.1.0.0 4-5|0.1.0.0 2-3|0.0.1 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:33.471
(s / show-01 
      :ARG0 (s2 / study-01 
            :ARG1 (p4 / previou) 
            :ARG1-of (p3 / perform-02 
                  :ARG0 (l / line 
                        :mod (c / cell)) 
                  :ARG2 (n / name 
                        :op1 "S-400")) 
            :ARG1-of (p / progress-01 
                  :mod (p2 / phase))) 
      :ARG1 (r / require-01 
            :ARG1 (a / activity-06 
                  :ARG1 (m / mammalian))))

# ::snt We show here that 3 d after transfection of the RNAi vector , p150CAF-1-depleted cells ( identified by a complete absence of CAF-1 IF signal ) appear still active for replication , as revealed by incorporation of the thymidine analog bromodeoxyuridine ( BrdU ) ( Figure 3A ) , the PCNA ( proliferating cell nuclear antigen ) pattern ( Figure 3B ) , and flow cytometry analysis ( Figure 3C ) .
# ::tok We show here that 3 d after transfection of the RNAi vector , p150CAF-1-depleted cells ( identified by a complete absence of CAF-1 IF signal ) appear still active for replication , as revealed by incorporation of the thymidine analog bromodeoxyuridine ( BrdU ) ( Figure 3A ) , the PCNA ( proliferating cell nuclear antigen ) pattern ( Figure 3B ) , and flow cytometry analysis ( Figure 3C ) .
# ::alignments 68-69|0.0.0.1 66-67|0.0.4 65-66|0.0.4.0 64-65|0.0.4.1 63-64|0.0 59-60|0.0.3 57-58|0.0.2 55-56|0.0.1.0.0.1.1.4.0 54-55|0.0.1.0.0.1.1.4 53-54|0.0.0.0 52-53|0.0.0 50-51|0.0.1.0.0.1.1.0.0.0+0.0.1.0.0.1.1.0.0+0.0.1.0.0.1.1.0 45-46|0.1.0.0 40-41|0.0.1 39-40|0.0.1.0 38-39|0.1.0.2.0 35-36|0.0.1.0.0.0 33-34|0.0.1.0.0 30-31|0.0.1.0.0.1.1.2 28-29|0.0.1.0.0.1.1 27-28|0.0.1.0.0.1.1.3 26-27|0.0.1.0.0.1 24-25|0.1 23-24|0 20-21|0.1.0 19-20|0.1.0.1 16-17|0.1.0.2 14-15|0.0.1.0.0.1.0 13-14|0.0.1.0.0.1.0.0 11-12|0.0.1.0.0.1.1.1.0.0 7-8|0.0.1.0.0.1.1.1 6-7|0.0.1.0.0.1.1.1.0 5-6|0.1.0.1.0 4-5|0.0.1.0.0.1.2.1 2-3|0.0.1.0.0.1.2.2 1-2|0.0.1.0.0.1.2 0-1|0.0.1.0.0.1.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:35.894
(c3 / cause-01 
      :ARG0 (a2 / and 
            :ARG0-of (p2 / proliferate-01 
                  :ARG1 (c2 / cell) 
                  :ARG2 (f / figure)) 
            :op1 (b / bromodeoxyuridine 
                  :mod (a4 / analog 
                        :ARG1-of (r / reveal-01 
                              :ARG0 (i / incorporation) 
                              :purpose-of (a6 / appear-02 
                                    :ARG0 (c5 / cell 
                                          :mod (p3 / p150caf-1-deplet)) 
                                    :ARG1 (a5 / activity-06 
                                          :ARG0 (o / organization 
                                                :name (n2 / name 
                                                      :op1 "PCNA")) 
                                          :ARG1 (t2 / transfection 
                                                :op1-of (a8 / after 
                                                      :op2 (v / vector))) 
                                          :ARG2 (r2 / replication) 
                                          :mod (s / still) 
                                          :mod (n / nucleus 
                                                :mod-of (a3 / antigen))) 
                                    :ARG1-of (s3 / show-01 
                                          :ARG0 (w / we) 
                                          :ARG2 3 
                                          :location (h / here)))))) 
            :op2 (p / pattern) 
            :op3 (f3 / figure) 
            :op4 (a / analyze-01 
                  :ARG1 (c / cytometry) 
                  :ARG1-of (f2 / flow-01))) 
      :ARG1 (s2 / signal 
            :ARG1-of (a7 / absent-01 
                  :ARG0 (f4 / figure) 
                  :ARG1-of (c4 / complete-02 
                        :ARG0 (d / d)) 
                  :manner-of (i2 / identify-01 
                        :ARG1 (t / thymidine)))))

# ::snt Hence , in these cells , DNA replication persists despite the drastic changes in heterochromatin organization .
# ::tok Hence , in these cells , DNA replication persists despite the drastic changes in heterochromatin organization .
# ::alignments 15-16|0.1.0 12-13|0.1 11-12|0.1.1 8-9|0 7-8|0.0 6-7|0.0.0 4-5|0.3 3-4|0.3.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:35.944
(p / persist-01 
      :ARG0 (r / replication 
            :mod (d2 / DNA)) 
      :ARG1 (c / change-01 
            :ARG1 (o / organization) 
            :mod (d / drastic)) 
      :mod (h / hence) 
      :time (c2 / cell 
            :mod (t / this)))

# ::snt However , 24 h later , ES cells cease to proliferate and die , revealing that p150CAF-1 is required for an essential cellular process , as in embryos .
# ::tok However , 24 h later , ES cells cease to proliferate and die , revealing that p150CAF-1 is required for an essential cellular process , as in embryos .
# ::alignments 27-28|0 23-24|0.0 22-23|0.0.0 21-22|0.0.2 18-19|0.0.1 14-15|0.0.1.1 12-13|0.0.1.1.0.0.1.0 11-12|0.0.1.1.0.0.1 10-11|0.0.1.1.0.0 8-9|0.0.1.1.0.0.0 7-8|0.0.1.1.0 6-7|0.0.1.1.0.1 4-5|0.0.1.1.0.0.0.0 3-4|0.0.1.0.0 2-3|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:36.243
(e / embryo 
      :mod-of (p / process-02 
            :ARG1 (c / cell) 
            :ARG2-of (r / require-01 
                  :ARG1 (2 / 24 
                        :quant-of (h / h)) 
                  :ARG1-of (r2 / reveal-01 
                        :ARG0 (c3 / cell 
                              :ARG0-of (p2 / proliferate-01 
                                    :ARG1-of (c2 / cease-01 
                                          :time (l / late)) 
                                    :op1-of (a / and 
                                          :op2 (d / die-01))) 
                              :mod (e3 / e)))) 
            :mod (e2 / essential)))

# ::snt Altogether , our data demonstrate that loss of p150CAF-1 function in ES cells and early embryos alters first the organization of heterochromatin in the nucleus and , in a subsequent step , cell cycle and viability .
# ::tok Altogether , our data demonstrate that loss of p150CAF-1 function in ES cells and early embryos alters first the organization of heterochromatin in the nucleus and , in a subsequent step , cell cycle and viability .
# ::alignments 35-36|0.4 34-35|0 33-34|0.3 32-33|0.3.1 30-31|0.1 29-30|0.1.0 25-26|0.2 24-25|0.0 21-22|0.0.0.1 19-20|0.2.0 16-17|0.2.0.0 15-16|0.2.0.0.0.2 14-15|0.2.0.0.0.1 13-14|0.2.0.0.0 12-13|0.0.0.0 11-12|0.0.0.0.0 9-10|0.0.0 6-7|0.2.0.0.0.0 4-5|0.2.0.0.1 3-4|0.2.0.0.1.0 2-3|0.2.0.0.1.0.0 0-1|0.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:37.312
(a / and 
      :op1 (n / nucleus 
            :op1 (f / function-01 
                  :ARG1 (c3 / cell 
                        :mod (e3 / e)) 
                  :op1-of (h / heterochromatin))) 
      :op2 (s / step 
            :mod (s2 / subsequent)) 
      :op2-of (a2 / and 
            :op1 (o / organization 
                  :ARG1-of (a3 / alter-01 
                        :ARG0 (a4 / and 
                              :op1 (l / loss) 
                              :op2 (e2 / early) 
                              :op3 (e / embryo)) 
                        :ARG1-of (d / demonstrate-01 
                              :ARG0 (d2 / data 
                                    :poss (w / we)))))) 
      :op3 (c / cycle-02 
            :ARG0 (a5 / altogeth) 
            :ARG1 (c2 / cell)) 
      :op4 (v / viability))

# ::snt In order to better characterize the defects in heterochromatin organization , we performed two-color DNA fluorescence in situ hybridization ( FISH ) experiments to reveal the spatial distribution of pericentric and centric chromosomal regions , which in mouse are mainly composed of large blocks of major and minor satellite repeats , respectively [ 20 ] .
# ::tok In order to better characterize the defects in heterochromatin organization , we performed two-color DNA fluorescence in situ hybridization ( FISH ) experiments to reveal the spatial distribution of pericentric and centric chromosomal regions , which in mouse are mainly composed of large blocks of major and minor satellite repeats , respectively [ 20 ] .
# ::alignments 53-54|0.2.0.0.0.2.1.0 51-52|0.2.0.0.0.2.0 49-50|0.0.0 48-49|0.0.0.0 47-48|0.1 46-47|0 45-46|0.0 43-44|0.2 42-43|0.2.1 40-41|0.2.0 39-40|0.2.0.2 37-38|0.2.0.1 33-34|0.2.0.0 32-33|0.2.0.0.0.2.1.1 31-32|0.2.0.0.0.2.1 30-31|0.2.0.0.0.2 27-28|0.2.0.0.0 26-27|0.2.0.0.0.1 24-25|0.2.0.0.0.0 22-23|0.2.0.0.0.0.1 20-21|0.2.0.0.0.2.1.2 18-19|0.2.0.0.0.0.0.1.0.0.0 15-16|0.2.0.0.0.0.0.1.0 14-15|0.2.0.0.0.0.0.1.0.0 12-13|0.2.0.0.0.0.0.1 11-12|0.2.0.0.0.0.0 9-10|0.2.0.0.0.0.0.0.0.0 8-9|0.2.0.0.0.0.0.0.0.0.0 6-7|0.2.0.0.0.0.0.0.0 4-5|0.2.0.0.0.0.0.0 3-4|0.2.0.0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:40.270
(a / and 
      :op1 (m2 / major-02 
            :ARG1 (r2 / repeat-01 
                  :ARG1 (s / satellite))) 
      :op2 (m / minor) 
      :quant (b / block 
            :ARG2-of (c / compose-01 
                  :ARG1 (r3 / region 
                        :ARG1-of (d / distribute-01 
                              :ARG1-of (r4 / reveal-01 
                                    :ARG0 (w / we 
                                          :ARG0-of (c4 / characterize-01 
                                                :ARG1 (d3 / defect-01 
                                                      :ARG1 (o / organization 
                                                            :mod (h2 / heterochromatin))) 
                                                :manner (g / good)) 
                                          :ARG0-of (p / perform-02 
                                                :ARG1 (f2 / fluorescence 
                                                      :mod (d2 / DNA 
                                                            :mod (h / hybridization))))) 
                                    :ARG1-of (e / experiment-01)) 
                              :ARG2 (s2 / spatial) 
                              :op1-of (a2 / and 
                                    :mod (r / respective) 
                                    :op2 (c3 / center-01 
                                          :ARG0 20 
                                          :ARG1 (c2 / chromosomal) 
                                          :ARG1-of (f / fish-01))))) 
                  :location (m4 / mouse) 
                  :mod (m3 / main)) 
            :mod (l / large)))

# ::snt Pericentric domains from different chromosomes form clusters , which are revealed by FISH as large spots that coincide with DAPI-dense foci in the interphase nucleus ( Figure 4A ) .
# ::tok Pericentric domains from different chromosomes form clusters , which are revealed by FISH as large spots that coincide with DAPI-dense foci in the interphase nucleus ( Figure 4A ) .
# ::alignments 26-27|0.0.0.0.0 24-25|0.1.1 20-21|0.1 17-18|0 15-16|0.0 14-15|0.0.1 12-13|0.0.0.0 10-11|0.0.0 6-7|0.0.0.1 5-6|0.1.0 4-5|0.0.0.1.1 3-4|0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:40.399
(c / coincide-01 
      :ARG0 (s / spot 
            :ARG2-of (r / reveal-01 
                  :ARG0 (f3 / fish-01 
                        :ARG1 (f / figure)) 
                  :ARG1 (c2 / cluster 
                        :ARG1-of (d / differ-02) 
                        :mod (c3 / chromosom))) 
            :mod (l / large)) 
      :ARG2 (f2 / focus-01 
            :ARG1 (f4 / form) 
            :location (n / nucleus)))

# ::snt At the periphery of each pericentric domain , centric regions form individual entities ( Figure 4A ) .
# ::tok At the periphery of each pericentric domain , centric regions form individual entities ( Figure 4A ) .
# ::alignments 14-15|0.0 12-13|0.1.0.1 11-12|0.1.0.1.0 10-11|0.1.0 9-10|0.1 8-9|0 6-7|0.1.0.0.0 4-5|0.1.0.0.0.0 2-3|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:40.482
(c / center-01 
      :ARG0 (f / figure) 
      :ARG1 (r / region 
            :mod-of (f2 / form 
                  :location (p / periphery 
                        :part-of (d / domain 
                              :mod (e2 / each))) 
                  :mod (e / entity 
                        :mod (i / individual)))))

# ::snt In p150CAF-1 RNAi-depleted cells , we observed a disruption of pericentric heterochromatin clusters that coincides with the disappearance of DAPI-dense foci ( Figure 4B ) .
# ::tok In p150CAF-1 RNAi-depleted cells , we observed a disruption of pericentric heterochromatin clusters that coincides with the disappearance of DAPI-dense foci ( Figure 4B ) .
# ::alignments 22-23|0.1.0.0.0 20-21|0.1.0.0.1 17-18|0.1.0.0 14-15|0.1.0 12-13|0.1.1 8-9|0.1 6-7|0 5-6|0.0 3-4|0.2 2-3|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:40.553
(o / observe-01 
      :ARG0 (w / we) 
      :ARG1 (d2 / disruption 
            :ARG0-of (c / coincide-01 
                  :ARG1 (d / disappear-01 
                        :ARG0 (f / figure) 
                        :ARG1 (f2 / focus-01))) 
            :poss (c2 / cluster)) 
      :prep-in (c3 / cell 
            :mod (r / rnai-deplet)))

# ::snt Individual pericentric domains from single chromosomes are now found either isolated or aggregated in a pattern less dense than the regular clusters observed in control cells ( Figure 4B ) .
# ::tok Individual pericentric domains from single chromosomes are now found either isolated or aggregated in a pattern less dense than the regular clusters observed in control cells ( Figure 4B ) .
# ::alignments 27-28|0.1.0.0.0.0.2.0 25-26|0.3 24-25|0.3.0 22-23|0 21-22|0.0 20-21|0.0.0 17-18|0.2 16-17|0.2.0 15-16|0.1.0.0.0.0.0.0 12-13|0.1.0.0.0.0.2 11-12|0.1.0.0.0.0 10-11|0.1.0.0.0 9-10|0.1.0.0.0.0.1 8-9|0.1.0.0.0.0.0 7-8|0.1.0.0.0.0.0.1 5-6|0.1.0 4-5|0.1 2-3|0.1.0.0 0-1|0.1.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:40.956
(o / observe-01 
      :ARG0 (c3 / cluster 
            :ARG1-of (r / regular-02)) 
      :ARG1 (s / single-02 
            :ARG1 (c4 / chromosom 
                  :source-of (d2 / domain 
                        :ARG1-of (i / isolate-01 
                              :op1-of (o2 / or 
                                    :ARG1-of (f2 / find-01 
                                          :location (p / pattern) 
                                          :time (n / now)) 
                                    :mod (e / either) 
                                    :op2 (a / aggregate-01 
                                          :ARG1 (f / figure)))) 
                        :mod (i2 / individual)))) 
      :domain-of (d / dense 
            :degree (l / less)) 
      :source (c / cell 
            :topic (c2 / control-01)))

# ::snt Such aggregates , which are often found at the nuclear periphery , are also revealed by DAPI staining as a typical signature of p150CAF-1 loss-of-function .
# ::tok Such aggregates , which are often found at the nuclear periphery , are also revealed by DAPI staining as a typical signature of p150CAF-1 loss-of-function .
# ::alignments 21-22|0.3 20-21|0.3.1 17-18|0.0 16-17|0.0.0.0.0+0.0.0.0+0.0.0 14-15|0 13-14|0.2 10-11|0.3.0.0.1 9-10|0.1 6-7|0.3.0.0 5-6|0.3.0.0.0 1-2|0.3.0 0-1|0.3.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:41.171
(r / reveal-01 
      :ARG0 (s2 / stain-01 
            :ARG0 (o / organization 
                  :name (n / name 
                        :op1 "DAPI"))) 
      :ARG1 (n2 / nucleus) 
      :mod (a / also) 
      :purpose (s / sign-01 
            :ARG1 (a2 / aggregate-01 
                  :ARG1-of (f / find-01 
                        :frequency (o2 / often) 
                        :location (p / periphery)) 
                  :mod (s3 / such)) 
            :ARG1-of (t / typical-02)))

# ::snt Quantification of fluorescence along a line randomly drawn across the nucleus revealed lower fluorescence intensity and a broader distribution of DAPI and major satellite hybridization signals in p150CAF-1-depleted cells ( Figure 4C and 4D ) , indicating decondensation of pericentric heterochromatin domains .
# ::tok Quantification of fluorescence along a line randomly drawn across the nucleus revealed lower fluorescence intensity and a broader distribution of DAPI and major satellite hybridization signals in p150CAF-1-depleted cells ( Figure 4C and 4D ) , indicating decondensation of pericentric heterochromatin domains .
# ::alignments 41-42|0.0.0.1 40-41|0.0.0.1.0 37-38|0.0.0.0 36-37|0.0.0 32-33|0.1.1 30-31|0.1.2 28-29|0.1.0.1.0.1 27-28|0.1.0.1.0.1.0 25-26|0.1.0.1.1 24-25|0.1.0.1.1.1 23-24|0.1.0.1.1.1.0 22-23|0.1.0.1.1.0 21-22|0.1.0.1 20-21|0.1.0.0.0+0.1.0.0+0.1.0 18-19|0.1.0.1.0 17-18|0.1.0.1.0.0 15-16|0.1 14-15|0.2 13-14|0.2.1 12-13|0.2.0 11-12|0 10-11|0.0.1.0.0.0.0.0 8-9|0.0.1.0.0.0.0 7-8|0.0.1.0.0.0 6-7|0.0.1.0.0.0.1 5-6|0.0.1.0.0 3-4|0.0.1.0 2-3|0.0.1 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:43.436
(r / reveal-01 
      :ARG0 (q / quantification 
            :ARG0-of (i / indicate-01 
                  :ARG1 (d2 / decondensation) 
                  :ARG3 (d / domain 
                        :mod (h / heterochromatin))) 
            :mod (f3 / fluorescence 
                  :location (a5 / along 
                        :op1 (l2 / line 
                              :ARG1-of (d4 / draw-02 
                                    :location (a4 / across 
                                          :op1 (n2 / nucleus)) 
                                    :manner (r2 / random)))))) 
      :ARG1 (a3 / and 
            :op1 (o / organization 
                  :name (n / name 
                        :op1 "DAPI") 
                  :op1-of (a2 / and 
                        :ARG1-of (d3 / distribute-01 
                              :ARG1-of (b / broad-02) 
                              :ARG2 (c / cell 
                                    :mod (p / p150caf-1-deplet))) 
                        :op2 (s / signal 
                              :ARG1-of (m / major-02) 
                              :mod (h2 / hybridization 
                                    :mod (s2 / satellite))))) 
            :op1-of (a / and) 
            :op2 (f / figure)) 
      :ARG2 (i2 / intensity 
            :ARG1-of (l / low-04) 
            :mod (f2 / fluorescence)))

# ::snt In contrast , centric domains showed an intensity and shape similar to control cells , suggesting that they remain unaffected by p150CAF-1 depletion ( Figure 4C and 4D ) .
# ::tok In contrast , centric domains showed an intensity and shape similar to control cells , suggesting that they remain unaffected by p150CAF-1 depletion ( Figure 4C and 4D ) .
# ::alignments 26-27|0.1.1.0.2.0 24-25|0.1.1.0.0.0.0 22-23|0.0 19-20|0.2+0 18-19|0.1 17-18|0.1.0 15-16|0.1.1 13-14|0.1.1.0.3.0.0.0.0 12-13|0.1.1.0.3.0.0.0 10-11|0.1.1.0.3.0.0 9-10|0.1.1.0.3.0 8-9|0.1.1.0.3 7-8|0.1.1.0.1 5-6|0.1.1.0 4-5|0.1.1.0.0 3-4|0.1.1.0.0.0 1-2|0.1.1.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:44.358
(a2 / affect-01 
      :ARG0 (d / depletion) 
      :ARG3-of (r / remain-01 
            :ARG1 (t / they) 
            :ARG1-of (s / suggest-01 
                  :purpose-of (s3 / show-01 
                        :ARG0 (d2 / domain 
                              :ARG1-of (c3 / center-01 
                                    :ARG0 (f / figure))) 
                        :ARG1 (i / intensity) 
                        :ARG1-of (c4 / contrast-01 
                              :ARG2 (a / and)) 
                        :op1-of (a3 / and 
                              :op2 (s2 / shape-01 
                                    :ARG1-of (r2 / resemble-01 
                                          :ARG2 (c2 / control-01 
                                                :ARG1 (c / cell)))))))) 
      :polarity -)

# ::snt In conclusion , these results show that p150CAF-1 is required for the proper condensation and clustering of pericentric heterochromatin domains .
# ::tok In conclusion , these results show that p150CAF-1 is required for the proper condensation and clustering of pericentric heterochromatin domains .
# ::alignments 19-20|0.1.0.1.0 15-16|0.1.0.1 14-15|0.1.0 13-14|0.1.0.0 12-13|0.1.0.0.0 9-10|0.1 5-6|0 4-5|0.0.0+0.0 3-4|0.0.1 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:44.500
(s / show-01 
      :ARG0 (t / thing 
            :ARG2-of (r2 / result-01) 
            :mod (t2 / this)) 
      :ARG1 (r / require-01 
            :ARG2 (a / and 
                  :op1 (c2 / condensation 
                        :mod (p / proper)) 
                  :op2 (c / cluster-01 
                        :ARG2 (d / domain)))) 
      :ARG1-of (c3 / conclude-01))

# ::snt Given the known role of CAF-1 in the deposition of histone H3 .1 and H4 associated with DNA synthesis [ 11,12 ] , we wondered whether this defect in higher-order chromatin organization could reflect an aberrant nucleosomal organization .
# ::tok Given the known role of CAF-1 in the deposition of histone H3 .1 and H4 associated with DNA synthesis [ 11,12 ] , we wondered whether this defect in higher-order chromatin organization could reflect an aberrant nucleosomal organization .
# ::alignments 37-38|0.1.0.1 36-37|0.1.0.1.0 35-36|0.1.0.1.1 33-34|0.1.0 32-33|0.1 31-32|0.1.0.0.0 30-31|0.1.0.0.0.0 29-30|0.1.1.0.1.0 27-28|0.1.0.0 26-27|0.1.0.0.1 24-25|0 23-24|0.0 18-19|0.1.1.0.1.2 17-18|0.1.1.0.0 15-16|0.1.1.0.1 13-14|0.1.1.0 10-12|0.1.1.0.1.1.0.1+0.1.1.0.1.1.0.0+0.1.1.0.1.1.0+0.1.1.0.1.1 8-9|0.1.1.0.1.1.1 5-6|0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 3-4|0.0.0 2-3|0.0.0.0 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:45.169
(w / wonder-01 
      :ARG0 (w2 / we 
            :poss-of (r2 / role 
                  :ARG1-of (k / know-02) 
                  :poss (p2 / person 
                        :name (n3 / name 
                              :op1 "CAF-1")))) 
      :ARG1 (p / possible-01 
            :ARG1 (r / reflect-01 
                  :ARG1 (d / defect-01 
                        :ARG1 (o2 / organization 
                              :mod (c / chromatin)) 
                        :mod (t / this)) 
                  :ARG2 (o / organization 
                        :mod (n / nucleosomal) 
                        :mod (a / aberrant))) 
            :ARG1-of (g / give-01 
                  :op1-of (a3 / and 
                        :location (d2 / DNA) 
                        :op2 (a2 / associate-01 
                              :ARG0 (h / higher-ord) 
                              :ARG1 (t2 / thing 
                                    :name (n2 / name 
                                          :op1 (h2 / histone) 
                                          :op2 (h3 / H3)) 
                                    :poss-of (d3 / deposition)) 
                              :ARG2 (s / synthesi))))))

# ::snt Using DNase I and micrococcal nuclease ( MNase ) assays , we could not observe any significant difference between control and p150CAF-1-depleted ES cells at the level of bulk genome chromatin or at pericentric repeats ( Figure 5 ) .
# ::tok Using DNase I and micrococcal nuclease ( MNase ) assays , we could not observe any significant difference between control and p150CAF-1-depleted ES cells at the level of bulk genome chromatin or at pericentric repeats ( Figure 5 ) .
# ::alignments 37-38|0.1.1.1.0 36-37|0.0 34-35|0.1.1.0.0.1.0 31-32|0.1.1.0.0.1 30-31|0.1.1.0.0.0 29-30|0.1.1.0.0.0.1 28-29|0.1.1.0.0.0.0 26-27|0.1.1.0.0 23-24|0.1.1.2 22-23|0.1.1.2.0 21-22|0.1.1.2.1 20-21|0.1.1.0.1 19-20|0.1.1.0 17-18|0.1.1 16-17|0.1.1.1 15-16|0.1.1.3 14-15|0.1 13-14|0.2 12-13|0 11-12|0.1.0 9-10|0.1.0.0.0.1 5-6|0.1.0.0.0.1.0 3-4|0.1.0.0.0 2-3|0.1.0.0.0.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:47.444
(p2 / possible-01 
      :ARG0 (f / figure) 
      :ARG1 (o2 / observe-01 
            :ARG0 (w / we 
                  :ARG0-of (u / use-01 
                        :ARG1 (a4 / and 
                              :op1 (i / i) 
                              :op2 (a3 / assay 
                                    :mod (n / nuclease))))) 
            :ARG1 (d / differ-02 
                  :ARG1 (c3 / control-01 
                        :ARG1 (l / level 
                              :mod (c / chromatin 
                                    :ARG1-of (b / bulk-01) 
                                    :mod (g / genome)) 
                              :op1-of (o / or 
                                    :op2 (r / repeat-01))) 
                        :op1-of (a / and)) 
                  :ARG1-of (s / significant-02 
                        :ARG0 5) 
                  :ARG2 (c2 / cell 
                        :mod (e / e) 
                        :mod (p / p150caf-1-deplet)) 
                  :mod (a2 / any))) 
      :polarity -)

# ::snt In a second series of experiments , we compared the association of histone H3 with chromatin in nuclei isolated from cells transfected with control and p150CAF-1 RNAi plasmid vectors .
# ::tok In a second series of experiments , we compared the association of histone H3 with chromatin in nuclei isolated from cells transfected with control and p150CAF-1 RNAi plasmid vectors .
# ::alignments 28-29|0.1 27-28|0.1.0 24-25|0 23-24|0.0 20-21|0.0.0.0.0.1.1.0.1 18-19|0.0.0.0.0.1.1.0 17-18|0.0.0.0.0.1.1.0.0 15-16|0.0.0.0.0.1.1 13-14|0.0.0.0.0.0 12-13|0.0.0.0.0.0.0 10-11|0.0.0.0.0 8-9|0.0.0.0.0.1 7-8|0.0.0.0.0.1.0 5-6|0.0.0.0 3-4|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:47.624
(a / and 
      :op1 (c / control-01 
            :ARG0 (s / series 
                  :quant-of (e / experiment-01 
                        :purpose-of (a2 / associate-01 
                              :ARG1 (h / H3 
                                    :mod (h2 / histone)) 
                              :ARG1-of (c4 / compare-01 
                                    :ARG0 (w / we) 
                                    :ARG2 (c3 / chromatin 
                                          :ARG1-of (i / isolate-01 
                                                :ARG0 (n / nucleus) 
                                                :source (c2 / cell)))))))) 
      :op2 (v / vector 
            :mod (p / plasmid)))

# ::snt Nuclei were incubated in buffers with different salt concentrations ranging from 100 mM NaCl to 1 M NaCl .
# ::tok Nuclei were incubated in buffers with different salt concentrations ranging from 100 mM NaCl to 1 M NaCl .
# ::alignments 16-18|0.0.1+0+0.0+0.0.0 15-16|0.0.0.1 12-13|0.0.0.0.0.0.0 11-12|0.0.0.0.0.1.1.0 9-10|0.0.0.0 8-9|0.0.0.0.0 7-8|0.0.0.0.0.2 6-7|0.0.0.0.0.0 4-5|0.0.0.0.0.1.1 2-3|0.0.0.0.0.1 0-1|0.0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:47.827
(m / M 
      :op1-of (n / name 
            :name-of (t / thing 
                  :ARG3-of (r / range-01 
                        :ARG1 (c / concentration 
                              :ARG1-of (d / differ-02 
                                    :ARG0 (m2 / mm)) 
                              :ARG2-of (i / incubate-01 
                                    :ARG1 (n3 / nucleus) 
                                    :manner (b / buffer-01 
                                          :ARG1 100)) 
                              :mod (s / salt))) 
                  :quant 1) 
            :op2 (n2 / NaCl)))

# ::snt In all conditions , the amount of histone H3 remaining associated with chromatin was indistinguishable in control and p150CAF-1-depleted ES cells ( unpublished data ) .
# ::tok In all conditions , the amount of histone H3 remaining associated with chromatin was indistinguishable in control and p150CAF-1-depleted ES cells ( unpublished data ) .
# ::alignments 23-24|0.0.1.0 22-23|0.0.1.0.0 20-21|0.1.2 19-20|0.1.2.0 18-19|0.1.2.1 17-18|0.1 16-17|0.1.1 14-15|0.1.0 12-13|0 10-11|0.0 9-10|0.0.1 8-9|0.0.0.0 7-8|0.0.0.0.0 5-6|0.0.0 2-3|0.1.1.0.0 1-2|0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:47.991
(c3 / chromatin 
      :ARG2-of (a2 / associate-01 
            :ARG1 (a3 / amount 
                  :quant-of (h / H3 
                        :mod (h2 / histone))) 
            :ARG1-of (r / remain-01 
                  :ARG0 (d / data 
                        :mod (u / unpublish)))) 
      :op1-of (a / and 
            :op2 (i / indistinguishable) 
            :op3 (c2 / control-01 
                  :ARG1 (a4 / all 
                        :quant-of (c4 / condition))) 
            :op4 (c / cell 
                  :mod (e / e) 
                  :mod (p / p150caf-1-deplet))))

# ::snt Therefore , the loss of clustering and decondensation of pericentric heterochromatin are unlikely to be the consequence of severe defects in nucleosomal organization .
# ::tok Therefore , the loss of clustering and decondensation of pericentric heterochromatin are unlikely to be the consequence of severe defects in nucleosomal organization .
# ::alignments 22-23|0.1 21-22|0.1.0 19-20|0 18-19|0.2 16-17|0.0.0.2.0 12-13|0.0.0.2.1+0.0.0.2 10-11|0.0.0.1.0 7-8|0.0 6-7|0.0.0 5-6|0.0.0.1 3-4|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:48.083
(d / defect-01 
      :ARG0 (d2 / decondensation 
            :op3-of (a / and 
                  :op1 (l2 / loss) 
                  :op2 (c2 / cluster-01 
                        :ARG1 (h / heterochromatin)) 
                  :op4 (l / likely-01 
                        :ARG1 (c / consequence) 
                        :polarity -))) 
      :ARG1 (o / organization 
            :mod (n / nucleosomal)) 
      :mod (s / severe))

# ::snt Our findings showed that the nuclear localization of HP1 is severely altered in Chaf1a  /  embryos and p150CAF-1-depleted ES cells .
# ::tok Our findings showed that the nuclear localization of HP1 is severely altered in Chaf1a  /  embryos and p150CAF-1-depleted ES cells .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:48.085
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt We therefore examined the status of other epigenetic marks previously shown to characterize pericentric heterochromatin .
# ::tok We therefore examined the status of other epigenetic marks previously shown to characterize pericentric heterochromatin .
# ::alignments 14-15|0.0 13-14|0 12-13|0.0.0 10-11|0.0.0.0 9-10|0.0.0.0.1 8-9|0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0 6-7|0.0.0.0.0.0.0.0.1 4-5|0.0.0.0.0.0.0 2-3|0.0.0.0.0.0 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:48.146
(p / pericentric 
      :mod-of (h / heterochromatin 
            :ARG1-of (c / characterize-01 
                  :ARG1-of (s / show-01 
                        :ARG0 (w / we 
                              :ARG0-of (e / examine-01 
                                    :ARG1 (s2 / status 
                                          :poss (t / thing 
                                                :ARG0-of (m / mark-01) 
                                                :mod (o / other))))) 
                        :time (p2 / previous)))))

# ::snt We first tested DNA CpG methylation [ 25 ] at major satellite repeats and found no significant difference between control and p150CAF-1-depleted cells ( Figure 6 ) .
# ::tok We first tested DNA CpG methylation [ 25 ] at major satellite repeats and found no significant difference between control and p150CAF-1-depleted cells ( Figure 6 ) .
# ::alignments 25-26|0.0.1.0 24-25|0.0.2.0.0 22-23|0.0.1.3 21-22|0.0.1.3.0 20-21|0 19-20|0.0 17-18|0.0.1 16-17|0.0.1.2 15-16|0.0.1.1.2 14-15|0.0.1.1 13-14|0.0.1.1.1 12-13|0.0.2.0 11-12|0.0.2 10-11|0.0.2.0.1 7-8|0.0.0 4-6|0.0.1.1.0.1.1+0.0.1.1.0.1.0+0.0.1.1.0.1+0.0.1.1.0 3-4|0.0.1.1.0.0 2-3|0.0.1.1.1.0 0-1|0.0.1.1.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:49.114
(a / and 
      :op1 (c2 / control-01 
            :ARG1 25 
            :ARG1-of (d / differ-02 
                  :ARG0 6 
                  :ARG1-of (f2 / find-01 
                        :ARG0 (t / thing 
                              :mod (d2 / DNA) 
                              :name (n / name 
                                    :op1 (c3 / CpG) 
                                    :op2 (m2 / methylation))) 
                        :op1-of (a2 / and 
                              :ARG1-of (t2 / test-01 
                                    :ARG0 (w / we))) 
                        :polarity -) 
                  :ARG1-of (s / significant-02) 
                  :ARG2 (c / cell 
                        :mod (p / p150caf-1-deplet))) 
            :mod (s2 / satellite 
                  :ARG1-of (r / repeat-01 
                        :ARG0 (f / figure) 
                        :ARG1-of (m / major-02)))))

# ::snt As the LTM7 ES cell line that we used in our RNAi experiments is a female ( XX ) cell line , DNA methylation is globally reduced in these cells [ 26 ] .
# ::tok As the LTM7 ES cell line that we used in our RNAi experiments is a female ( XX ) cell line , DNA methylation is globally reduced in these cells [ 26 ] .
# ::alignments 31-32|0.3.2 29-30|0.3.3 28-29|0.3.1.2 26-27|0.1.0 25-26|0.1.0.1 22-24|0.1.0.0.0.1+0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 20-21|0.3.0.0 19-20|0.3.0.0.0 17-18|0.0 15-16|0.2 12-13|0 10-11|0.1 8-9|0.3 7-8|0.3.0 5-6|0.3.1 4-5|0.3.1.0 2-4|0.3.1.1.0.1+0.3.1.1.0.0+0.3.1.1.0+0.3.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:49.977
(e / experiment-01 
      :ARG0 (x / xx) 
      :ARG1 (w / we 
            :ARG0-of (r / reduce-01 
                  :ARG1 (t2 / thing 
                        :name (n / name 
                              :op1 (d / DNA) 
                              :op2 (m / methylation))) 
                  :manner (g / globe))) 
      :ARG2 (f / female) 
      :ARG2-of (u / use-01 
            :ARG0 (w2 / we 
                  :poss-of (l / line 
                        :mod (c2 / cell))) 
            :ARG1 (l2 / line 
                  :mod (c3 / cell) 
                  :mod (t3 / thing 
                        :name (n2 / name 
                              :op1 (l3 / LTM7) 
                              :op2 (e2 / ES))) 
                  :mod (t / this)) 
            :op1-of 26 
            :op1-of (c / cell)))

# ::snt To rule out the possibility that hypomethylation of pericentric repeats might contribute to the destabilization of heterochromatin domains in p150CAF-1-depleted ES cells , we tested our RNAi plasmid vector in a XY ES cell line , and confirmed that loss of p150CAF-1 leads to disruption of heterochromatin organization independently of the degree of DNA methylation at pericentric repeats ( unpublished data ) .
# ::tok To rule out the possibility that hypomethylation of pericentric repeats might contribute to the destabilization of heterochromatin domains in p150CAF-1-depleted ES cells , we tested our RNAi plasmid vector in a XY ES cell line , and confirmed that loss of p150CAF-1 leads to disruption of heterochromatin organization independently of the degree of DNA methylation at pericentric repeats ( unpublished data ) .
# ::alignments 60-61|0.0.0.0 59-60|0.0.0 57-58|0.2.2.0 54-55|0.2.2.0.0 53-54|0.2.2.0.0.0 51-52|0.2.2.0.0.1 48-49|0.1.0.0.0.0.0.1 47-48|0.2.2.1 44-45|0.2.2 42-43|0.0 39-40|0.2.1 37-38|0.2 36-37|0 34-35|0.1.2 33-34|0.1.2.0 31-33|0.1.2.1.0.1+0.1.2.1.0.0+0.1.2.1.0+0.1.2.1 28-29|0.1.1 27-28|0.1.1.0 25-26|0.1.0 24-25|0.1 23-24|0.2.0 21-22|0.1.0.0.0.0.0.2.0.0 20-21|0.1.0.0.0.0.0.2.0 19-20|0.1.0.0.0.0.0.2.0.0.0 17-18|0.1.0.0.0.0.0.2.1 16-17|0.1.0.0.0.0.0.2.1.0 14-15|0.1.0.0.0.0.0.2 11-12|0.1.0.0.0.0.0 10-11|0.1.0.0.0.0 9-10|0.1.0.0.0.0.0.0.0 6-7|0.1.0.0.0.0.0.0 4-5|0.1.0.0.0 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:52.360
(a / and 
      :ARG2-of (l / lead-03 
            :ARG0 (u / unpublish 
                  :mod-of (d / data))) 
      :op1 (t2 / test-01 
            :ARG0 (w / we 
                  :ARG0-of (r3 / rule-03 
                        :ARG1 (p4 / possible-01 
                              :ARG1 (p3 / possible-01 
                                    :ARG1 (c4 / contribute-01 
                                          :ARG0 (h2 / hypomethylation 
                                                :ARG1-of (r2 / repeat-01)) 
                                          :ARG1 (i / independent) 
                                          :ARG2 (d6 / destabilization 
                                                :location (e2 / e 
                                                      :mod-of (c3 / cell 
                                                            :mod (p2 / p150caf-1-deplet))) 
                                                :quant-of (d5 / domain 
                                                      :mod (h / heterochromatin)))))))) 
            :ARG1 (v / vector 
                  :mod (p / plasmid)) 
            :manner (l3 / line 
                  :mod (c2 / cell) 
                  :mod (t / thing 
                        :name (n / name 
                              :op1 (x / XY) 
                              :op2 (e / ES))))) 
      :op2 (c / confirm-01 
            :ARG0 (w2 / we) 
            :ARG1 (l2 / loss) 
            :ARG2 (d4 / disruption 
                  :op1 (r / repeat-01 
                        :ARG1 (m / methylation 
                              :mod (d2 / DNA) 
                              :mod-of (d3 / degree))) 
                  :poss (o / organization))))

# ::snt We next analyzed specific histone modifications [ 27 ] in chromatin immunoprecipitation ( ChIP ) experiments using native chromatin [ 28 ] .
# ::tok We next analyzed specific histone modifications [ 27 ] in chromatin immunoprecipitation ( ChIP ) experiments using native chromatin [ 28 ] .
# ::alignments 20-21|0.0.1.0 18-19|0 17-18|0.0.0 16-17|0.0.2.0 15-16|0.0.2 13-14|0.0.2.0.0 11-12|0.0.2.1 10-11|0.0.2.1.0 7-8|0.0.2.0.0.0 5-6|0.0 4-5|0.0.4 3-4|0.0.1 2-3|0.0.3 1-2|0.0.3.1 0-1|0.0.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:52.791
(c / chromatin 
      :ARG1-of (m / modify-01 
            :ARG0 (n / native) 
            :ARG1-of (s / specific-02 
                  :ARG2 28) 
            :ARG1-of (e / experiment-01 
                  :ARG1-of (u / use-01 
                        :ARG0 (c2 / chip-01 
                              :ARG1 27)) 
                  :mod (i / immunoprecipitation 
                        :mod (c3 / chromatin))) 
            :ARG1-of (a / analyze-01 
                  :ARG0 (w / we) 
                  :manner (n2 / next)) 
            :mod (h / histone)))

# ::snt We found that pericentric DNA was immunoprecipitated with a 2-fold lower efficiency with H4K20me3 [ 29,30 ] antibodies following p150CAF-1 depletion ( Figure 7A and 7B ) .
# ::tok We found that pericentric DNA was immunoprecipitated with a 2-fold lower efficiency with H4K20me3 [ 29,30 ] antibodies following p150CAF-1 depletion ( Figure 7A and 7B ) .
# ::alignments 25-26|0.3 24-25|0 23-24|0.2 22-23|0.2.0 20-21|0.1 18-19|0.1.0 17-18|0.1.0.1 13-14|0.0.1.1.0+0.0.1.1+0.0.1 11-12|0.0.1.0 10-11|0.0.1.0.0 4-5|0.1.0.0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:53.062
(a / and 
      :op1 (f3 / find-01 
            :ARG0 (w / we) 
            :ARG1 (t / thing 
                  :ARG2-of (e / efficient-01 
                        :ARG1-of (l / low-04)) 
                  :name (n / name 
                        :op1 "H4K20me3"))) 
      :op2 (d / depletion 
            :ARG2-of (f2 / follow-01 
                  :ARG0 (d2 / DNA) 
                  :ARG1 (a2 / antibodi))) 
      :op3 (72 / 7A 
            :mod-of (f / figure)) 
      :op4 7B)

# ::snt Immunoprecipitation of minor satellite repeats in the same experiment was less affected ( Figure 7B ) , showing that loss of p150CAF-1 function mainly affects H4K20me3 at pericentric heterochromatin .
# ::tok Immunoprecipitation of minor satellite repeats in the same experiment was less affected ( Figure 7B ) , showing that loss of p150CAF-1 function mainly affects H4K20me3 at pericentric heterochromatin .
# ::alignments 28-29|0.0.0.3 25-26|0.0.0.1.1.0+0.0.0.1.1+0.0.0.1 24-25|0.0.0 23-24|0.0.0.2 22-23|0.0.0.0.0 19-20|0.0.0.0 17-18|0.0 14-15|0.1 13-14|0.1.0 11-12|0 10-11|0.2 8-9|0.0.0.1.0.0 7-8|0.0.0.1.0 4-5|0.0.0.1.0.0.0 3-4|0.0.0.1.0.0.0.0 2-3|0.0.0.1.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:53.604
(a2 / affect-01 
      :ARG0 (s / show-01 
            :ARG1 (a / affect-01 
                  :ARG0 (l / loss 
                        :ARG1-of (f / function-01)) 
                  :ARG1 (t / thing 
                        :ARG2-of (s2 / same-01 
                              :ARG1 (e / experiment-01 
                                    :ARG1 (r / repeat-01 
                                          :ARG1 (s3 / satellite) 
                                          :mod (m2 / minor)))) 
                        :name (n / name 
                              :op1 "H4K20me3")) 
                  :mod (m / main) 
                  :time (h / heterochromatin))) 
      :ARG1 (7 / 7B 
            :mod-of (f2 / figure)) 
      :degree (l2 / less))

# ::snt Moreover , no significant difference in immunoprecipitation efficiency was detected at intracisternal A particle ( IAP ) elements ( Figure 7B ) , which are noncentromeric repeated DNA elements also enriched in H4K20me3 [ 31 ] .
# ::tok Moreover , no significant difference in immunoprecipitation efficiency was detected at intracisternal A particle ( IAP ) elements ( Figure 7B ) , which are noncentromeric repeated DNA elements also enriched in H4K20me3 [ 31 ] .
# ::alignments 34-35|0.0.1.0 32-33|0.0.0.0.0+0.0.0.0+0.0.0 30-31|0.0.1.3.1.0 29-30|0.0.1.3.1.0.0 28-29|0.0.1.3.1 27-28|0.0.1.3.1.1 26-27|0.0.1.3 20-21|0.0.1.2.0 19-20|0.0.1.2.0.0 17-18|0.0.1.1.0 13-14|0.0.1.1.0.0 9-10|0.0.1.1 7-8|0.0 6-7|0 4-5|0.0.1 3-4|0.0.1.2 2-3|0.0.1.1.1 0-1|0.0.1.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:54.018
(i / immunoprecipitation 
      :ARG1-of (e4 / efficient-01 
            :ARG0 (t / thing 
                  :name (n / name 
                        :op1 "H4K20me3")) 
            :ARG1-of (d3 / differ-02 
                  :ARG0 31 
                  :ARG1-of (d2 / detect-01 
                        :ARG2 (e3 / element 
                              :mod (p / particle)) 
                        :polarity -) 
                  :ARG1-of (s / significant-02 
                        :ARG0 (7 / 7B 
                              :mod-of (f / figure))) 
                  :ARG2 (r / repeat-01 
                        :ARG0 (m / moreover) 
                        :ARG1 (e2 / element 
                              :ARG1-of (e / enrich-01 
                                    :mod (a / also)) 
                              :mod (d / DNA))))))

# ::snt This result shows that p150CAF-1 contributes to normal levels of H4K20me3 at pericentric heterochromatin , but not necessarily at other loci .
# ::tok This result shows that p150CAF-1 contributes to normal levels of H4K20me3 at pericentric heterochromatin , but not necessarily at other loci .
# ::alignments 20-21|0.1.0.0 19-20|0.1.0 17-18|0.0 16-17|0.1.2.1 15-16|0 13-14|0.1.2.0 10-11|0.1.3.1 8-9|0.1.3 7-8|0.1.3.0 5-6|0.1 2-3|0.1.1 1-2|0.1.2 0-1|0.1.2.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:54.197
(c / contrast-01 
      :ARG1 (n / necessarily) 
      :ARG2 (c2 / contribute-01 
            :ARG0 (o / other 
                  :mod-of (l / locus)) 
            :ARG1-of (s / show-01) 
            :ARG2-of (r / result-01 
                  :ARG0 (h / heterochromatin) 
                  :ARG1 - 
                  :mod (t / this)) 
            :ARG4 (l2 / level 
                  :ARG1-of (n2 / normal-02) 
                  :mod (h2 / H4K20me3))))

# ::snt The H3K9me3 mark [ 32 ] was also significantly reduced in p150CAF-1-depleted cells , though to a lesser extent than H4K20me3 ( Figure 7A and 7B ) .
# ::tok The H3K9me3 mark [ 32 ] was also significantly reduced in p150CAF-1-depleted cells , though to a lesser extent than H4K20me3 ( Figure 7A and 7B ) .
# ::alignments 25-26|0.3 24-25|0 23-24|0.2 22-23|0.2.1 20-21|0.1.1.0+0.1.1+0.1 18-19|0.1.0.0 17-18|0.1.0 12-13|0.0.0 11-12|0.0.0.0 9-10|0.0 8-9|0.0.1 7-8|0.0.2 4-5|0.3.0 2-3|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:54.368
(a / and 
      :op1 (r / reduce-01 
            :ARG1 (c / cell 
                  :mod (p / p150caf-1-deplet)) 
            :ARG2 (s / significant-02) 
            :mod (a2 / also)) 
      :op2 (t / thing 
            :compared-to-of (l / less 
                  :compared-to (e / extent)) 
            :name (n / name 
                  :op1 "H4K20me3")) 
      :op3 (72 / 7A 
            :ARG1-of (m / mark-01) 
            :mod-of (f / figure)) 
      :op4 (7 / 7B 
            :mod-of 32))

# ::snt In wild-type cells , most of H4K20me3 and H3K9me3 signals are present at the level of DAPI-dense domains when visualized by IF [ 29 ] ( Figures 7C and 7D ) .
# ::tok In wild-type cells , most of H4K20me3 and H3K9me3 signals are present at the level of DAPI-dense domains when visualized by IF [ 29 ] ( Figures 7C and 7D ) .
# ::alignments 28-29|0.0.2 26-27|0.0.2.1 23-24|0.0.2.0.0.0 21-22|0 19-20|0.0.2.0 17-18|0.0.2.0.1 14-15|0.0.2.0.1.0 11-12|0.0.2.0.1.0.0 9-10|0.0.1 7-8|0.0 6-7|0.0.0.0.0+0.0.0.0+0.0.0 4-5|0.1 2-3|0.0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:54.569
(c / cause-01 
      :ARG0 (a2 / and 
            :op1 (t / thing 
                  :name (n / name 
                        :op1 "H4K20me3")) 
            :op2 (s / signal) 
            :op3 (a / and 
                  :ARG0-of (v / visualize-01 
                        :ARG1 (c2 / cell 
                              :mod 29) 
                        :ARG2 (d / domain 
                              :mod-of (l / level 
                                    :location-of (p / present)))) 
                  :op1 (f / figure))) 
      :ARG2 (m / most))

# ::snt H3K9me3 was severely perturbed in p150CAF-1-depleted cells , displaying a diffuse pattern similar to HP1 ( Figure 7C ) .
# ::tok H3K9me3 was severely perturbed in p150CAF-1-depleted cells , displaying a diffuse pattern similar to HP1 ( Figure 7C ) .
# ::alignments 16-17|0.1.0.0.1.0 12-13|0.1.0.0.0 11-12|0.1.0.0 10-11|0.1.0.0.1 8-9|0.1.0 6-7|0.0 5-6|0.0.0 3-4|0 2-3|0.2 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:54.724
(p3 / perturb-01 
      :ARG0 (c / cell 
            :mod (p2 / p150caf-1-deplet)) 
      :ARG1 (h / H3K9me3 
            :ARG0-of (d2 / display-01 
                  :ARG1 (p / pattern 
                        :ARG1-of (r / resemble-01) 
                        :mod (d / diffuse-01 
                              :ARG1 (f / figure))))) 
      :degree (s / severe))

# ::snt The H4K20me3 pattern was even more severely altered , showing both a loss of the typical dots revealed in control cells and a reduction in signal intensity ( Figure 7D ) .
# ::tok The H4K20me3 pattern was even more severely altered , showing both a loss of the typical dots revealed in control cells and a reduction in signal intensity ( Figure 7D ) .
# ::alignments 28-29|0.2 26-27|0.1.0 25-26|0.1.0.0 23-24|0.1 21-22|0 20-21|0.0.2 19-20|0.0.2.0 17-18|0.0 16-17|0.0.1 15-16|0.0.1.0 12-13|0.0.0 10-11|0.0.0.1 9-10|0.0.0.0 7-8|0.0.0.0.0.0 6-7|0.0.0.0.0.0.0 5-6|0.0.0.0.0.0.0.0.0 4-5|0.0.0.0.0.0.0.0 2-3|0.0.0.0.0 1-2|0.0.0.0.0.1.0.0+0.0.0.0.0.1.0+0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:55.098
(a / and 
      :ARG2-of (r2 / reveal-01 
            :ARG0 (l / loss 
                  :ARG1-of (s2 / show-01 
                        :ARG0 (p / pattern 
                              :ARG1-of (a2 / alter-01 
                                    :manner (s3 / severe 
                                          :degree-of (e / even 
                                                :mod-of (m / more)))) 
                              :mod (t2 / thing 
                                    :name (n / name 
                                          :op1 "H4K20me3")))) 
                  :mod (b / both)) 
            :ARG1 (d / dot-01 
                  :ARG1-of (t / typical-02)) 
            :location (c / cell 
                  :topic (c2 / control-01))) 
      :op1 (r / reduce-01 
            :ARG1 (i / intensity 
                  :mod (s / signal))) 
      :op2 (f / figure))

# ::snt Consistent with our ChIP experiments , residual H4K20me3 epitopes were detected at the level of relocated DAPI-dense material .
# ::tok Consistent with our ChIP experiments , residual H4K20me3 epitopes were detected at the level of relocated DAPI-dense material .
# ::alignments 17-18|0.1.0 15-16|0.1.0.0 13-14|0.1 10-11|0 8-9|0.0 7-8|0.0.0.0.0+0.0.0.0+0.0.0 6-7|0.0.1 4-5|0.1.0.0.0.0 3-4|0.1.0.0.0 2-3|0.1.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:55.264
(d / detect-01 
      :ARG1 (e / epitop 
            :mod (t / thing 
                  :name (n / name 
                        :op1 "H4K20me3")) 
            :mod (r2 / residual)) 
      :location (l / level 
            :poss (m / material 
                  :ARG1-of (r / relocate-01 
                        :ARG1-of (c / chip-01 
                              :ARG1-of (e2 / experiment-01 
                                    :ARG2 (w / we)))))))

# ::snt Altogether , our results show that depletion of CAF-1 in ES cells leads to a simultaneous disruption of heterochromatin 3-D organization and an alteration in epigenetic marking .
# ::tok Altogether , our results show that depletion of CAF-1 in ES cells leads to a simultaneous disruption of heterochromatin 3-D organization and an alteration in epigenetic marking .
# ::alignments 26-27|0 23-24|0.0.0.0.2.1.1.0 21-22|0.0.0.0.2.1.1 20-21|0.0.0.0.2.1 19-20|0.0.0.0.2.1.0 16-17|0.0.0.0.2 15-16|0.0.0.0.2.0 12-13|0.0.0.0 11-12|0.0 10-11|0.0.1 8-9|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 6-7|0.0.0 4-5|0.0.0.0.1 3-4|0.0.0.0.1.0.0+0.0.0.0.1.0 2-3|0.0.0.0.1.0.0.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:55.474
(m / mark-01 
      :ARG0 (c / cell 
            :location-of (d2 / depletion 
                  :ARG0-of (l / lead-03 
                        :ARG1 (p / person 
                              :name (n / name 
                                    :op1 "CAF-1")) 
                        :ARG1-of (s2 / show-01 
                              :ARG0 (t / thing 
                                    :ARG2-of (r / result-01 
                                          :ARG1 (w / we)))) 
                        :ARG2 (d / disruption 
                              :mod (s / simultaneous) 
                              :poss (o / organization 
                                    :mod 3-d 
                                    :op1-of (a2 / and 
                                          :op2 (a / alteration)))))) 
            :mod (e / e)) 
      :ARG1 (a3 / altogeth))

# ::snt Here , we provide evidence that p150CAF-1 has a crucial function during mouse early embryogenesis and in ES cells .
# ::tok Here , we provide evidence that p150CAF-1 has a crucial function during mouse early embryogenesis and in ES cells .
# ::alignments 18-19|0.0.1.0 17-18|0.0.1.0.0 15-16|0 14-15|0.0.0 13-14|0.0.0.0 12-13|0.0.0.1 10-11|0.0 9-10|0.0.2 4-5|0.0.1 3-4|0.0.1.1 2-3|0.0.1.1.0 0-1|0.0.1.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:55.636
(a / and 
      :ARG1-of (f / function-01 
            :ARG0 (e2 / embryogenesi 
                  :mod (e3 / early) 
                  :mod (m / mouse)) 
            :ARG1-of (e4 / evidence-01 
                  :ARG0 (c / cell 
                        :mod (e / e)) 
                  :ARG1-of (p / provide-01 
                        :ARG0 (w / we) 
                        :location (h / here))) 
            :mod (c2 / crucial)))

# ::snt Previous studies showed that CAF-1 is essential for the progression of DNA replication in vertebrates .
# ::tok Previous studies showed that CAF-1 is essential for the progression of DNA replication in vertebrates .
# ::alignments 14-15|0.1.1.1 12-13|0.1.1.0 11-12|0.1.1.0.0 9-10|0.1.1 6-7|0.1 4-5|0.1.0.0.0+0.1.0.0+0.1.0 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:55.798
(s / show-01 
      :ARG0 (s2 / study-01 
            :ARG1 (p3 / previou)) 
      :ARG1 (e / essential 
            :domain (p2 / person 
                  :name (n / name 
                        :op1 "CAF-1")) 
            :purpose (p / progress-01 
                  :ARG1 (r / replication 
                        :mod (d / DNA)) 
                  :ARG2 (v / vertebrat))))

# ::snt In Xenopus laevis , p150CAF-1 function is required for the rapid cell divisions that occur during early development [ 33 ] .
# ::tok In Xenopus laevis , p150CAF-1 function is required for the rapid cell divisions that occur during early development [ 33 ] .
# ::alignments 19-20|0.0.0 17-18|0.1.0.0.0 16-17|0.1.0.0 14-15|0.1.0 12-13|0.1 11-12|0.1.1 10-11|0.1.0.0.0.1 7-8|0 5-6|0.0 2-3|0.1.0.0.0.0.0 1-2|0.1.0.0.0.0.1.0+0.1.0.0.0.0.1+0.1.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:55.881
(r2 / require-01 
      :ARG1 (f / function-01 
            :ARG1 33) 
      :ARG2 (d2 / division 
            :ARG0-of (o / occur-01 
                  :time (e / early 
                        :ARG1-of (d / develop-02 
                              :ARG0 (c2 / country 
                                    :mod-of (l / laevi) 
                                    :name (n / name 
                                          :op1 "Xenopus")) 
                              :manner (r / rapid)))) 
            :mod (c / cell)))

# ::snt Similarly , CAF-1 is essential in mammalian cell lines for the progression of DNA replication [ 16,23,24,34 ] .
# ::tok Similarly , CAF-1 is essential in mammalian cell lines for the progression of DNA replication [ 16,23,24,34 ] .
# ::alignments 14-15|0.0 13-14|0 11-12|0.0.0 8-9|0.0.1 7-8|0.0.1.1 6-7|0.0.1.2 4-5|0.0.1.0 2-3|0.0.1.0.0.0.0+0.0.1.0.0.0+0.0.1.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:55.955
(d / DNA 
      :mod-of (r / replication 
            :ARG1-of (p / progress-01 
                  :ARG0 (s / similarly)) 
            :poss-of (l / line 
                  :location-of (e / essential 
                        :domain (p2 / person 
                              :name (n / name 
                                    :op1 "CAF-1"))) 
                  :mod (c / cell) 
                  :mod (m / mammalian))))

# ::snt Our findings reveal a role for CAF-1 in the nuclear organization of heterochromatin domains during early development and in ES cells .
# ::tok Our findings reveal a role for CAF-1 in the nuclear organization of heterochromatin domains during early development and in ES cells .
# ::alignments 20-21|0.1.0.2 19-20|0.1.0.2.0 17-18|0.1.0.0.0 16-17|0.1.0.0 15-16|0.1.0.0.1 13-14|0.1.0.0.0.0 10-11|0.2 9-10|0.2.0 6-7|0.1.0.1.0+0.1.0.1+0.1.0 4-5|0.1 2-3|0 1-2|0.0.0+0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:56.306
(r2 / reveal-01 
      :ARG0 (t / thing 
            :ARG1-of (f / find-01 
                  :ARG0 (w / we))) 
      :ARG1 (r / role 
            :prep-for (p / person 
                  :ARG0-of (d / develop-02 
                        :op2-of (a / and 
                              :op1 (d2 / domain)) 
                        :time (e2 / early)) 
                  :name (n2 / name 
                        :op1 "CAF-1") 
                  :part-of (c / cell 
                        :mod (e / e)))) 
      :ARG2 (o / organization 
            :mod (n / nucleus)))

# ::snt We show that in p150CAF-1-depleted ES cells , while DNA replication initially persists without significant perturbation in nucleosomal organization , severe heterochromatin organization defects can be observed .
# ::tok We show that in p150CAF-1-depleted ES cells , while DNA replication initially persists without significant perturbation in nucleosomal organization , severe heterochromatin organization defects can be observed .
# ::alignments 26-27|0.1.0 24-25|0.1 23-24|0.1.0.0 22-23|0.1.0.0.0 21-22|0.1.0.0.1 20-21|0.1.0.0.2 18-19|0.2.0.0 15-16|0.2.0 14-15|0.2 12-13|0.2.0.1 11-12|0.2.0.1.2 10-11|0.2.0.1.0 9-10|0.2.0.1.0.0 6-7|0.2.0.1.1 5-6|0.2.0.1.1.0 4-5|0.2.0.1.1.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:57.122
(s3 / show-01 
      :ARG0 (w / we) 
      :ARG1 (p / possible-01 
            :ARG1 (o / observe-01 
                  :ARG1 (d / defect-01 
                        :ARG0 (o2 / organization) 
                        :ARG1 (h / heterochromatin) 
                        :mod (s / severe)))) 
      :manner-of (s2 / significant-02 
            :ARG1 (p2 / perturbation 
                  :location (o3 / organization) 
                  :manner-of (p3 / persist-01 
                        :ARG0 (r / replication 
                              :mod (d2 / DNA)) 
                        :ARG1 (c / cell 
                              :mod (e / e) 
                              :mod (p4 / p150caf-1-deplet)) 
                        :time (i / initial)))))

# ::snt Loss of p150CAF-1 did not affect PML bodies in ES cell nuclei , showing that nuclear architecture is not generally altered .
# ::tok Loss of p150CAF-1 did not affect PML bodies in ES cell nuclei , showing that nuclear architecture is not generally altered .
# ::alignments 20-21|0.3.1 19-20|0.3.1.1 18-19|0.3.1.2 16-17|0.3.1.0 15-16|0.3.1.0.0 13-14|0.3 11-12|0.1 10-11|0.1.0 9-10|0.1.0.0 7-8|0.0 6-7|0.0.0.0.0+0.0.0.0+0.0.0 5-6|0 4-5|0.2 0-1|0.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:57.244
(a3 / affect-01 
      :ARG1 (b / body 
            :mod (o / organization 
                  :name (n3 / name 
                        :op1 "PML"))) 
      :manner (n2 / nucleus 
            :mod (c / cell 
                  :mod (e / e))) 
      :polarity - 
      :purpose (s / show-01 
            :ARG0 (l / los) 
            :ARG1 (a / alter-01 
                  :ARG1 (a2 / architecture 
                        :mod (n / nucleus)) 
                  :ARG1-of (g / general-02) 
                  :polarity -)))

# ::snt Ultimately , p150CAF-1 depletion results in the arrest of ES cell division and cell death .
# ::tok Ultimately , p150CAF-1 depletion results in the arrest of ES cell division and cell death .
# ::alignments 14-15|0.1.0.1 13-14|0.1.0.1.0 12-13|0.1.0 11-12|0.1.0.0 10-11|0.1.0.0.0 9-10|0.1.0.0.0.0 7-8|0.1 4-5|0 3-4|0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:57.362
(r / result-01 
      :ARG1 (d3 / depletion) 
      :ARG2 (a2 / arrest-01 
            :ARG1 (a / and 
                  :op1 (d2 / division 
                        :mod (c2 / cell 
                              :mod (e / e))) 
                  :op2 (d / die-01 
                        :mod (c / cell)))) 
      :time (u / ultimate))

# ::snt Given the major defects observed in heterochromatin organization , it is tempting to speculate that these defects cause the developmental arrest in the embryos and death in ES cells .
# ::tok Given the major defects observed in heterochromatin organization , it is tempting to speculate that these defects cause the developmental arrest in the embryos and death in ES cells .
# ::alignments 28-29|0.0.0.0.1.1.0 27-28|0.0.0.0.1.1.0.0 25-26|0.0.0.0.1.2 24-25|0.0.0.0.1 23-24|0.0.0.0.1.1 20-21|0.0.0.0 19-20|0.0.0.0.2 17-18|0.0.0 16-17|0.0.0.0.0 15-16|0.0.0.0.0.0 13-14|0.0 11-12|0 7-8|0.0.0.0.1.0.0.0 6-7|0.0.0.0.1.0.0.0.0 4-5|0.0.0.0.1.0.0 3-4|0.0.0.0.1.0.0.1 2-3|0.0.0.0.1.0.0.1.0 0-1|0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:57.574
(t2 / tempt-01 
      :ARG1 (s / speculate-01 
            :ARG1 (c2 / cause-01 
                  :ARG1 (a2 / arrest-01 
                        :ARG0 (d3 / defect-01 
                              :mod (t / this)) 
                        :ARG1 (a / and 
                              :ARG2-of (g / give-01 
                                    :ARG1 (o2 / observe-01 
                                          :ARG0 (o / organization 
                                                :mod (h / heterochromatin)) 
                                          :ARG1 (d4 / defect-01 
                                                :ARG1-of (m / major-02)))) 
                              :op1 (e2 / embryo 
                                    :location (c / cell 
                                          :mod (e / e))) 
                              :op2 (d / die-01)) 
                        :mod (d2 / developmental)))))

# ::snt The role of CAF-1 in the nuclear organization of heterochromatin includes spatial localization , condensation , and clustering of pericentric domains .
# ::tok The role of CAF-1 in the nuclear organization of heterochromatin includes spatial localization , condensation , and clustering of pericentric domains .
# ::alignments 20-21|0.1.3.1 17-18|0.1.3 16-17|0.1 14-15|0.1.2 12-13|0.1.1 11-12|0.1.0 10-11|0 9-10|0.0 7-8|0.2.1 6-7|0.1.3.0 3-4|0.2.0.0.0+0.2.0.0+0.2.0 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:58.026
(i / include-01 
      :ARG0 (h / heterochromatin) 
      :ARG1 (a / and 
            :mod (s / spatial) 
            :op1 (l / localization) 
            :op2 (c2 / condensation) 
            :op3 (c / cluster-01 
                  :ARG0 (n / nucleus) 
                  :ARG1 (d / domain))) 
      :ARG2 (r / role 
            :poss (p / person 
                  :name (n2 / name 
                        :op1 "CAF-1")) 
            :poss (o / organization)))

# ::snt This important function of CAF-1 was not revealed in primary MEFs , 3T3 cells , or human cell lines , suggesting that it is specific of pluripotent embryonic cells .
# ::tok This important function of CAF-1 was not revealed in primary MEFs , 3T3 cells , or human cell lines , suggesting that it is specific of pluripotent embryonic cells .
# ::alignments 28-29|0.0.1.0.0 27-28|0.0.1.0.0.0 24-25|0.0.1.0 20-21|0.0.1 18-19|0.1.2.1.1 17-18|0.1.2.1 16-17|0.1.2.1.0 15-16|0.1.2 13-14|0.1.2.0 10-11|0.1.1.0+0.1.1+0.1 9-10|0.1.0 7-8|0 6-7|0.2 4-5|0.0.0.0.0+0.0.0.0+0.0.0 2-3|0.0 1-2|0.0.2 0-1|0.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:58.547
(r / reveal-01 
      :ARG1 (f / function-01 
            :ARG0 (p2 / person 
                  :name (n2 / name 
                        :op1 "CAF-1")) 
            :ARG0-of (s2 / suggest-01 
                  :ARG2-of (s / specific-02 
                        :ARG1 (c / cell 
                              :mod (e / embryonic)))) 
            :ARG1 (i / important) 
            :mod (t2 / this)) 
      :medium (t / thing 
            :mod (p / primary) 
            :name (n / name 
                  :op1 "MEFs") 
            :op1-of (o / or 
                  :op2 (c3 / cell) 
                  :op3 (c2 / cell 
                        :mod (h / human) 
                        :mod-of (l / line)))) 
      :polarity -)

# ::snt Alternatively , early embryos and ES cells , whose genome is more plastic than somatic cells , might represent a particularly sensitive context in which the importance of CAF-1 in heterochromatin organization is exacerbated .
# ::tok Alternatively , early embryos and ES cells , whose genome is more plastic than somatic cells , might represent a particularly sensitive context in which the importance of CAF-1 in heterochromatin organization is exacerbated .
# ::alignments 33-34|0.0.0.0.0 31-32|0.0.0.0.0.0.1 30-31|0.0.0.0.0.0.1.0 28-29|0.0.0.0.0.0.0.1.0+0.0.0.0.0.0.0.1+0.0.0.0.0.0.0 26-27|0.0.0.0.0.0 22-23|0.0.1 21-22|0.0.1.0 20-21|0.0.1.0.1 18-19|0.0 17-18|0 15-16|0.0.1.0.0.0.0 14-15|0.0.1.0.0.0.0.0 12-13|0.0.1.0.0.0 11-12|0.0.1.0.0.0.1 9-10|0.0.1.0.0 6-7|0.0.0.1 5-6|0.0.0.1.0 4-5|0.0.0 3-4|0.0.0.0 2-3|0.0.0.0.1 0-1|0.0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:59.285
(p3 / possible-01 
      :ARG1 (r / represent-01 
            :ARG0 (a / and 
                  :op1 (e3 / embryo 
                        :ARG0-of (e / exacerbate-01 
                              :ARG1 (i / important 
                                    :domain (p / person 
                                          :mod-of (a2 / alternatively) 
                                          :name (n / name 
                                                :op1 "CAF-1")) 
                                    :location (o / organization 
                                          :mod (h / heterochromatin)))) 
                        :mod (e4 / early)) 
                  :op2 (c3 / cell 
                        :mod (e2 / e))) 
            :ARG1 (c / context 
                  :ARG1-of (s / sensitive-03 
                        :ARG0 (g / genome 
                              :domain-of (p4 / plastic 
                                    :domain (c2 / cell 
                                          :mod (s2 / somatic)) 
                                    :quant (m / more))) 
                        :manner (p2 / particular)))))

# ::snt In ES cells , major architectural chromatin proteins are hyperdynamic and bind relatively loosely to chromatin [ 35 ] .
# ::tok In ES cells , major architectural chromatin proteins are hyperdynamic and bind relatively loosely to chromatin [ 35 ] .
# ::alignments 17-18|0.0.0 13-14|0.1.2 12-13|0.1.1 11-12|0.1 10-11|0 7-8|0.0.1 6-7|0.0.1.0 5-6|0.0.1.1 4-5|0.0 2-3|0.1.0.0 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:59.411
(a / and 
      :op1 (m / major-02 
            :ARG0 35 
            :ARG1 (p / protein 
                  :mod (c / chromatin) 
                  :mod (a2 / architectural))) 
      :op2 (b / bind-01 
            :ARG0 (e / e 
                  :mod-of (c2 / cell)) 
            :ARG1 (r / relative) 
            :ARG2 (l / loosely)))

# ::snt In this cellular context , our findings show that proper heterochromatin nuclear architecture relies on CAF-1 function .
# ::tok In this cellular context , our findings show that proper heterochromatin nuclear architecture relies on CAF-1 function .
# ::alignments 16-17|0.1.1 15-16|0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 13-14|0.1 12-13|0.1.0 11-12|0.1.0.1 9-10|0.1.0.0 7-8|0 6-7|0.0.0+0.0 5-6|0.0.0.0 3-4|0.2 2-3|0.2.1 1-2|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:29:59.502
(s / show-01 
      :ARG0 (t / thing 
            :ARG1-of (f2 / find-01 
                  :ARG0 (w / we))) 
      :ARG1 (r / rely-01 
            :ARG0 (a / architecture 
                  :mod (p2 / proper) 
                  :mod (n2 / nucleus)) 
            :ARG1 (f / function-01 
                  :ARG1 (p / person 
                        :name (n / name 
                              :op1 "CAF-1")))) 
      :ARG2 (c / context 
            :mod (t2 / this) 
            :mod (c2 / cell)))

# ::snt In contrast , in undifferentiated cells that are already lineage committed ( such as MEFs ) genome architecture might be more stable than in ES cells and thus can not be disrupted by CAF-1 depletion .
# ::tok In contrast , in undifferentiated cells that are already lineage committed ( such as MEFs ) genome architecture might be more stable than in ES cells and thus can not be disrupted by CAF-1 depletion .
# ::alignments 34-35|0.1.2.0.0 33-34|0.1.2.0.0.0.1.0+0.1.2.0.0.0.1+0.1.2.0.0.0 31-32|0.1.2.0 29-30|0.1.2.0.2.0 28-29|0.1.2.0.2 27-28|0.0 26-27|0.1.2 25-26|0.1.2.1.0 24-25|0.1.2.1 21-22|0.1 20-21|0.1.1 18-19|0 17-18|0.1.0 16-17|0.1.0.1 14-15|0.1.2.0.0.0.0.2.0.0+0.1.2.0.0.0.0.2.0+0.1.2.0.0.0.0.2 12-13|0.1.0.0.0 10-11|0.1.2.0.0.0.0 9-10|0.1.2.0.1 8-9|0.1.2.0.0.0.0.1 5-6|0.1.2.0.0.0.0.0 4-5|0.1.2.0.0.0.0.0.0 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:00.605
(p3 / possible-01 
      :ARG0 (t / thus-far) 
      :ARG1 (s / stable-03 
            :ARG1 (a2 / architecture 
                  :ARG0-of (c4 / contrast-01 
                        :ARG1 (s2 / such)) 
                  :mod (g / genome)) 
            :degree (m / more) 
            :op1-of (a / and 
                  :op2 (d2 / disrupt-01 
                        :ARG0 (d / depletion 
                              :mod (p / person 
                                    :ARG0-of (c2 / commit-01 
                                          :ARG1 (c3 / cell 
                                                :mod (u / undifferentiat)) 
                                          :time (a3 / already) 
                                          :time (t2 / thing 
                                                :name (n2 / name 
                                                      :op1 "MEFs"))) 
                                    :name (n / name 
                                          :op1 "CAF-1"))) 
                        :ARG1 (l / lineage) 
                        :ARG1-of (p2 / possible-01 
                              :polarity -)) 
                  :poss-of (e / e 
                        :mod-of (c / cell)))))

# ::snt This important function of CAF-1 in pluripotent embryonic cells could be partially conserved during evolution .
# ::tok This important function of CAF-1 in pluripotent embryonic cells could be partially conserved during evolution .
# ::alignments 14-15|0.0.2 12-13|0.0 11-12|0.0.1 9-10|0 8-9|0.0.0.1 7-8|0.0.0.1.0 4-5|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 2-3|0.0.0 1-2|0.0.0.2 0-1|0.0.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:00.697
(p2 / possible-01 
      :ARG1 (c / conserve-01 
            :ARG1 (f / function-01 
                  :ARG0 (p3 / person 
                        :name (n / name 
                              :op1 "CAF-1")) 
                  :ARG1 (c2 / cell 
                        :mod (e2 / embryonic)) 
                  :mod (i / important) 
                  :mod (t / this)) 
            :manner (p / partial) 
            :time (e / evolve-02)))

# ::snt Indeed , in Arabidopsis thaliana , in which CAF-1 is not essential for viability [ 36 ] , loss of CAF-1 is associated with a mild alteration in chromocenter size [ 37 ] .
# ::tok Indeed , in Arabidopsis thaliana , in which CAF-1 is not essential for viability [ 36 ] , loss of CAF-1 is associated with a mild alteration in chromocenter size [ 37 ] .
# ::alignments 31-32|0.0.1.0.4 29-30|0.0.1.0.3 28-29|0.0.1.0.3.0 26-27|0.0.1.0.2 25-26|0.0.1.0.2.0 22-23|0.0.1.0 18-19|0.0.1.0.1 15-16|0.0.1.0.0 13-14|0 11-12|0.0 10-11|0.0.2 8-9|0.0.0.0.0+0.0.0.0+0.0.0 3-5|0.0.1.2.1+0.0.1.2.0+0.0.1.2+0.0.1 0-1|0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:01.082
(v / viability 
      :purpose-of (e / essential 
            :domain (p / person 
                  :name (n / name 
                        :op1 "CAF-1")) 
            :location (t / thing 
                  :medium-of (a2 / associate-01 
                        :ARG0 36 
                        :ARG1 (l / loss) 
                        :ARG2 (a / alteration 
                              :mod (m / mild)) 
                        :manner (s / size 
                              :mod (c / chromocent)) 
                        :op1-of 37) 
                  :mod (i / indeed) 
                  :name (n2 / name 
                        :op1 (a3 / Arabidopsis) 
                        :op2 (t2 / thaliana))) 
            :polarity -))

# ::snt This phenotype is somehow reminiscent of loss of CAF-1-mediated defects in heterochromatin organization in early mouse embryos .
# ::tok This phenotype is somehow reminiscent of loss of CAF-1-mediated defects in heterochromatin organization in early mouse embryos .
# ::alignments 16-17|0.1 15-16|0 14-15|0.1.0 12-13|0.0.1 11-12|0.0.1.0 9-10|0.0 8-9|0.0.2 6-7|0.0.3 4-5|0.0.0.0 3-4|0.0.0.0.0 1-2|0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:01.168
(m / mouse 
      :ARG2-of (d / defect-01 
            :ARG0 (p / phenotype 
                  :domain-of (r / reminiscent 
                        :degree (s / somehow)) 
                  :mod (t / this)) 
            :ARG1 (o / organization 
                  :mod (h / heterochromatin)) 
            :mod (c / caf-1-mediat) 
            :mod-of (l / loss)) 
      :mod-of (e / embryo 
            :mod (e2 / early)))

# ::snt In mouse ES cells , we show that CAF-1 is also required for regular levels of H4K20me3 at pericentric repeats , but not at IAP elements , which are repeated sequences spread all over the mouse genome .
# ::tok In mouse ES cells , we show that CAF-1 is also required for regular levels of H4K20me3 at pericentric repeats , but not at IAP elements , which are repeated sequences spread all over the mouse genome .
# ::alignments 36-37|0.0.1.2.1.1.0.0 35-36|0.0.1.2.1.1.0.0.0 32-33|0.0.1.2.2 31-32|0.0.1.2.1.1.0 30-31|0.0.1.2.1.1 29-30|0.0.1.2.1 25-26|0.0.1.2.1.0 24-25|0.0.1.2.1.0.0 22-23|0.0.1.0 21-22|0 19-20|0.0.1.1.0 16-17|0.0.2 14-15|0.0 13-14|0.0.0 11-12|0.0.1 10-11|0.0.1.3 8-9|0.0.1.1.1.0+0.0.1.1.1+0.0.1.1 6-7|0.0.1.2 5-6|0.0.1.2.0 3-4|0.0.1.2.3 2-3|0.0.1.2.3.0 1-2|0.0.1.2.3.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:02.190
(c / contrast-01 
      :ARG1 (l / level 
            :ARG1-of (r3 / regular-02) 
            :ARG2-of (r4 / require-01 
                  :ARG0 - 
                  :ARG1 (p / person 
                        :ARG1-of (r2 / repeat-01) 
                        :name (n / name 
                              :op1 "CAF-1")) 
                  :ARG1-of (s3 / show-01 
                        :ARG0 (w / we) 
                        :ARG2-of (r / repeat-01 
                              :ARG0 (e / element 
                                    :mod (i / IAP)) 
                              :ARG1 (s2 / sequence 
                                    :ARG1-of (s / spread-02 
                                          :time (g / genome 
                                                :mod (m / mouse))))) 
                        :mod (a / all) 
                        :time (c2 / cell 
                              :mod (e2 / e 
                                    :mod (m2 / mouse)))) 
                  :mod (a2 / also)) 
            :mod (h / H4K20me3)))

# ::snt These data suggest that proper nuclear organization and epigenetic marking of pericentric heterochromatin are coupled in ES cells .
# ::tok These data suggest that proper nuclear organization and epigenetic marking of pericentric heterochromatin are coupled in ES cells .
# ::alignments 17-18|0.1.0 16-17|0.1.0.0 14-15|0.1 12-13|0.1.1.0.0 9-10|0.1.1.0 8-9|0.1.1.1 7-8|0.1.1 6-7|0.1.2 5-6|0.1.1.1.0 4-5|0.1.2.0 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:02.421
(s / suggest-01 
      :ARG0 (d / data 
            :mod (t / this)) 
      :ARG1 (c2 / couple-01 
            :ARG0 (c / cell 
                  :mod (e / e)) 
            :ARG1 (a / and 
                  :ARG0-of (m / mark-01 
                        :ARG1 (h / heterochromatin)) 
                  :op1 (e2 / epigenetic 
                        :mod (n / nucleus))) 
            :ARG2 (o / organization 
                  :mod (p / proper))))

# ::snt Alternatively , 3-D organization of heterochromatin and epigenetic marking might represent two independent functions of CAF-1 .
# ::tok Alternatively , 3-D organization of heterochromatin and epigenetic marking might represent two independent functions of CAF-1 .
# ::alignments 15-16|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 13-14|0.0.1 12-13|0.0.1.1.1+0.0.1.1 11-12|0.0.1.2 10-11|0.0 9-10|0 8-9|0.0.2 7-8|0.0.2.0 6-7|0.0.2.0.0 5-6|0.0.2.0.0.0 3-4|0.0.0 2-3|0.0.0.0 0-1|0.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:02.699
(p2 / possible-01 
      :ARG1 (r / represent-01 
            :ARG0 (o / organization 
                  :mod 3-d) 
            :ARG1 (f / function-01 
                  :ARG0 (p / person 
                        :name (n / name 
                              :op1 "CAF-1")) 
                  :ARG1 (d / depend-01 
                        :ARG1 (a2 / alternatively) 
                        :polarity -) 
                  :quant 2) 
            :time (m / mark-01 
                  :ARG1 (e / epigenetic 
                        :op2-of (a / and 
                              :op1 (h / heterochromatin))))))

# ::snt The variable requirement for CAF-1 across species might reflect the acquisition of new properties affecting the function of histone H3 variants during evolution of eukaryotes .
# ::tok The variable requirement for CAF-1 across species might reflect the acquisition of new properties affecting the function of histone H3 variants during evolution of eukaryotes .
# ::alignments 24-25|0.0.1.0.0.1.0 22-23|0.0.1.0.0.1 20-21|0.0.1.0.0.0.0 19-20|0.0.1.0.0.0.0.0 18-19|0.0.1.0.0.0.1 16-17|0.0.1.0.0.0 14-15|0.0.1.0.0 13-14|0.0.1.0 12-13|0.0.1.0.1 10-11|0.0.1 8-9|0.0 7-8|0 6-7|0.0.0.1 5-6|0.0.0.1.0 4-5|0.0.0.2.0.0+0.0.0.2.0+0.0.0.2 2-3|0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:03.648
(p2 / possible-01 
      :ARG1 (r / reflect-01 
            :ARG1 (r2 / require-01 
                  :ARG0 (v2 / variable) 
                  :ARG1 (s / species 
                        :op1-of (a3 / across)) 
                  :purpose (p3 / person 
                        :name (n2 / name 
                              :op1 "CAF-1"))) 
            :ARG2 (a2 / acquire-01 
                  :ARG1 (p / property 
                        :ARG0-of (a / affect-01 
                              :ARG1 (f / function-01 
                                    :ARG1 (v / variant 
                                          :mod (h / H3)) 
                                    :location (h2 / histone)) 
                              :time (e2 / evolve-02 
                                    :ARG1 (e / eukaryot))) 
                        :mod (n / new)))))

# ::snt CAF-1 is essential in mammals but dispensable in Saccharomyces cerevisiae [ 38 ] .
# ::tok CAF-1 is essential in mammals but dispensable in Saccharomyces cerevisiae [ 38 ] .
# ::alignments 11-12|0.0 8-10|0.3.0.1+0.3.0.0+0.3.0+0.3 6-7|0.2 5-6|0 4-5|0.1.0.1 2-3|0.1 0-1|0.1.0.0.0+0.1.0.0+0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:03.897
(c2 / contrast-01 
      :ARG0 38 
      :ARG1 (e / essential 
            :domain (p / person 
                  :name (n2 / name 
                        :op1 "CAF-1") 
                  :poss-of (m / mammal))) 
      :ARG2 (d / dispensable) 
      :location (t / thing 
            :name (n / name 
                  :op1 (s / Saccharomyces) 
                  :op2 (c / cerevisiae))))

# ::snt Interestingly , the budding yeast genome does not contain heterochromatin regions equivalent to those of higher eukaryotes , and several hallmark features of heterochromatin such as di - and trimethylation at H3K9 , H3K27 , and H4K20 are not observed in the silent chromatin of S. cerevisiae .
# ::tok Interestingly , the budding yeast genome does not contain heterochromatin regions equivalent to those of higher eukaryotes , and several hallmark features of heterochromatin such as di - and trimethylation at H3K9 , H3K27 , and H4K20 are not observed in the silent chromatin of S. cerevisiae .
# ::alignments 46-47|0.2.1.0.0.2.0 45-46|0.2.1.0.0.2.0.0.0.0+0.2.1.0.0.2.0.0.0+0.2.1.0.0.2.0.0 43-44|0.2.1.0.0.2 42-43|0.0 39-40|0.2.1.0.0 38-39|0.2.1.0.0.3 35-36|0.2.1 31-32|0.2.1.1.0.0+0.2.1.1.0+0.2.1.1 29-30|0.2.1.0.0.1 28-29|0.2.1.0 24-25|0.2.1.0.0.0.1.0 21-22|0 20-21|0.1 19-20|0.3 18-19|0.2 16-17|0.2.0 15-16|0.2.0.0 11-12|0.2.1.0.0.0.0.1 10-11|0.2.1.0.0.0.0.0 9-10|0.2.1.0.0.0.0.0.0 8-9|0.2.1.0.0.0.0 7-8|0.2.1.0.0.0.0.3 5-6|0.2.1.0.0.0 4-5|0.2.1.0.0.0.2 3-4|0.2.1.0.0.0.1 0-1|0.2.1.0.0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:04.771
(f / feature-01 
      :ARG0 (s / silent) 
      :ARG1 (h / hallmark) 
      :op2-of (a3 / and 
            :op1 (e / eukaryot 
                  :ARG1-of (h2 / high-02)) 
            :op1-of (a / and 
                  :op1-of (a2 / and 
                        :op2 (o / observe-01 
                              :ARG0 (g / genome 
                                    :ARG0-of (c4 / contain-01 
                                          :ARG1 (r / region 
                                                :mod (h3 / heterochromatin)) 
                                          :ARG2 (e2 / equivalent) 
                                          :manner (i / interesting) 
                                          :polarity -) 
                                    :ARG1-of (b / bud-01 
                                          :ARG0 (s2 / such)) 
                                    :mod (y / yeast)) 
                              :ARG1 (t2 / trimethylation) 
                              :ARG2 (c3 / chromatin 
                                    :mod (c / cerevisiae 
                                          :mod (c2 / country 
                                                :name (n / name 
                                                      :op1 "S.")))) 
                              :polarity -)) 
                  :op2 (t / thing 
                        :name (n2 / name 
                              :op1 "H3K9")))) 
      :quant (s3 / several))

# ::snt In mammals , H3K9 dimethylation is predominantly associated with H3 .1 , but not with H3 .3 , which carries modifications typically found in transcribed chromatin regions [ 39 ] .
# ::tok In mammals , H3K9 dimethylation is predominantly associated with H3 .1 , but not with H3 .3 , which carries modifications typically found in transcribed chromatin regions [ 39 ] .
# ::alignments 28-29|0.1 26-27|0.2.1.0.1 25-26|0.2.1.0.1.1 24-25|0.2.1.0.1.0 22-23|0.2.1.0 21-22|0.2.1.0.0 20-21|0.2.1.0.2.0 19-20|0.2.1.0.2 13-14|0.2.0 12-13|0 7-8|0.2 6-7|0.2.1.0.2.0.0 3-5|0.2.1.1.1+0.2.1.1.0+0.2.1.1+0.2.1 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:05.313
(c3 / contrast-01 
      :ARG0 (m2 / mammal) 
      :ARG1 39 
      :ARG2 (a / associate-01 
            :ARG0 - 
            :ARG1 (t3 / thing 
                  :ARG1-of (f / find-01 
                        :ARG1-of (t2 / typical-02) 
                        :location (r / region 
                              :ARG1-of (t / transcribe-01) 
                              :mod (c / chromatin)) 
                        :purpose-of (c2 / carry-out-03 
                              :ARG1 (m / modify-01 
                                    :ARG1 (p / predominant)))) 
                  :name (n / name 
                        :op1 (h / H3K9) 
                        :op2 (d / dimethylation)))))

# ::snt Outside of the centromeric H3 variant , S. cerevisiae possesses only H3 .3 , which is expressed and incorporated into chromatin in a replication-independent fashion in higher eukaryotes [ 12 ] .
# ::tok Outside of the centromeric H3 variant , S. cerevisiae possesses only H3 .3 , which is expressed and incorporated into chromatin in a replication-independent fashion in higher eukaryotes [ 12 ] .
# ::alignments 29-30|0.3.1.0 27-28|0.3.0.1.1 26-27|0.3.0.1 24-25|0.2 20-21|0.1 18-19|0.3.1 17-18|0.3 16-17|0 10-11|0.0 9-10|0.3.0 7-9|0.3.0.0.0.1+0.3.0.0.0.0+0.3.0.0.0+0.3.0.0 5-6|0.3.0.1.0 4-5|0.3.0.1.0.0 3-4|0.3.0.1.0.1 0-1|0.3.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:05.606
(e2 / express-01 
      :ARG1 (o / only) 
      :ARG2 (c / chromatin) 
      :manner (f / fashion) 
      :op1-of (a / and 
            :ARG1-of (p / possess-01 
                  :ARG0 (t / thing 
                        :name (n / name 
                              :op1 (s / S.) 
                              :op2 (c2 / cerevisiae))) 
                  :ARG2-of (h / high-02 
                        :ARG0 (v / variant 
                              :mod (h2 / H3) 
                              :mod (c3 / centromeric)) 
                        :ARG1 (e / eukaryot)) 
                  :time (o2 / outside)) 
            :op2 (i / incorporate-01 
                  :ARG0 12)))

# ::snt These data suggest a specific role for H3 .1 in heterochromatin regions .
# ::tok These data suggest a specific role for H3 .1 in heterochromatin regions .
# ::alignments 11-12|0.1.0.0 5-6|0.1 4-5|0.1.0 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:05.670
(s2 / suggest-01 
      :ARG0 (d / data 
            :mod (t / this)) 
      :ARG1 (r2 / role 
            :ARG1-of (s / specific-02 
                  :ARG0 (r / region))))

# ::snt We show here that CAF-1 , which is a H3 .1 replication-dependent loading complex [ 11 ] , is specifically required for the nuclear organization of pericentric heterochromatin in embryos and ES cells .
# ::tok We show here that CAF-1 , which is a H3 .1 replication-dependent loading complex [ 11 ] , is specifically required for the nuclear organization of pericentric heterochromatin in embryos and ES cells .
# ::alignments 32-33|0.1.1.3 31-32|0.1.1.3.0 30-31|0.1.1 29-30|0.1.1.2 27-28|0.1.1.1 24-25|0.1.0 23-24|0.1.1.0.1 20-21|0.1 19-20|0.1.3 15-16|0.1.3.0 13-14|0.1.1.0.0 12-13|0.1.1.0 4-5|0.1.2.0.0+0.1.2.0+0.1.2 2-3|0.2 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:06.010
(s2 / show-01 
      :ARG0 (w / we) 
      :ARG1 (r / require-01 
            :ARG0 (o / organization) 
            :ARG1 (a / and 
                  :ARG2-of (l / load-01 
                        :ARG0 (c2 / complex) 
                        :ARG1 (n / nucleus)) 
                  :location-of (h / heterochromatin) 
                  :op1 (e2 / embryo) 
                  :op2 (c / cell 
                        :mod (e / e))) 
            :ARG2 (p / person 
                  :name (n2 / name 
                        :op1 "CAF-1")) 
            :manner (s / specific-02 
                  :ARG1 11)) 
      :location (h2 / here))

# ::snt One possibility would be a scenario in which incorporation of H3 .1 into chromatin is required for the proper nuclear organization of constitutive heterochromatin in an embryonic context .
# ::tok One possibility would be a scenario in which incorporation of H3 .1 into chromatin is required for the proper nuclear organization of constitutive heterochromatin in an embryonic context .
# ::alignments 27-28|0.0.0.0.0.0 26-27|0.0.0.0.0 23-24|0.0.2.1 22-23|0.0.2.1.0 20-21|0.0.2 19-20|0.0.0.0.1 18-19|0.0.2.0 15-16|0.0 13-14|0 8-9|0.0.1 5-6|0.0.0 1-2|0.0.0.0 0-1|0.0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:06.346
(c3 / chromatin 
      :ARG1-of (r / require-01 
            :ARG0 (s / scenario 
                  :domain (p2 / possible-01 
                        :ARG0 (e / embryonic 
                              :mod-of (c / context)) 
                        :ARG2 (n / nucleus) 
                        :quant 1)) 
            :ARG2 (i / incorporation) 
            :beneficiary (o / organization 
                  :mod (p / proper) 
                  :quant-of (h / heterochromatin 
                        :mod (c2 / constitutive)))))

# ::snt While this has to be addressed experimentally , it is worthwhile to mention an alternate possible mechanism that might explain the disruption of heterochromatin domains in p150CAF-1 null embryos and ES cells .
# ::tok While this has to be addressed experimentally , it is worthwhile to mention an alternate possible mechanism that might explain the disruption of heterochromatin domains in p150CAF-1 null embryos and ES cells .
# ::alignments 31-32|0.0.2.1 30-31|0.0.2.1.0 29-30|0.0.2 28-29|0.0.2.0 27-28|0.0.2.0.0 24-25|0.0.2.0.0.0 23-24|0.0.2.0.0.0.0 21-22|0.0.1 19-20|0.0 18-19|0 16-17|0.0.0 15-16|0.0.0.1 14-15|0.0.0.2 12-13|0.0.0.0 10-11|0.0.0.0.0 6-7|0.0.0.0.0.0.0.0.0 5-6|0.0.0.0.0.0.0.0 1-2|0.0.0.0.0.0.0 0-1|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:07.411
(p / possible-01 
      :ARG1 (e3 / explain-01 
            :ARG0 (m / mechanism 
                  :ARG1-of (m2 / mention-01 
                        :domain-of (w / worthwhile 
                              :ARG0-of (w2 / while-01 
                                    :ARG1 (t / this 
                                          :ARG1-of (a3 / address-02 
                                                :manner (e4 / experimentally)))))) 
                  :ARG1-of (p2 / possible-01) 
                  :mod (a2 / alternate-01)) 
            :ARG1 (d2 / disruption) 
            :op1-of (a / and 
                  :op2 (e2 / embryo 
                        :ARG1-of (n / null-02 
                              :ARG0 (d / domain 
                                    :mod (h / heterochromatin)))) 
                  :op3 (c / cell 
                        :mod (e / e)))))

# ::snt CAF-1 could be required for the loading , into heterochromatin , of an interacting partner required for the clustering of pericentric domains .
# ::tok CAF-1 could be required for the loading , into heterochromatin , of an interacting partner required for the clustering of pericentric domains .
# ::alignments 21-22|0.0.0.0.0.2.0.0 18-19|0.0.0.0.0.2.0 15-16|0.0.0.0.0.2 14-15|0.0.0.0.0 13-14|0.0.0.0.0.1 9-10|0.0.0.0.0.0 6-7|0.0.0.0 3-4|0.0 1-2|0 0-1|0.0.0.1.0+0.0.0.1+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:07.572
(p2 / possible-01 
      :ARG1 (r2 / require-01 
            :ARG1 (p3 / person 
                  :ARG1-of (l / load-01 
                        :ARG2 (p / partner-01 
                              :ARG0 (h / heterochromatin) 
                              :ARG1-of (i / interact-01) 
                              :ARG1-of (r / require-01 
                                    :ARG2 (c / cluster-01 
                                          :ARG1 (d / domain))))) 
                  :name (n / name 
                        :op1 "CAF-1"))))

# ::snt Following one or two rounds of DNA replication in the absence of p150CAF-1 , heterochromatin would become deprived of this molecule , which would cause the disruption of its 3-D organization .
# ::tok Following one or two rounds of DNA replication in the absence of p150CAF-1 , heterochromatin would become deprived of this molecule , which would cause the disruption of its 3-D organization .
# ::alignments 30-31|0.1.0 29-30|0.1.0.0 26-27|0.1 24-25|0 20-21|0.0 19-20|0.0.1 17-18|0.0.0 16-17|0.0.0.1 14-15|0.0.0.1.0 10-11|0.0.0.1.1.0.0 7-8|0.0.0.1.1.0.1 6-7|0.0.0.1.1.0.1.0 4-5|0.0.0.1.1.0 3-4|0.0.0.0 2-3|0.0.0.1.1.1 0-1|0.0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:08.052
(c / cause-01 
      :ARG0 (m / molecule 
            :ARG1-of (d2 / deprive-01 
                  :ARG0 2 
                  :ARG2-of (b / become-01 
                        :ARG1 (h / heterochromatin) 
                        :ARG1-of (f / follow-01 
                              :ARG2 (r2 / round 
                                    :ARG2-of (a / absent-01) 
                                    :mod (r / replication 
                                          :mod (d3 / DNA))) 
                              :op1-of (o2 / or)))) 
            :mod (t / this)) 
      :ARG1 (d / disruption 
            :poss (o / organization 
                  :mod 3-d)))

# ::snt A potential candidate is the HP1 protein , which interacts with CAF-1 [ 13,16 ] .
# ::tok A potential candidate is the HP1 protein , which interacts with CAF-1 [ 13,16 ] .
# ::alignments 11-12|0.0.0.0.0+0.0.0.0+0.0.0 9-10|0.0 6-7|0 2-3|0.1 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:08.080
(p2 / protein 
      :ARG1-of (i / interact-01 
            :ARG0 (p / person 
                  :name (n / name 
                        :op1 "CAF-1"))) 
      :domain (c / candidate 
            :mod (p3 / potential)))

# ::snt In agreement with a recent report [ 40 ] , our analysis of heterochromatin in pre-implantation embryos has revealed drastic changes in nuclear organization between the two-cell and blastocyst stages .
# ::tok In agreement with a recent report [ 40 ] , our analysis of heterochromatin in pre-implantation embryos has revealed drastic changes in nuclear organization between the two-cell and blastocyst stages .
# ::alignments 29-30|0.1.1.0.1 28-29|0.1.1.0.0 27-28|0.1.1.0 23-24|0.1.1 22-23|0.2.0 20-21|0.1 19-20|0.1.2 18-19|0 16-17|0.1.0 13-14|0.0.1 11-12|0.0 10-11|0.0.0 7-8|0.2.1 5-6|0.2.2 4-5|0.2.2.0 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:08.454
(r / reveal-01 
      :ARG0 (a2 / analyze-01 
            :ARG0 (w / we) 
            :ARG1 (h / heterochromatin)) 
      :ARG1 (c / change-01 
            :ARG0 (e / embryo) 
            :ARG1 (o / organization 
                  :op1-of (a / and 
                        :op2 (b / blastocyst) 
                        :op3 (s / stage))) 
            :mod (d / drastic)) 
      :medium (a3 / agree-01 
            :ARG0 (n / nucleus) 
            :ARG1 40 
            :ARG2 (r2 / report 
                  :time (r3 / recent))))

# ::snt Cloning experiments in mouse revealed that the nuclear organization of heterochromatin in ES cell nuclei was quickly reverted into the one-cell stage-specific form after nuclear transfer [ 40 ] .
# ::tok Cloning experiments in mouse revealed that the nuclear organization of heterochromatin in ES cell nuclei was quickly reverted into the one-cell stage-specific form after nuclear transfer [ 40 ] .
# ::alignments 27-28|0.0.0 25-26|0.0.1.0 24-25|0.0.1.0.0 23-24|0.1.3 22-23|0.1.2 17-18|0.1 16-17|0.1.1 14-15|0.1.2.0 13-14|0.1.2.0.1 12-13|0.2 10-11|0.1.2.0.0 8-9|0.1.0 7-8|0.0.1.0.1 4-5|0 3-4|0.0.1 1-2|0.0 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:09.130
(r2 / reveal-01 
      :ARG0 (e2 / experiment-01 
            :ARG0 40 
            :ARG1 (m / mouse 
                  :ARG1-of (t / transfer-01 
                        :mod (n / nucleus) 
                        :mod (n3 / nucleus))) 
            :ARG1-of (c2 / clone-01)) 
      :ARG1 (r / revert-01 
            :ARG1 (o / organization) 
            :ARG1-of (q / quick-02) 
            :ARG2 (f / form 
                  :consist-of (n2 / nucleus 
                        :location-of (h / heterochromatin) 
                        :mod (c / cell))) 
            :time (a / after)) 
      :topic (e / e))

# ::snt Hence , remodeling of heterochromatin 3-D organization parallels nuclear reprogramming toward an early embryonic status in cloned embryos .
# ::tok Hence , remodeling of heterochromatin 3-D organization parallels nuclear reprogramming toward an early embryonic status in cloned embryos .
# ::alignments 17-18|0.2.1 16-17|0.2 14-15|0.2.1.0 13-14|0.2.1.0.0 12-13|0.2.1.0.1 9-10|0.1 8-9|0.1.0 7-8|0 6-7|0.0.0 5-6|0.0.0.0 2-3|0.0 0-1|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:09.388
(p / parallel-01 
      :ARG0 (r2 / remodel-01 
            :ARG1 (o / organization 
                  :mod 3-d)) 
      :ARG1 (r / reprogramm 
            :mod (n / nucleus)) 
      :purpose (c / clone-01 
            :ARG0 (h / hence) 
            :ARG1 (e / embryo 
                  :location-of (s / status 
                        :mod (e2 / embryonic) 
                        :mod (e3 / early)))))

# ::snt This drastic reorganization of heterochromatin organization is similar to that observed in p150CAF-1-depleted ES cells , and in developmentally arrested 16-cell stage Chaf1a  /  embryos .
# ::tok This drastic reorganization of heterochromatin organization is similar to that observed in p150CAF-1-depleted ES cells , and in developmentally arrested 16-cell stage Chaf1a  /  embryos .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:09.390
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt These data show that CAF-1 is involved in setting up proper heterochromatin architecture during the first cell divisions of embryonic life .
# ::tok These data show that CAF-1 is involved in setting up proper heterochromatin architecture during the first cell divisions of embryonic life .
# ::alignments 20-21|0.1.0.1 19-20|0.1.0.1.0 17-18|0.1.0.1.1 16-17|0.1.0.1.1.0 12-13|0.1.1.0 10-11|0.1.1.0.0 8-9|0.1.1 6-7|0.1 4-5|0.1.0.0.0+0.1.0.0+0.1.0 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:09.766
(s2 / show-01 
      :ARG0 (d2 / data 
            :mod (t / this)) 
      :ARG1 (i / involve-01 
            :ARG1 (p2 / person 
                  :name (n / name 
                        :op1 "CAF-1") 
                  :poss-of (l / life 
                        :mod (e / embryonic) 
                        :mod-of (d / division 
                              :mod (c / cell)))) 
            :ARG2 (s / set-02 
                  :ARG1 (a / architecture 
                        :mod (p / proper)))))

# ::snt Given the importance of nuclear organization in the control of gene expression [ 21,41 ] , this finding suggests that CAF-1 contributes to the coordinated programs of gene expression during early embryogenesis .
# ::tok Given the importance of nuclear organization in the control of gene expression [ 21,41 ] , this finding suggests that CAF-1 contributes to the coordinated programs of gene expression during early embryogenesis .
# ::alignments 31-32|0.0.1.0 30-31|0.0.1.0.0 28-29|0.0.1 27-28|0.0.1.1 25-26|0.0.0.1 24-25|0.0.0.1.0 21-22|0.0.0 20-21|0.0.2.0+0.0.2+0.0 18-19|0.0.0.0 17-18|0.0.0.0.0 16-17|0.0.0.0.0.1 11-12|0 10-11|0.1 8-9|0.0.0.0.0.0.1 5-6|0.0.0.0.0.0.0.0 4-5|0.0.0.1.1 2-3|0.0.0.0.0.0.0 0-1|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:10.161
(e4 / express-01 
      :ARG0 (p2 / person 
            :ARG0-of (c2 / contribute-01 
                  :ARG1-of (s / suggest-01 
                        :ARG0 (f / find-01 
                              :ARG2-of (g3 / give-01 
                                    :ARG1 (i / important 
                                          :mod (o / organization)) 
                                    :ARG2-of (c3 / control-01)) 
                              :mod (t / this))) 
                  :ARG2 (p / program 
                        :ARG1-of (c / coordinate-01) 
                        :mod (n2 / nucleus))) 
            :ARG0-of (e3 / express-01 
                  :ARG1 (e / embryogenesi 
                        :mod (e2 / early)) 
                  :mod (g / gene)) 
            :name (n / name 
                  :op1 "CAF-1")) 
      :ARG1 (g2 / gene))

# ::snt Our findings open new perspectives in the understanding of chromatin dynamics during early development and in pluripotent embryonic cells .
# ::tok Our findings open new perspectives in the understanding of chromatin dynamics during early development and in pluripotent embryonic cells .
# ::alignments 18-19|0.0 17-18|0 14-15|0.0.0.1.0.1.1 13-14|0.0.0.1.0.2 12-13|0.0.0.1.0.2.0 10-11|0.0.0.1.0.1 9-10|0.0.0.1.0.1.0 7-8|0.0.0.1.0.1.1.0 4-5|0.0.0.1.0.0 3-4|0.0.0.1.0.0.0 2-3|0.0.0.1.0 1-2|0.0.0+0.0.0.1 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:10.660
(e / embryonic 
      :mod-of (c / cell 
            :ARG2-of (f / find-01 
                  :ARG0 (w / we) 
                  :ARG1 (t / thing 
                        :ARG0-of (o / open-01 
                              :ARG1 (p / perspective 
                                    :mod (n / new)) 
                              :time (d2 / dynamic 
                                    :mod (c2 / chromatin) 
                                    :op1-of (a / and 
                                          :ARG1-of (u / understand-01))) 
                              :time (d / develop-02 
                                    :time (e2 / early)))))))

# ::snt While most studies focused on the role of DNA methylation and histone modifying enzymes [ 3 ] , our data point to the importance of the chromatin assembly machinery .
# ::tok While most studies focused on the role of DNA methylation and histone modifying enzymes [ 3 ] , our data point to the importance of the chromatin assembly machinery .
# ::alignments 28-29|0.0.0.1.0.0 27-28|0.0.0.1.0.0.0 26-27|0.0.0.1.0.0.0.0 23-24|0.0.0.1.0 20-21|0.0.0.0.0 19-20|0.0.0.0 18-19|0.0.0.0.1 15-16|0.0.0.1.2 13-14|0.0.0.1.1.0 12-13|0.0.0.1.1 11-12|0.1 10-11|0 9-10|0.0.1 8-9|0.0.1.0 6-7|0.0 3-4|0.0.0 2-3|0.0.0.1 1-2|0.0.0.1.4 0-1|0.0.0.1.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:11.008
(a2 / and 
      :op1 (r / role 
            :ARG2-of (f / focus-01 
                  :ARG0 (d / data 
                        :mod-of (p / point) 
                        :poss (w / we)) 
                  :ARG1 (s / study-01 
                        :ARG0 (i / important 
                              :domain (m / machinery 
                                    :mod (a / assembly 
                                          :mod (c / chromatin)))) 
                        :ARG0-of (m2 / modify-01 
                              :ARG1 (e / enzym)) 
                        :ARG1 3 
                        :ARG2-of (w2 / while-01) 
                        :quant (m4 / most))) 
            :poss (m3 / methylation 
                  :mod (d2 / DNA))) 
      :op2 (h / histone))

# ::snt We show that in addition to assembling nucleosomes , CAF-1 provides spatial and epigenetic information to heterochromatin domains in early embryos and ES cells .
# ::tok We show that in addition to assembling nucleosomes , CAF-1 provides spatial and epigenetic information to heterochromatin domains in early embryos and ES cells .
# ::alignments 23-24|0.0.3.2 22-23|0.0.3.2.0 21-22|0.0.3 20-21|0.0.3.1 19-20|0.0.5 17-18|0.0.3.0 16-17|0.0.3.0.0 14-15|0.0.1 12-13|0 11-12|0.1 10-11|0.0 9-10|0.0.0.0.0+0.0.0.0+0.0.0 7-8|0.0.4.0 6-7|0.0.4 4-5|0.0.4.1 1-2|0.0.2 0-1|0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:12.354
(a2 / and 
      :op1 (p / provide-01 
            :ARG0 (p2 / person 
                  :name (n / name 
                        :op1 "CAF-1")) 
            :ARG1 (i / information) 
            :ARG1-of (s2 / show-01 
                  :ARG0 (w / we)) 
            :ARG2 (a / and 
                  :op1 (d / domain 
                        :mod (h / heterochromatin)) 
                  :op2 (e2 / embryo) 
                  :op3 (c / cell 
                        :mod (e / e))) 
            :condition-of (a3 / assemble-01 
                  :ARG1 (n2 / nucleosom) 
                  :ARG2 (a4 / addition)) 
            :time (e3 / early)) 
      :op2 (s / spatial))

# ::snt Generation of Chaf1a mutant mice and embryos .
# ::tok Generation of Chaf1a mutant mice and embryos .
# ::alignments 6-7|0.0.2.0 5-6|0.0.2 4-5|0.0 3-4|0.0.0 2-3|0.0.1.0.0+0.0.1.0+0.0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:12.382
(g / generation 
      :consist-of (m / mouse 
            :mod (m2 / mutant) 
            :mod (t / thing 
                  :name (n / name 
                        :op1 "Chaf1a")) 
            :op1-of (a / and 
                  :op2 (e / embryo))))

# ::snt Using PCR , we amplified two genomic fragments ( about 3 kb each ) flanking Chaf1a exon 3 .
# ::tok Using PCR , we amplified two genomic fragments ( about 3 kb each ) flanking Chaf1a exon 3 .
# ::alignments 17-18|0.1.0.0.0.0.0 16-17|0.1.0.0.1.0 15-16|0.1.0.0.1.0.0.0.0+0.1.0.0.1.0.0.0+0.1.0.0.1.0.0 14-15|0.1.0.0.1 12-13|0.1.0.1.0 11-12|0 10-11|0.0 9-10|0.1 7-8|0.1.0.1 5-6|0.1.0.1.1 4-5|0.1.0 3-4|0.1.0.0 1-2|0.1.0.0.0.0 0-1|0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:12.816
(k / kb 
      :quant 3 
      :quant (a / about 
            :ARG2-of (a2 / amplify-01 
                  :ARG0 (w / we 
                        :ARG0-of (u / use-01 
                              :ARG1 (p / PCR 
                                    :mod-of 3)) 
                        :ARG0-of (f / flank-01 
                              :ARG1 (e / exon 
                                    :mod (t / thing 
                                          :name (n / name 
                                                :op1 "Chaf1a"))))) 
                  :ARG1 (f2 / fragment-01 
                        :ARG1 (e2 / each) 
                        :quant 2))))

# ::snt These DNA fragments were assembled by conventional cloning with the neomycin and DT ( diphtheria toxin ) cassettes , as described in Figure 1A .
# ::tok These DNA fragments were assembled by conventional cloning with the neomycin and DT ( diphtheria toxin ) cassettes , as described in Figure 1A .
# ::alignments 22-23|0.0.2.0 20-21|0.0.2 17-18|0.0.1.0.0.1 15-16|0.1 14-15|0 11-12|0.0.1.0.0 10-11|0.0.1.0.0.0 7-8|0.0.1.0 6-7|0.0.1.0.1 4-5|0.0.1 2-3|0.0 1-2|0.0.0 0-1|0.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:13.129
(d2 / diphtheria 
      :ARG0-of (f2 / fragment-01 
            :ARG1 (d3 / DNA) 
            :ARG1-of (a2 / assemble-01 
                  :ARG0 (c2 / clone-01 
                        :ARG1 (a / and 
                              :op1 (n / neomycin) 
                              :op2 (c / cassett)) 
                        :mod (c3 / conventional))) 
            :ARG1-of (d / describe-01 
                  :ARG2 (f / figure)) 
            :mod (t2 / this)) 
      :mod-of (t / toxin))

# ::snt The construct was transfected in ES cells by electroporation .
# ::tok The construct was transfected in ES cells by electroporation .
# ::alignments 8-9|0 6-7|0.0.0 5-6|0.0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:13.148
(e / electroporation 
      :ARG1-of (c2 / construct-01 
            :location (c / cell 
                  :mod (e2 / e))))

# ::snt We identified recombinant ES cells carrying the mutant Chaf1atm1Ger ( abbreviated Chaf1a  in the manuscript ) allele by Southern blot ( Figure 1A ) .
# ::tok We identified recombinant ES cells carrying the mutant Chaf1atm1Ger ( abbreviated Chaf1a  in the manuscript ) allele by Southern blot ( Figure 1A ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:13.150
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt We derived Chaf1a + /  mice by injecting recombined ES cells into C57BL/6N blastocysts .
# ::tok We derived Chaf1a + /  mice by injecting recombined ES cells into C57BL/6N blastocysts .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:13.158
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt E4 embryos obtained from the intercross of Chaf1a + /  mice were genotyped by nested-PCR amplification .
# ::tok E4 embryos obtained from the intercross of Chaf1a + /  mice were genotyped by nested-PCR amplification .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:13.162
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Embryos were collected in a PCR reaction mix containing oligonucleotide primers 1 , 2 , and 3 ( Figure 1A ) that amplify the wild-type and mutant alleles .
# ::tok Embryos were collected in a PCR reaction mix containing oligonucleotide primers 1 , 2 , and 3 ( Figure 1A ) that amplify the wild-type and mutant alleles .
# ::alignments 27-28|0.2 26-27|0.1 25-26|0 22-23|0.2.0 18-19|0.2.0.0.0.0.0.0 16-17|0.2.0.0.0.1.0 15-16|0.0 13-14|0.2.0.0.0.0.0.1 11-12|0.2.0.0.0.1.2 10-11|0.2.0.0 8-9|0.2.0.0.0 7-8|0.2.0.0.0.0 6-7|0.2.0.0.0.0.0 2-3|0.2.0.0.0.1 0-1|0.2.0.0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:13.583
(a2 / and 
      :op1 (a4 / and) 
      :op2 (m / mutant) 
      :op3 (a / allel 
            :ARG1-of (a3 / amplify-01 
                  :ARG0 (p / primer 
                        :ARG1-of (c / contain-01 
                              :ARG0 (m2 / mix-01 
                                    :ARG1 (r / react-01 
                                          :ARG0 (f / figure) 
                                          :ARG1 2)) 
                              :manner-of (c2 / collect-01 
                                    :ARG0 3 
                                    :ARG1 (e / embryo) 
                                    :op1-of 1))))))

# ::snt After 30 cycles of amplification , 1 l of each PCR reaction was used in a second round of PCR amplification with a new set of oligonucleotide primers .
# ::tok After 30 cycles of amplification , 1 l of each PCR reaction was used in a second round of PCR amplification with a new set of oligonucleotide primers .
# ::alignments 27-28|0.1.0 24-25|0.1.0.0 23-24|0.1.0.0.0 20-21|0.2.0 17-18|0.2 13-14|0 11-12|0.1 9-10|0.1.1 7-8|0.0 6-7|0.0.0 4-5|0.3.0.0 2-3|0.3.0 1-2|0.3.0.1 0-1|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:13.963
(u / use-01 
      :ARG0 (l / l 
            :quant 1) 
      :ARG1 (r2 / react-01 
            :ARG0 (p / primer 
                  :consist (s / set 
                        :mod (n / new))) 
            :mod (e / each)) 
      :ARG2 (r / round 
            :mod (a / amplification)) 
      :time (a3 / after 
            :op1 (c / cycle-02 
                  :ARG1 (a2 / amplification) 
                  :quant 30)))

# ::snt After 30 cycles of amplification , PCR reactions were run onto an agarose gel , which revealed the presence of the wild-type ( 150 bp ) and recombinant ( 200 bp ) alleles .
# ::tok After 30 cycles of amplification , PCR reactions were run onto an agarose gel , which revealed the presence of the wild-type ( 150 bp ) and recombinant ( 200 bp ) alleles .
# ::alignments 32-33|0.0 29-30|0.1.0.0.1.0.1.0 27-28|0.1.0.0.1.0.0 26-27|0 23-24|0.1.0.0.1.0.2.0.0 18-19|0.1 16-17|0.1.0 13-14|0.1.0.0 12-13|0.1.0.0.0 10-11|0.1.0.0.1 9-10|0.1.0.0.1.0 7-8|0.1.0.0.1.0.1 4-5|0.1.0.0.1.0.2.0.1 2-3|0.1.0.0.1.0.2.0 1-2|0.1.0.0.1.0.2.0.2 0-1|0.1.0.0.1.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:14.386
(a2 / and 
      :op1 (a / allel) 
      :poss-of (p / presence 
            :ARG1-of (r2 / reveal-01 
                  :ARG0 (g / gel 
                        :mod (a3 / agarose) 
                        :op1-of (o / onto 
                              :time-of (r3 / run-01 
                                    :ARG0 (r / recombinant) 
                                    :ARG1 (r4 / react-01 
                                          :ARG0 200) 
                                    :time (a5 / after 
                                          :op1 (c / cycle-02 
                                                :ARG0 150 
                                                :ARG1 (a4 / amplification) 
                                                :quant 30))))))))

# ::snt P150CAF-1 depletion by RNAi .
# ::tok P150CAF-1 depletion by RNAi .
# ::alignments 3-4|0.0.0.0+0.0.0+0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:14.394
(d / depletion 
      :location (t / thing 
            :name (n / name 
                  :op1 "RNAi")))

# ::snt The RNAi plasmid vector that we used in this study contains the mouse H1 promoter and a puromycin selection gene ( SB and MG , unpublished data ) .
# ::tok The RNAi plasmid vector that we used in this study contains the mouse H1 promoter and a puromycin selection gene ( SB and MG , unpublished data ) .
# ::alignments 26-27|0.1.1 25-26|0.1.1.0 23-24|0.0.0.2.1 22-23|0.0.0.2 21-22|0.0.0.2.0 19-20|0.1.0 18-19|0.1.0.0 15-16|0.1 14-15|0.2 13-14|0.2.0 12-13|0.0.0.1.0 10-11|0 9-10|0.0.0.1 8-9|0.0.0.1.1 6-7|0.0.0 5-6|0.0.0.0 3-4|0.0 2-3|0.0.2 1-2|0.0.1.0.0+0.0.1.0+0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:15.659
(c / contain-01 
      :ARG0 (v / vector 
            :ARG1-of (u2 / use-01 
                  :ARG0 (w / we) 
                  :ARG2 (s3 / study-01 
                        :ARG1 (m2 / mouse) 
                        :mod (t / this)) 
                  :op1-of (a / and 
                        :op2 (s / sb) 
                        :op3 (m / mg))) 
            :mod (t2 / thing 
                  :name (n / name 
                        :op1 "RNAi")) 
            :mod (p2 / plasmid)) 
      :ARG1 (a2 / and 
            :op1 (g / gene 
                  :ARG1-of (s2 / select-01)) 
            :op2 (d / data 
                  :mod (u / unpublish))) 
      :ARG2 (p / promote-01 
            :ARG1 (h / H1)))

# ::snt We characterized in detail the properties of this new vector using a GFP target gene and FACS : Extinction of target genes in ES cells is highly efficient in 70 % of the cells , of intermediate efficiency in 15 % , and inefficient in the remaining 15 % of cells analysis .
# ::tok We characterized in detail the properties of this new vector using a GFP target gene and FACS : Extinction of target genes in ES cells is highly efficient in 70 % of the cells , of intermediate efficiency in 15 % , and inefficient in the remaining 15 % of cells analysis .
# ::alignments 51-52|0.1.0.1.1.0.0.0 50-51|0.1.0.1.1.0.0.0.0 48-49|0.1.0.1.1.0.0 47-48|0.1.0.1.1.0.0.1 46-47|0.1.0.1.1.0.0.0.1 43-44|0.1.0.1.1.2.1+0.1.0.1.1.2 42-43|0.1.0.1.1 40-41|0.1.0.1.1.1.1 39-40|0.1.0.1.1.1.1.0 37-38|0.1.0.1.1.1 36-37|0.1.0.1.1.1.2 33-34|0.1.0.1.1.1.0 30-31|0.1.0.1.1.1.0.0 29-30|0.1.0.1.1.1.0.0.0 27-28|0.1.0.1.1.0 26-27|0.1.0.1.1.0.1 24-25|0.1.0.1.1.3.1 23-24|0.1.0.1.1.3.1.0 21-22|0.1.0.1.1.3 20-21|0.1.0.1.1.3.0 18-19|0.1.0.1.1.2.0 16-17|0.2 15-16|0 14-15|0.1 13-14|0.1.1 12-13|0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 10-11|0.0 9-10|0.0.0 8-9|0.0.0.0 7-8|0.0.0.1 5-6|0.1.0.0 3-4|0.1.0 1-2|0.1.0.1 0-1|0.1.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:18.934
(a3 / and 
      :ARG1-of (u / use-01 
            :ARG0 (v / vector 
                  :mod (n2 / new) 
                  :mod (t3 / this))) 
      :op1 (g2 / gene 
            :ARG0-of (d / detail-01 
                  :ARG1 (p4 / property) 
                  :ARG2-of (c4 / characterize-01 
                        :ARG0 (w / we) 
                        :ARG1 (a2 / and 
                              :op1 (e3 / efficient-01 
                                    :ARG0 (p / percentage-entity 
                                          :ARG2-of (a / analyze-01 
                                                :ARG1 (c / cell) 
                                                :ARG1-of (r / remain-01)) 
                                          :value 15) 
                                    :degree (h / high)) 
                              :op2 (e2 / efficient-01 
                                    :ARG1 (c2 / cell 
                                          :domain-of (p3 / percentage-entity 
                                                :value 70)) 
                                    :ARG2 (p2 / percentage-entity 
                                          :value 15) 
                                    :mod (i / intermediate)) 
                              :op3 (e / efficient-01 
                                    :ARG1 (e5 / extinction) 
                                    :polarity -) 
                              :poss (g / gene 
                                    :ARG1-of (t / target-01) 
                                    :location (c3 / cell 
                                          :mod (e4 / e)))))) 
            :ARG1-of (t2 / target-01 
                  :ARG0 (o / organization 
                        :name (n / name 
                              :op1 "GFP")))) 
      :op2 (f / fac))

# ::snt The sequence of p150CAF-1 siRNA ( short interfering RNA ) duplex [ 16 ] was cloned into this plasmid .
# ::tok The sequence of p150CAF-1 siRNA ( short interfering RNA ) duplex [ 16 ] was cloned into this plasmid .
# ::alignments 18-19|0.0.1.2 17-18|0.0.1.2.0 15-16|0.0.1 12-13|0.0.0 10-11|0.0.1.0 8-9|0 7-8|0.0 6-7|0.1 4-5|0.0.1.3 1-2|0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:19.057
(r / rna 
      :ARG1-of (i / interfere-01 
            :ARG0 16 
            :purpose-of (c / clone-01 
                  :ARG0 (d / duplex) 
                  :ARG1 (s3 / sequence) 
                  :ARG2 (p / plasmid 
                        :mod (t / this)) 
                  :op1-of (s2 / siRNA))) 
      :mod (s / short))

# ::snt The control vector expressed a siRNA that targets GFP RNA degradation .
# ::tok The control vector expressed a siRNA that targets GFP RNA degradation .
# ::alignments 10-11|0.1.0.0 9-10|0.1.0.0.0 8-9|0.1.0.0.1.0.0+0.1.0.0.1.0+0.1.0.0.1 7-8|0.1.0 5-6|0.1 3-4|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:19.099
(e / express-01 
      :ARG0 (v / vector 
            :mod (c / control-01)) 
      :ARG1 (s / siRNA 
            :ARG0-of (t / target-01 
                  :ARG1 (d / degradation 
                        :mod (r / rna) 
                        :mod (o / organization 
                              :name (n / name 
                                    :op1 "GFP"))))))

# ::snt ES cells were transfected by electroporation with the RNA plasmid vector , seeded onto gelatin-coated slides , and cultured for 24 h in the absence of selection .
# ::tok ES cells were transfected by electroporation with the RNA plasmid vector , seeded onto gelatin-coated slides , and cultured for 24 h in the absence of selection .
# ::alignments 26-27|0.2.0 24-25|0.2 21-22|0.1.1 20-21|0.1.1.0 18-19|0.1 17-18|0 15-16|0.0.1 14-15|0.0.1.1 13-14|0.0.1.2 12-13|0.0 10-11|0.0.1.0.0 9-10|0.0.1.0 8-9|0.0.1.0.0.0 5-6|0.1.0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:19.545
(a2 / and 
      :op1 (s3 / seed-01 
            :ARG1 (c2 / cell 
                  :mod (e2 / e)) 
            :ARG2 (s2 / slide-01 
                  :ARG0 (p / plasmid 
                        :mod-of (v / vector 
                              :mod (r / rna))) 
                  :mod (g / gelatin-coat) 
                  :op1-of (o / onto))) 
      :op2 (c / culture-01 
            :ARG0 (e / electroporation) 
            :ARG1 (h / h 
                  :quant 24)) 
      :time (a / absent-01 
            :ARG1 (s / select-01)))

# ::snt Puromycin ( 2 g/ml ) was added to the culture medium and cells were cultured for an additional 48-h period .
# ::tok Puromycin ( 2 g/ml ) was added to the culture medium and cells were cultured for an additional 48-h period .
# ::alignments 19-20|0.2.0.2 17-18|0.2.0.2.0 14-15|0.2.0 12-13|0.2.0.1 11-12|0.2 10-11|0.1 9-10|0.1.0 6-7|0 2-3|0.2.0.0 0-2|0.0.0.1+0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:19.921
(a3 / add-01 
      :ARG1 (o / organization 
            :name (n / name 
                  :op1 "Puromycin" 
                  :op2 "(")) 
      :ARG2 (m / medium 
            :mod (c3 / culture)) 
      :op1-of (a2 / and 
            :op2 (c / culture-01 
                  :ARG0 2 
                  :ARG1 (c2 / cell) 
                  :time (p / period 
                        :mod (a / additional)))))

# ::snt Using the p150CAF-1 RNAi vector , IF microscopy quantification reveals a complete CAF-1 depletion in most cells ( Figure S1B ) .
# ::tok Using the p150CAF-1 RNAi vector , IF microscopy quantification reveals a complete CAF-1 depletion in most cells ( Figure S1B ) .
# ::alignments 18-20|0.0.1.0.0.1+0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 16-17|0.1.1 15-16|0.1.1.0 13-14|0.1 12-13|0.1.2.0.0+0.1.2.0+0.1.2 11-12|0.1.0 9-10|0 8-9|0.0 7-8|0.0.2 6-7|0.0.1 4-5|0.0.0.0 3-4|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:20.346
(r / reveal-01 
      :ARG0 (q / quantification 
            :ARG0-of (u / use-01 
                  :ARG1 (v / vector 
                        :mod (t3 / thing 
                              :name (n3 / name 
                                    :op1 "RNAi")))) 
            :ARG1-of (c3 / cause-01 
                  :ARG0 (t / thing 
                        :name (n / name 
                              :op1 (f / Figure) 
                              :op2 (s / S1B)))) 
            :mod (m2 / microscopy)) 
      :ARG1 (d / depletion 
            :ARG1-of (c2 / complete-02) 
            :location (c / cell 
                  :quant (m / most)) 
            :mod (t2 / thing 
                  :name (n2 / name 
                        :op1 "CAF-1"))))

# ::snt Western blot analysis ( Figure S1A ) reveals residual p150CAF-1 expression , as expected from the 15 % of cells that do not inhibit the target gene .
# ::tok Western blot analysis ( Figure S1A ) reveals residual p150CAF-1 expression , as expected from the 15 % of cells that do not inhibit the target gene .
# ::alignments 26-27|0.0.0.1.0.0.0 25-26|0.0.0.1.0.0.0.0 23-24|0.0.0.1.0.0 22-23|0.0.0.1.0.0.1 19-20|0.0.0.1.0 17-18|0.0.0.1 16-17|0.0.0.1.1 13-14|0.0.0 10-11|0.1 8-9|0.1.0 7-8|0 5-6|0.0.0.0 4-5|0.0.0.0.0 2-3|0.0 1-2|0.0.1 0-1|0.0.2.1+0.0.2.0.0+0.0.2.0+0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:20.886
(r2 / reveal-01 
      :ARG0 (a / analyze-01 
            :ARG0-of (e / expect-01 
                  :ARG1 (s / S1A 
                        :mod-of (f / figure)) 
                  :ARG4 (p / percentage-entity 
                        :domain (c / cell 
                              :ARG0-of (i / inhibit-01 
                                    :ARG1 (g / gene 
                                          :ARG1-of (t / target-01)) 
                                    :polarity -)) 
                        :value 15)) 
            :ARG1 (b / blot-01) 
            :manner (w / world-region 
                  :name (n / name 
                        :op1 "West") 
                  :wiki "Western_world")) 
      :ARG1 (e2 / express-01 
            :mod (r / residual)))

# ::snt MEFs ( passage 3 , 90 % confluence ) were transfected during 4 h with the RNAi plasmid vector using Lipofectamine 2000 ( Invitrogene , Carlsbad , California , United States ) according to manufacturer 's conditions .
# ::tok MEFs ( passage 3 , 90 % confluence ) were transfected during 4 h with the RNAi plasmid vector using Lipofectamine 2000 ( Invitrogene , Carlsbad , California , United States ) according to manufacturer 's conditions .
# ::alignments 36-37|0.0 34-35|0.0.0 32-33|0 29-31|0.1.0.0.0.1.1+0.1.0.0.0.1.0.1+0.1.0.0.0.1.0.0+0.1.0.0.0.1.0+0.1.0.0.0.1 27-28|0.0.0.1.1+0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 25-26|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 23-24|0.1.0.0.0.0.0.0+0.1.0.0.0.0.0+0.1.0.0.0.0 21-22|0.1.0.0.0.2.0+0.1.0.0.0.2 20-21|0.1.1.0.0+0.1.1.0+0.1.1 19-20|0.1 18-19|0.1.0 17-18|0.1.0.1 16-17|0.1.0.0.1.0+0.1.0.0.1+0.1.0.0 13-14|0.1.0.2 12-13|0.1.0.2.0 7-8|0.2 6-7|0.2.0 5-6|0.2.0.1 3-4|0.2.0.0 2-3|0.1.0.0.0 0-1|0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:22.667
(s / say-01 
      :ARG0 (c / condition 
            :poss (m / manufacture-01 
                  :ARG0 (c3 / country 
                        :name (n3 / name 
                              :op1 "Carlsbad")) 
                  :ARG1 (s2 / state 
                        :name (n2 / name 
                              :op1 "California") 
                        :wiki "California"))) 
      :ARG1 (u / use-01 
            :ARG0 (v / vector 
                  :mod (t / thing 
                        :ARG1-of (p3 / pass-01 
                              :ARG0 (o / organization 
                                    :name (n4 / name 
                                          :op1 "Invitrogene")) 
                              :op1-of (c2 / country 
                                    :name (n / name 
                                          :op1 "United" 
                                          :op2 "States") 
                                    :wiki "United_States") 
                              :time (d / date-entity 
                                    :year 2000)) 
                        :name (n6 / name 
                              :op1 "RNAi")) 
                  :mod (p / plasmid) 
                  :mod (h / h 
                        :quant 4)) 
            :ARG1 (o2 / organization 
                  :name (n5 / name 
                        :op1 "Lipofectamine")) 
            :ARG2 (m2 / mef)) 
      :ARG2 (c4 / confluence 
            :mod (p2 / percentage-entity 
                  :quant 3 
                  :value 90)))

# ::snt Cells were trypsinized , plated at 1/3 dilution , and cultured for 48 h in the presence of puromycin .
# ::tok Cells were trypsinized , plated at 1/3 dilution , and cultured for 48 h in the presence of puromycin .
# ::alignments 16-17|0.1.1.0 13-14|0.1.1 12-13|0.1.1.1 10-11|0.1 9-10|0 7-8|0.0.0 4-5|0.0 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:22.809
(a / and 
      :op1 (p2 / plate-01 
            :ARG1 (d / dilution)) 
      :op2 (c / culture-01 
            :ARG1 (c2 / cell) 
            :ARG2 (h / h 
                  :location (p / presence) 
                  :quant 48)))

# ::snt Cell lines .
# ::tok Cell lines .
# ::alignments 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:22.814
(l / line 
      :mod (c / cell))

# ::snt AT-1 ES cells [ 42 ] ( a gift of M. Vernet ) were used for gene targeting .
# ::tok AT-1 ES cells [ 42 ] ( a gift of M. Vernet ) were used for gene targeting .
# ::alignments 17-18|0.2.0 16-17|0.2 14-15|0 10-12|0.1.0.0.0.1+0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 8-9|0.1.0+0.1 4-5|0.2.0.0 2-3|0.0 0-2|0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:23.303
(u / use-01 
      :ARG0 (c / cell 
            :mod (t3 / thing 
                  :name (n2 / name 
                        :op1 (a / AT-1) 
                        :op2 (e / ES)))) 
      :ARG1 (t2 / thing 
            :ARG1-of (g2 / gift-01 
                  :ARG0 (p / person 
                        :name (n / name 
                              :op1 "M." 
                              :op2 "Vernet")))) 
      :ARG2 (g / gene 
            :ARG1-of (t / target-01 
                  :ARG0 42)))

# ::snt LTM7 ES cells were used in all RNAi experiments .
# ::tok LTM7 ES cells were used in all RNAi experiments .
# ::alignments 8-9|0.1 7-8|0.1.0.0.0+0.1.0.0+0.1.0 6-7|0.1.1 4-5|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:23.332
(u / use-01 
      :ARG1 (c / cell 
            :mod (e2 / e)) 
      :ARG2 (e / experiment-01 
            :ARG1 (t / thing 
                  :name (n / name 
                        :op1 "RNAi")) 
            :quant (a / all)))

# ::snt We derived this cell line from ( C57BL/6  129 ) F1 females bred with C3H/HeJ males .
# ::tok We derived this cell line from ( C57BL/6  129 ) F1 females bred with C3H/HeJ males .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:23.334
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt LTM7 are XX ES cells , competent for germ line transmission .
# ::tok LTM7 are XX ES cells , competent for germ line transmission .
# ::alignments 10-11|0.0.1 9-10|0.0 8-9|0 6-7|0.0.1.0 4-5|0.0.1.0.0 2-4|0.0.1.0.0.0.0.1+0.0.1.0.0.0.0.0+0.0.1.0.0.0.0+0.0.1.0.0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:23.545
(g / germ 
      :mod-of (l / line 
            :mod-of (l2 / LTM7) 
            :mod-of (t / transmission 
                  :prep-with-of (c / competent-01 
                        :ARG1 (c2 / cell 
                              :mod (t2 / thing 
                                    :name (n / name 
                                          :op1 (x / XX) 
                                          :op2 (e / ES))))))))

# ::snt Primary MEFs were derived from E13 embryos as described in [ 43 ] .
# ::tok Primary MEFs were derived from E13 embryos as described in [ 43 ] .
# ::alignments 11-12|0.0 8-9|0.1.0 6-7|0.2 5-6|0.2.0 3-4|0 1-2|0.1 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:23.577
(d2 / derive-01 
      :ARG0 43 
      :ARG1 (m / mef 
            :ARG1-of (d / describe-01) 
            :mod (p / primary)) 
      :ARG2 (e / embryo 
            :mod (e2 / E13)))

# ::snt Immunofluorescence .
# ::tok Immunofluorescence .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:23.580
(i / immunofluorescence)

# ::snt Cells were fixed for 20 min in PBS with 4 % paraformaldehyde , and immunodetection was performed as previously described [ 44 ] .
# ::tok Cells were fixed for 20 min in PBS with 4 % paraformaldehyde , and immunodetection was performed as previously described [ 44 ] .
# ::alignments 21-22|0.1.0 19-20|0.3.0.0 18-19|0.3.0.0.0 16-17|0.3 14-15|0.3.0 13-14|0 11-12|0.2 10-11|0.2.0 9-10|0.2.0.0 7-8|0.0 5-6|0.1.2 4-5|0.1.2.0 2-3|0.1 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:23.876
(a / and 
      :mod (p5 / pb) 
      :op1 (f / fix-03 
            :ARG0 44 
            :ARG1 (c / cell) 
            :ARG2 (m / min 
                  :quant 20)) 
      :op2 (p3 / paraformaldehyde 
            :mod (p4 / percentage-entity 
                  :value 4)) 
      :op3 (p2 / perform-02 
            :ARG1 (i / immunodetection 
                  :ARG1-of (d / describe-01 
                        :time (p / previous)))))

# ::snt E4 embryos were collected and treated with tyrode acid to remove the zona pellucida , deposited onto microscope slides , and processed for immunostaining as described for ES cells .
# ::tok E4 embryos were collected and treated with tyrode acid to remove the zona pellucida , deposited onto microscope slides , and processed for immunostaining as described for ES cells .
# ::alignments 28-29|0.1.1.0.0 27-28|0.1.1.0.0.0 25-26|0.1.1.0 21-22|0.1.1.2 20-21|0.1.1 18-19|0.1.1.1.0 17-18|0.1.1.1.0.0 16-17|0.1.1.1.0.1 15-16|0.1.1.1 13-14|0.1.0.0.0 12-13|0.1.0.0.0.0 10-11|0.1.0.0 8-9|0.1.0.1 5-6|0.1.0 4-5|0.1 3-4|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:24.109
(c2 / collect-01 
      :ARG1 (e2 / embryo 
            :mod (e3 / E4)) 
      :op1-of (a3 / and 
            :op2 (t / treat-01 
                  :ARG0-of (r / remove-01 
                        :ARG1 (p2 / pellucida 
                              :mod (z / zona))) 
                  :ARG1 (a2 / acid)) 
            :op3 (a / and 
                  :ARG1-of (d / describe-01 
                        :ARG2 (c / cell 
                              :mod (e / e))) 
                  :op1 (d2 / deposit-01 
                        :ARG1 (s / slide-01 
                              :ARG1 (m / microscope) 
                              :op1-of (o / onto))) 
                  :op2 (p / process-01))))

# ::snt Antibodies anti-HP1 ( 2HP1H5 , Euromedex , France ) , anti-H4K20me3 ( Abcam , Cambridge , United Kingdom ) , anti-BrdU ( DakoCytomation , Glostrup , Denmark ) , anti-PCNA ( DakoCytomation ) , and anti-PML ( Upstate Biotechnology , Lake Placid , New York , United States ) were all used at 1/1000 dilution .
# ::tok Antibodies anti-HP1 ( 2HP1H5 , Euromedex , France ) , anti-H4K20me3 ( Abcam , Cambridge , United Kingdom ) , anti-BrdU ( DakoCytomation , Glostrup , Denmark ) , anti-PCNA ( DakoCytomation ) , and anti-PML ( Upstate Biotechnology , Lake Placid , New York , United States ) were all used at 1/1000 dilution .
# ::alignments 54-55|0.5.2 51-52|0.5 50-51|0.5.3 46-48|0.4.1+0.4.0.1+0.4.0.0+0.4.0+0.4 43-45|0.5.0.0.5+0.5.0.0.3.1+0.5.0.0.3.0+0.5.0.0.3+0.5.0.0 40-42|0.3.0.1+0.3.0.0+0.3.0+0.3 37-39|0.5.1.0.1+0.5.1.0.0+0.5.1.0+0.5.1 34-35|0 26-27|0.5.0.2+0.5.0.1.0+0.5.0.1+0.5.0 24-25|0.5.0.0.0.0.0+0.5.0.0.0.0+0.5.0.0.0 16-18|0.5.0.0.1.1+0.5.0.0.1.0.1+0.5.0.0.1.0.0+0.5.0.0.1.0+0.5.0.0.1 14-15|0.5.0.0.2.0.0+0.5.0.0.2.0+0.5.0.0.2 12-13|0.2.0.0+0.2.0+0.2 7-8|0.1.1+0.1.0.0+0.1.0+0.1 5-6|0.0.0.0+0.0.0+0.0 0-2|0.5.0.0.4.0.1+0.5.0.0.4.0.0+0.5.0.0.4.0+0.5.0.0.4 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:24.908
(a2 / and 
      :op1 (c11 / country 
            :name (n11 / name 
                  :op1 "Euromedex")) 
      :op2 (c10 / country 
            :name (n10 / name 
                  :op1 "France") 
            :wiki "France") 
      :op3 (c9 / country 
            :name (n9 / name 
                  :op1 "Abcam")) 
      :op4 (c3 / country 
            :name (n3 / name 
                  :op1 "Lake" 
                  :op2 "Placid")) 
      :op5 (c / country 
            :name (n / name 
                  :op1 "United" 
                  :op2 "States") 
            :wiki "United_States") 
      :op6 (u / use-01 
            :ARG0 (c5 / country 
                  :location-of (c2 / city 
                        :location (c6 / country 
                              :name (n6 / name 
                                    :op1 "Glostrup")) 
                        :location (c7 / country 
                              :name (n7 / name 
                                    :op1 "United" 
                                    :op2 "Kingdom") 
                              :wiki "United_Kingdom") 
                        :location (c8 / country 
                              :name (n8 / name 
                                    :op1 "Cambridge")) 
                        :name (n2 / name 
                              :op1 "New" 
                              :op2 "York") 
                        :poss-of (t / thing 
                              :name (n12 / name 
                                    :op1 (a3 / Antibodies) 
                                    :op2 (a4 / anti-HP1))) 
                        :wiki "New_York_City") 
                  :name (n5 / name 
                        :op1 "Denmark") 
                  :wiki "Denmark") 
            :ARG1 (c4 / country 
                  :name (n4 / name 
                        :op1 "Upstate" 
                        :op2 "Biotechnology")) 
            :ARG2 (d / dilution) 
            :mod (a / all)))

# ::snt Antibodies anti-mouse p150CAF1 [ 16 ] and anti-H3K9me3 ( Upstate Biotechnology ) were used at 1/250 and 1/500 , respectively .
# ::tok Antibodies anti-mouse p150CAF1 [ 16 ] and anti-H3K9me3 ( Upstate Biotechnology ) were used at 1/250 and 1/500 , respectively .
# ::alignments 19-20|0.0.1.2 16-17|0.0 13-14|0.0.1 9-11|0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 6-7|0 4-5|0.0.1.0 2-3|0.0.1.1 0-1|0.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:24.983
(a2 / and 
      :op1 (a / and 
            :op1 (c / country 
                  :name (n / name 
                        :op1 "Upstate" 
                        :op2 "Biotechnology")) 
            :op2 (u / use-01 
                  :ARG0 16 
                  :ARG1 (p / p150CAF1 
                        :mod (a3 / antibodi)) 
                  :mod (r / respective))))

# ::snt All secondary antibodies were purchased from Molecular Probes ( Sunnyvale , California , United States ) .
# ::tok All secondary antibodies were purchased from Molecular Probes ( Sunnyvale , California , United States ) .
# ::alignments 13-15|0.1.0.0.2+0.1.0.0.0.1+0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 11-12|0.1.0.1.1+0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 9-10|0.0.0.0+0.0.0+0.0 6-8|0.2.0.1+0.2.0.0+0.2.0+0.2 4-5|0 2-3|0.1 1-2|0.1.0.0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:25.258
(p / purchase-01 
      :ARG0 (c2 / country 
            :name (n3 / name 
                  :op1 "Sunnyvale")) 
      :ARG1 (a / antibodi 
            :quant (a2 / all 
                  :mod-of (c / country 
                        :name (n / name 
                              :op1 "United" 
                              :op2 "States") 
                        :poss (s2 / secondary) 
                        :wiki "United_States") 
                  :mod-of (s / state 
                        :name (n2 / name 
                              :op1 "California") 
                        :wiki "California"))) 
      :ARG2 (o / organization 
            :name (n4 / name 
                  :op1 "Molecular" 
                  :op2 "Probes")))

# ::snt Western blot analysis .
# ::tok Western blot analysis .
# ::alignments 2-3|0 1-2|0.0 0-1|0.1.1+0.1.0.0+0.1.0+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:25.285
(a / analyze-01 
      :ARG1-of (b / blot-01) 
      :mod (w / world-region 
            :name (n / name 
                  :op1 "West") 
            :wiki "Western_world"))

# ::snt Cells were lysed in Laemli buffer and run onto a 4 % -- 12 % SDS PAGE gradient gel .
# ::tok Cells were lysed in Laemli buffer and run onto a 4 % -- 12 % SDS PAGE gradient gel .
# ::alignments 18-19|0.0.0.0.0.0 17-18|0.0.0.0.0.0.0 16-17|0.0.0.0.0 15-16|0.0.0.0.0.0.1.0.0+0.0.0.0.0.0.1.0+0.0.0.0.0.0.1 14-15|0.0.1.0.0 13-14|0.0.1.0.0.0 11-12|0.0.1.0 10-11|0.0.1.0.1 8-9|0.0.1 7-8|0.0 6-7|0 5-6|0.0.0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:25.428
(a / and 
      :op1 (r / run-01 
            :ARG1 (c / cell 
                  :ARG0-of (b / buffer-01 
                        :ARG1 (p / page-01 
                              :ARG1 (g / gel 
                                    :mod (g2 / gradient) 
                                    :mod (o / organization 
                                          :name (n / name 
                                                :op1 "SDS")))))) 
            :time (o2 / onto 
                  :op1 (p3 / percentage-entity 
                        :mod (p2 / percentage-entity 
                              :quant 12) 
                        :value 4))))

# ::snt We used antibodies against p150CAF-1 ( [ 16 ] ; dilution 1/500 ) , HP1 ( 2G9 , Euromedex ; 1/500 ) , Histone H3 ( Abcam ; 1/500 ) , H3K9me3 ( Upstate ; 1/500 ) and -actin ( Upstate ; 1/40 000 ) .
# ::tok We used antibodies against p150CAF-1 ( [ 16 ] ; dilution 1/500 ) , HP1 ( 2G9 , Euromedex ; 1/500 ) , Histone H3 ( Abcam ; 1/500 ) , H3K9me3 ( Upstate ; 1/500 ) and -actin ( Upstate ; 1/40 000 ) .
# ::alignments 37-38|0 33-34|0.0.1.0 31-32|0.3.0.0+0.3.0+0.3 23-25|0.2.0.1+0.2.0.0+0.2.0+0.2 18-19|0.0.3.0.0+0.0.3.0+0.0.3 14-15|0.1.0.0+0.1.0+0.1 10-11|0.3.1.0 9-10|0.3.1 7-8|0.0.2 2-3|0.0.1 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:25.840
(a / and 
      :op1 (u2 / use-01 
            :ARG0 (w / we) 
            :ARG1 (a3 / antibodi 
                  :mod (u / upstate)) 
            :ARG2 16 
            :location (c / country 
                  :name (n3 / name 
                        :op1 "Euromedex"))) 
      :op2 (p3 / person 
            :name (n4 / name 
                  :op1 "HP1")) 
      :op3 (p2 / person 
            :name (n2 / name 
                  :op1 "Histone" 
                  :op2 "H3")) 
      :op4 (p / person 
            :name (n / name 
                  :op1 "H3K9me3") 
            :op2-of (a2 / and 
                  :op1 (d / dilution))))

# ::snt DNA FISH .
# ::tok DNA FISH .
# ::alignments 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:25.844
(f / fish-01 
      :ARG1 (d / DNA))

# ::snt Probes were described previously [ 20 ] .
# ::tok Probes were described previously [ 20 ] .
# ::alignments 5-6|0.0.0 3-4|0.1 2-3|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:25.862
(d / describe-01 
      :ARG1 (p2 / probe-01 
            :ARG1 20) 
      :time (p / previous))

# ::snt Biotin-16-dUTP or Digoxigenin-11-dUTP ( Roche , Basel , Switzerland ) labeled probes were generated by nick translation ( Roche ) and FISH performed as described [ 20 ] .
# ::tok Biotin-16-dUTP or Digoxigenin-11-dUTP ( Roche , Basel , Switzerland ) labeled probes were generated by nick translation ( Roche ) and FISH performed as described [ 20 ] .
# ::alignments 26-27|0.0.1.0.0.0.0 24-25|0.1.1 22-23|0.1 21-22|0.1.0 20-21|0 16-17|0.0.1.0.0+0.0.1.0 15-16|0.0.1.0.0.0 13-14|0.0.1 11-12|0.0.1.1 10-11|0.0 8-9|0.1.0.0.1+0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 6-7|0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 4-5|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:26.840
(a / and 
      :op1 (l / label-01 
            :ARG0 (o / or 
                  :op1 (p3 / person 
                        :name (n4 / name 
                              :op1 "Roche"))) 
            :ARG1 (g / generate-01 
                  :ARG0 (t / thing 
                        :ARG2-of (t2 / translate-01 
                              :ARG1 (n / nick-01 
                                    :ARG1 20))) 
                  :ARG1 (p2 / probe))) 
      :op2 (p / perform-02 
            :ARG0 (f / fish-01 
                  :ARG1 (c / country 
                        :name (n2 / name 
                              :op1 "Switzerland") 
                        :wiki "Switzerland")) 
            :ARG1 (d / describe-01 
                  :ARG1 (c2 / country 
                        :name (n3 / name 
                              :op1 "Basel")))))

# ::snt Image acquisition was performed with the Deltavision RT microscope ( 100  , 1.4 NA objective ) , images were deconvoluted , and fluorescence profiles measured along an arbitrary line using SoftWorx .
# ::tok Image acquisition was performed with the Deltavision RT microscope ( 100  , 1.4 NA objective ) , images were deconvoluted , and fluorescence profiles measured along an arbitrary line using SoftWorx .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:26.842
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Nuclei preparation , nuclease digestion , and biochemical analysis of chromatin .
# ::tok Nuclei preparation , nuclease digestion , and biochemical analysis of chromatin .
# ::alignments 10-11|0.2.1 8-9|0.2 7-8|0.2.0 6-7|0 4-5|0.1 3-4|0.1.0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:27.035
(a2 / and 
      :op1 (p / prepare-02 
            :ARG2 (n2 / nucleus)) 
      :op2 (d / digestion 
            :mod (n / nuclease)) 
      :op3 (a / analyze-01 
            :ARG0 (b / biochemical) 
            :ARG1 (c / chromatin)))

# ::snt ES cells were incubated on ice for 10 min in buffer 1 ( 15 mM Tris-HCl [ pH 7.5 ] , 0.3 M sucrose , 60 mM KCl , 15 mM NaCl , 5 mM MgCl2 , 0.1 mM EGTA ) with 0.15 % IGEPAL ( Sigma , St. Louis , Missouri , United States ) .
# ::tok ES cells were incubated on ice for 10 min in buffer 1 ( 15 mM Tris-HCl [ pH 7.5 ] , 0.3 M sucrose , 60 mM KCl , 15 mM NaCl , 5 mM MgCl2 , 0.1 mM EGTA ) with 0.15 % IGEPAL ( Sigma , St. Louis , Missouri , United States ) .
# ::alignments 53-55|0.0.0.1.0.1+0.0.0.1.0.0.1+0.0.0.1.0.0.0+0.0.0.1.0.0+0.0.0.1.0 51-52|0.0.0.0.0.1+0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 48-50|0.0.0.2.1+0.0.0.2.0+0.0.0.2+0.0.0 46-47|0.0.0.1.2.0.1.1 43-44|0.0.0.1.2 42-43|0.0.0.1.2.0 37-38|0.0.0.1.2.0.1.2 35-36|0.0.0.0.2.0 33-34|0.0.0.1.2.0.1.3 29-30|0.0.0.1.2.0.1.0.0.0.1 27-28|0.0.0.0.1.0+0.0.0.0.1+0.0.0.0 25-26|0.0.0.1.2.0.1.0.0.0.2 23-24|0 22-23|0.0.2+0.0.1.0+0.0.1+0.0 17-18|0.0.0.1.2.0.0 15-16|0.0.0.1.3.0+0.0.0.1.3+0.0.0.1 14-15|0.0.0.1.1 13-14|0.0.0.1.4 11-12|0.0.0.0.2 10-11|0.0.0.1.2.0.1 8-9|0.0.0.1.2.0.1.0.0.0.3 7-8|0.0.0.1.2.1 5-6|0.0.0.1.2.0.1.0.0.0.0 3-4|0.0.0.1.2.0.1.0.0.0 1-2|0.0.0.1.2.0.1.0.0 0-1|0.0.0.1.2.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:27.855
(s3 / sucrose 
      :mod (v / vehicle 
            :mod (c2 / country 
                  :domain-of (t / thing 
                        :mod (s / state 
                              :name (n2 / name 
                                    :op1 "Missouri") 
                              :wiki "Missouri") 
                        :name (n4 / name 
                              :op1 "KCl") 
                        :quant (13 / 1 
                              :mod (m / MgCl2))) 
                  :mod-of (p3 / person 
                        :mod (c / country 
                              :name (n / name 
                                    :op1 "United" 
                                    :op2 "States") 
                              :wiki "United_States") 
                        :mod (m2 / mm) 
                        :mod (p / percentage-entity 
                              :value (0 / 0.15 
                                    :mod (p2 / ph) 
                                    :op1 (b / buffer-01 
                                          :ARG1 (e / e 
                                                :mod-of (c3 / cell 
                                                      :ARG1-of (i2 / incubate-01 
                                                            :location (i / ice) 
                                                            :op1-of 15 
                                                            :op1-of 60 
                                                            :purpose (m3 / min)))) 
                                          :op1-of (s2 / sigma) 
                                          :op1-of 0.1 
                                          :op1-of 5)) 
                              :value 10) 
                        :name (n6 / name 
                              :op1 "Tris-HCl") 
                        :quant 15) 
                  :name (n3 / name 
                        :op1 "St." 
                        :op2 "Louis")) 
            :name (n5 / name 
                  :op1 "M1") 
            :wiki "M1_Abrams"))

# ::snt Nuclei were purified by centrifugation ( 10,000  g for 30 min , at 4 C ) on sucrose cushions ( buffer 1 with 1.2 M sucrose ) and resuspended in nuclease buffer ( 50 mM Tris-HCl [ pH 7.5 ] , 20 mM NaCl , 0.32 M sucrose , 4 mM MgCl2 , 1 mM CaCl2 ) .
# ::tok Nuclei were purified by centrifugation ( 10,000  g for 30 min , at 4 C ) on sucrose cushions ( buffer 1 with 1.2 M sucrose ) and resuspended in nuclease buffer ( 50 mM Tris-HCl [ pH 7.5 ] , 20 mM NaCl , 0.32 M sucrose , 4 mM MgCl2 , 1 mM CaCl2 ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:27.857
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt About 2.106 nuclei were incubated with increasing quantities of MNase ( 0.04 -- 1.6 units ) or DNase I ( 0.25 -- 16 units ) .
# ::tok About 2.106 nuclei were incubated with increasing quantities of MNase ( 0.04 -- 1.6 units ) or DNase I ( 0.25 -- 16 units ) .
# ::alignments 23-24|0.2.1 22-23|0.2.1.0 18-19|0.2.0.0.1.0 16-17|0.2.0.0.1 14-15|0.0 9-10|0.2.0.0.0.0+0.2.0.0.0+0.2.0.0 7-8|0.2.0 6-7|0.2 4-5|0 2-3|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:28.075
(i3 / incubate-01 
      :ARG0 (u2 / unit) 
      :ARG1 (n2 / nucleus 
            :op1-of (a / about)) 
      :ARG2 (i2 / increase-01 
            :ARG1 (q / quantity 
                  :quant-of (t / thing 
                        :name (n / name 
                              :op1 "MNase") 
                        :op1-of (o / or 
                              :op2 (i / i)))) 
            :ARG2 (u / unit 
                  :quant 16)))

# ::snt Digestion time at 37 C was 10 min for MNase and 2 min for DNase I. Digestions were stopped by adding SDS to 1 % and EDTA to 50 mM .
# ::tok Digestion time at 37 C was 10 min for MNase and 2 min for DNase I. Digestions were stopped by adding SDS to 1 % and EDTA to 50 mM .
# ::alignments 28-29|0.0.2.0 26-27|0.2 25-26|0 24-25|0.1 23-24|0.2.0 21-22|0.0.1.0.0+0.0.1.0+0.0.1 20-21|0.0 18-19|0.0.2 15-17|0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 12-13|0.0.2.1 11-12|0.0.2.1.0 10-11|0.0.2.2 9-10|0.0.2.2.1.0.0+0.0.2.2.1.0+0.0.2.2.1 7-8|0.0.2.2.0 6-7|0.1.0 4-5|0.0.3.0 3-4|0.0.3 1-2|0.0.2.2.0.0 0-1|0.0.2.2.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:28.663
(a / and 
      :ARG2-of (a2 / add-02 
            :ARG0 (t / thing 
                  :name (n2 / name 
                        :op1 (i / I.) 
                        :op2 (d / Digestions))) 
            :ARG1 (o / organization 
                  :name (n / name 
                        :op1 "SDS")) 
            :ARG2-of (s / stop-01 
                  :ARG0 50 
                  :ARG1 (m / min 
                        :quant 2) 
                  :op3-of (a3 / and 
                        :op1 (m2 / min 
                              :domain (t3 / time 
                                    :mod (d2 / digestion))) 
                        :op2 (t2 / thing 
                              :name (n3 / name 
                                    :op1 "MNase")))) 
            :op1-of (3 / 37 
                  :era (c / C))) 
      :op1 (p / percentage-entity 
            :value 10) 
      :op2 (e / edta 
            :quant 1))

# ::snt DNAs were prepared by proteinase K digestion followed by phenol-chloroform extraction and isopropanol precipitation .
# ::tok DNAs were prepared by proteinase K digestion followed by phenol-chloroform extraction and isopropanol precipitation .
# ::alignments 13-14|0.0 12-13|0 11-12|0.0.0 10-11|0.0.0.1 7-8|0.0.0.0 6-7|0.0.0.0.0 5-6|0.0.0.0.0.1 4-5|0.0.0.0.0.2 2-3|0.0.0.0.0.0 0-1|0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:28.757
(i / isopropanol 
      :mod-of (p / precipitation 
            :op2-of (a / and 
                  :ARG0-of (f / follow-01 
                        :ARG1 (d / digestion 
                              :ARG0-of (p3 / prepare-02 
                                    :ARG1 (d2 / dna)) 
                              :mod (k / k) 
                              :mod (p2 / proteinase))) 
                  :op1 (e / extract-01))))

# ::snt To test the association of histone H3 with chromatin in control and p150-depleted cells , isolated nuclei were incubated on ice for 30 min in buffer 2 ( 50 mM Hepes [ pH7 .9 ] , 20 % Glycerol , 3 mM MgCl2 , 0.1 % IGEPAL , 0.5 mM DTT , 0.5 mM PMSF ) supplemented with either 0.1 M , 0.3 M , 0.45 M , 0.7 M , or 1 M NaCl .
# ::tok To test the association of histone H3 with chromatin in control and p150-depleted cells , isolated nuclei were incubated on ice for 30 min in buffer 2 ( 50 mM Hepes [ pH7 .9 ] , 20 % Glycerol , 3 mM MgCl2 , 0.1 % IGEPAL , 0.5 mM DTT , 0.5 mM PMSF ) supplemented with either 0.1 M , 0.3 M , 0.45 M , 0.7 M , or 1 M NaCl .
# ::alignments 73-75|0.0.6.2.2.1.5.0.1+0.0.6.2.2.1.5.0.0+0.0.6.2.2.1.5.0+0.0.6.2.2.1.5 72-73|0.0.6.2.2.1.5.1 71-72|0.0.6.2.2.1 69-70|0.0.6.2.2.1.4.1+0.0.6.2.2.1.4.0.0+0.0.6.2.2.1.4.0+0.0.6.2.2.1.4 68-69|0.0.0.0.0.0 65-67|0.0.6.2.2.1.3.0.1+0.0.6.2.2.1.3.0.0+0.0.6.2.2.1.3.0+0.0.6.2.2.1.3 63-64|0.0.6.2.2.1.2.1+0.0.6.2.2.1.2.0.0+0.0.6.2.2.1.2.0+0.0.6.2.2.1.2 60-61|0.0.6.2.2.1.1.1+0.0.6.2.2.1.1.0.0+0.0.6.2.2.1.1.0+0.0.6.2.2.1.1 59-60|0.0.3 58-59|0.0.4 56-57|0.0.6.2.2.1.0 52-53|0.0.2 48-49|0.0.5 45-46|0.0.6.2.2.1.0.0.0 44-45|0.0.6.2.2.1.0.0 42-43|0 40-41|0.0.1 38-39|0.0.0.0.2.0 37-38|0.0.0.0.2 36-37|0.0.0.0.1 30-31|0.0.6.2.2.0.0+0.0.6.2.2.0+0.0.6.2.2 29-30|0.0.6.0.2 28-29|0.0.6.0.3 26-27|0.0.6.0.1 25-26|0.0.0.0.0 23-24|0.0.7 22-23|0.0.7.0 20-21|0.0.6.2.0.0 18-19|0.0 16-17|0.0.0 15-16|0.0.0.0 13-14|0.0.6.2.1 12-13|0.0.6.2.1.0 11-12|0.0.6.2 10-11|0.0.6.2.0 8-9|0.0.6.1 6-7|0.0.6.0.0 5-6|0.0.6.0.0.0 3-4|0.0.6.0 1-2|0.0.6 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:31.549
(m3 / MgCl2 
      :op1 (i2 / incubate-01 
            :ARG1 (n8 / nucleus 
                  :ARG1-of (i3 / isolate-01 
                        :ARG1-of (b / buffer-01 
                              :op1-of 0.7) 
                        :ARG2 20 
                        :op1-of (p2 / percentage-entity 
                              :mod-of (g / glycerol)))) 
            :op1-of 3 
            :op1-of 0.5 
            :op1-of 0.1 
            :op1-of (e / either) 
            :op1-of 0.5 
            :purpose (t3 / test-01 
                  :ARG1 (a2 / associate-01 
                        :ARG1 (h / H3 
                              :mod (h2 / histone)) 
                        :op1-of 2 
                        :op1-of (m4 / mm) 
                        :op1-of 50) 
                  :ARG2 (c3 / chromatin) 
                  :op1-of (a / and 
                        :op2 (c2 / control-01 
                              :ARG1 (i / ice)) 
                        :op3 (c / cell 
                              :mod (p4 / p150-deplet)) 
                        :op4 (p3 / person 
                              :name (n7 / name 
                                    :op1 "Hepes") 
                              :op1-of (o / or 
                                    :ARG1-of (s / supplement-01 
                                          :ARG0 (06 / 0.1 
                                                :value-of (p / percentage-entity))) 
                                    :op2 (v3 / vehicle 
                                          :name (n6 / name 
                                                :op1 "M1") 
                                          :wiki "M1_Abrams") 
                                    :op3 (v2 / vehicle 
                                          :name (n5 / name 
                                                :op1 "M1") 
                                          :wiki "M1_Abrams") 
                                    :op4 (t2 / thing 
                                          :name (n4 / name 
                                                :op1 0.45 
                                                :op2 (m2 / M))) 
                                    :op5 (v / vehicle 
                                          :name (n3 / name 
                                                :op1 "M1") 
                                          :wiki "M1_Abrams") 
                                    :op6 (t / thing 
                                          :name (n / name 
                                                :op1 (m / M) 
                                                :op2 (n2 / NaCl)) 
                                          :quant 1))))) 
            :purpose (m5 / min 
                  :quant 30)))

# ::snt After centrifugation at 15,000 g , pellets and supernants were analyzed by Western blot using a histone H3 antibody ( Abcam ) .
# ::tok After centrifugation at 15,000 g , pellets and supernants were analyzed by Western blot using a histone H3 antibody ( Abcam ) .
# ::alignments 18-19|0.0.0.0 17-18|0.0.0.0.0 16-17|0.0.0.0.0.0 14-15|0.0.0 13-14|0.0 12-13|0.0.2.1+0.0.2.0.0+0.0.2.0+0.0.2 10-11|0 8-9|0.1.1 7-8|0.1 6-7|0.1.0 4-5|0.0.1 1-2|0.2.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:31.746
(a2 / analyze-01 
      :ARG0 (b / blot-01 
            :ARG0-of (u / use-01 
                  :ARG1 (a / antibody 
                        :mod (h / H3 
                              :mod (h2 / histone)))) 
            :ARG1 (g / g) 
            :mod (w / world-region 
                  :name (n / name 
                        :op1 "West") 
                  :wiki "Western_world")) 
      :ARG1 (a3 / and 
            :op1 (p / pellet) 
            :op2 (s / supernant)) 
      :time (a4 / after 
            :op1 (c / centrifugation)))

# ::snt ChIP .
# ::tok ChIP .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:31.751
(c / chip-01)

# ::snt We prepared native chromatin fragments of two to six nucleosomes in length as described [ 28 ] .
# ::tok We prepared native chromatin fragments of two to six nucleosomes in length as described [ 28 ] .
# ::alignments 15-16|0.3 13-14|0.2 11-12|0.2.1 9-10|0.2.0 8-9|0.2.0.0 6-7|0.2.2 4-5|0.1 3-4|0.1.0 2-3|0.1.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:31.947
(p / prepare-02 
      :ARG0 (w / we) 
      :ARG1 (f / fragment-01 
            :ARG1 (c / chromatin) 
            :mod (n2 / native)) 
      :ARG2 (d / describe-01 
            :ARG0 (n / nucleosom 
                  :quant 6) 
            :ARG1 (l / length) 
            :ARG2 2) 
      :op1-of 28)

# ::snt 5 g of chromatin were incubated overnight with 10 l of commercial antibodies .
# ::tok 5 g of chromatin were incubated overnight with 10 l of commercial antibodies .
# ::alignments 12-13|0.1.0 11-12|0.1.0.0 9-10|0.1 8-9|0.1.1 6-7|0.2 5-6|0 3-4|0.0.0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:31.992
(i / incubate-01 
      :ARG1 (g / g 
            :mod (c2 / chromatin) 
            :quant 5) 
      :ARG2 (l / l 
            :mod (a / antibodi 
                  :mod (c / commerce)) 
            :quant 10) 
      :duration (o / overnight))

# ::snt After incubation with protein-G sepharose and three washes , immunoprecipitated DNA was purified , sized onto an agarose gel , and analyzed by Southern blot .
# ::tok After incubation with protein-G sepharose and three washes , immunoprecipitated DNA was purified , sized onto an agarose gel , and analyzed by Southern blot .
# ::alignments 24-25|0.2.0 23-24|0.2.0.0.0.0+0.2.0.0.0+0.2.0.0 21-22|0.2 20-21|0 18-19|0.1.1 15-16|0.1.1.0 14-15|0.1 12-13|0.0 10-11|0.0.0 9-10|0.1.0 7-8|0.3.0.0.1 6-7|0.2.1 5-6|0.3.0.0 4-5|0.3.0.0.0 1-2|0.3.0 0-1|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:32.138
(a2 / and 
      :op1 (p / purify-01 
            :ARG1 (d / DNA)) 
      :op2 (s / size-01 
            :ARG0 (i / immunoprecipitat) 
            :ARG1 (g / gel 
                  :op1-of (o / onto))) 
      :op3 (a / analyze-01 
            :ARG0 (b / blot-01 
                  :ARG1 (t / thing 
                        :name (n / name 
                              :op1 "Southern"))) 
            :ARG1 3) 
      :time (a4 / after 
            :op1 (i2 / incubation 
                  :topic (a3 / and 
                        :op1 (s2 / sepharose) 
                        :op2 (w / wash-01)))))

# ::snt Hybridization signals were quantified using an Instant Imager ( PerkinElmer , Wellesley , California , United States ) .
# ::tok Hybridization signals were quantified using an Instant Imager ( PerkinElmer , Wellesley , California , United States ) .
# ::alignments 15-17|0.0.1+0.0.0.1+0.0.0.0+0.0.0+0.0 13-14|0.2.1+0.2.0.0+0.2.0+0.2 11-12|0.1.0.0.0+0.1.0.0+0.1.0 9-10|0.1.2.0.0.0.0+0.1.2.0.0.0+0.1.2.0.0 6-8|0.1.1.0.1+0.1.1.0.0+0.1.1.0+0.1.1 4-5|0.1 3-4|0 1-2|0.1.2 0-1|0.1.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:33.238
(q / quantify-01 
      :ARG0 (c / country 
            :name (n / name 
                  :op1 "United" 
                  :op2 "States") 
            :wiki "United_States") 
      :ARG1 (u / use-01 
            :ARG0 (c2 / country 
                  :name (n3 / name 
                        :op1 "Wellesley")) 
            :ARG1 (t / thing 
                  :name (n5 / name 
                        :op1 (i / Instant) 
                        :op2 (i2 / Imager))) 
            :ARG2 (s2 / signal 
                  :mod (h / hybridization 
                        :mod (o / organization 
                              :name (n4 / name 
                                    :op1 "PerkinElmer"))))) 
      :ARG2 (s / state 
            :name (n2 / name 
                  :op1 "California") 
            :wiki "California"))

# ::snt Antibodies specific for H4K20me3 were purchased from Abcam .
# ::tok Antibodies specific for H4K20me3 were purchased from Abcam .
# ::alignments 7-8|0.1.0.0+0.1.0+0.1 5-6|0 3-4|0.0.0.0.0+0.0.0.0+0.0.0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:33.271
(p / purchase-01 
      :ARG1 (s / specific-02 
            :ARG1 (t / thing 
                  :name (n2 / name 
                        :op1 "H4K20me3")) 
            :mod (a / antibodi)) 
      :ARG2 (c / country 
            :name (n / name 
                  :op1 "Abcam")))

# ::snt Antibodies for H3K9me3 were purchased from both Abcam and Upstate Biotechnology and gave similar results .
# ::tok Antibodies for H3K9me3 were purchased from both Abcam and Upstate Biotechnology and gave similar results .
# ::alignments 14-15|0.2.1.1+0.2.1 13-14|0.2.1.0 12-13|0.2 11-12|0 9-11|0.1.0.1+0.1.0.0+0.1.0+0.1 8-9|0.2.2 7-8|0.2.2.1.0.0+0.2.2.1.0+0.2.2.1 6-7|0.2.2.0 4-5|0.0 2-3|0.2.0.0.0+0.2.0.0+0.2.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:33.524
(a / and 
      :op1 (p / purchase-01 
            :ARG1 (a3 / antibodi)) 
      :op2 (c / country 
            :name (n / name 
                  :op1 "Upstate" 
                  :op2 "Biotechnology")) 
      :op3 (g / give-01 
            :ARG0 (p2 / person 
                  :name (n3 / name 
                        :op1 "H3K9me3")) 
            :ARG1 (t / thing 
                  :ARG1-of (r2 / resemble-01) 
                  :ARG2-of (r / result-01)) 
            :op2-of (a2 / and 
                  :mod (b / both) 
                  :op1 (c2 / country 
                        :name (n2 / name 
                              :op1 "Abcam")))))

# ::snt For Southern blot analysis , we used a 240-bp EcoRI/BamHI fragment from pSAT ( major satellite probe ) [ 45 -- 47 ] and a 360-bp EcoRI/HindIII fragment from R198 , corresponding to three copies of the 120-bp minor satellite repeat [ 49 ] .
# ::tok For Southern blot analysis , we used a 240-bp EcoRI/BamHI fragment from pSAT ( major satellite probe ) [ 45 -- 47 ] and a 360-bp EcoRI/HindIII fragment from R198 , corresponding to three copies of the 120-bp minor satellite repeat [ 49 ] .
# ::alignments 42-43|0.0.1.3.0.0.0.0.1.2.0 40-41|0.0.1.3.0.0.0.0 39-40|0.0.1.3.0.0.0.0.1.1 38-39|0.0.1.3.0.0.0.0.1.1.0 34-35|0.0.1.3.0.0.0.0.1 33-34|0.0.1.3.0.0.0.0.1.2.1 31-32|0.0.1.3.0.0.0.0.1.2 29-30|0.0.2.0.0+0.0.2.0+0.0.2 27-28|0.0 26-27|0.0.0.0.0+0.0.0.0+0.0.0 23-24|0 21-22|0.0.1.0 19-20|0.0.1.3.0.0.0.0.1.0 16-17|0.0.1.3.0.0.0.0.0.0 15-16|0.0.1.3.0.0.0.0.0 14-15|0.0.1.3.0.0.0.0.0.0.0 12-13|0.0.1.3.0.1 10-11|0.0.1.3.0 9-10|0.0.1.3.1.0+0.0.1.3.1+0.0.1.3 6-7|0.0.1.3.0.0 5-6|0.0.1.3.0.0.0 3-4|0.0.1 2-3|0.0.1.2 1-2|0.0.1.1.0.0+0.0.1.1.0+0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:34.455
(a / and 
      :op1 (f / fragment-01 
            :ARG1 (t / thing 
                  :name (n2 / name 
                        :op1 "EcoRI/HindIII")) 
            :ARG2 (a2 / analyze-01 
                  :ARG0 47 
                  :ARG1 (t3 / thing 
                        :name (n4 / name 
                              :op1 "Southern")) 
                  :ARG1-of (b / blot-01) 
                  :ARG2 (t2 / thing 
                        :ARG1-of (f2 / fragment-01 
                              :ARG1-of (u / use-01 
                                    :ARG0 (w / we 
                                          :ARG0-of (r / repeat-01 
                                                :ARG1 (s2 / satellite 
                                                      :ARG0-of (p / probe-01 
                                                            :ARG1-of (m2 / major-02))) 
                                                :ARG2-of (c / copy-01 
                                                      :ARG0 45 
                                                      :ARG1 (s / satellite 
                                                            :mod (m / minor)) 
                                                      :ARG1-of (c2 / correspond-01 
                                                            :ARG0 49 
                                                            :ARG2 3))))) 
                              :source (p2 / pSAT)) 
                        :name (n3 / name 
                              :op1 "EcoRI/BamHI"))) 
            :source (c3 / country 
                  :name (n / name 
                        :op1 "R198"))))

# ::snt Probes used in FISH experiments were described in [ 46 -- 48 ] .
# ::tok Probes used in FISH experiments were described in [ 46 -- 48 ] .
# ::alignments 11-12|0.0.0 9-10|0.0.1.0 6-7|0 4-5|0.0.1.1 3-4|0.0.1.1.0 1-2|0.0.1 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:34.502
(d / describe-01 
      :ARG1 (p / probe-01 
            :ARG1 48 
            :ARG1-of (u / use-01 
                  :ARG0 46 
                  :ARG2 (e / experiment-01 
                        :ARG1 (f / fish-01)))))

# ::snt The probe for IAP elements was described in [ 50 ] .
# ::tok The probe for IAP elements was described in [ 50 ] .
# ::alignments 9-10|0.0.0 6-7|0 4-5|0.0.1 3-4|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:34.531
(d / describe-01 
      :ARG1 (p / probe-01 
            :ARG0 50 
            :ARG1 (e / element 
                  :mod (o / organization 
                        :name (n / name 
                              :op1 "IAP")))))

# ::snt Analysis of p150CAF-1 Depletion by RNAi with Western Blot and IF .
# ::tok Analysis of p150CAF-1 Depletion by RNAi with Western Blot and IF .
# ::alignments 10-11|0.0.0.2 9-10|0.0.0 8-9|0.0.0.1 7-8|0.0.0.1.0.1+0.0.0.1.0.0.0+0.0.0.1.0.0+0.0.0.1.0 5-6|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 3-4|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:34.577
(a2 / analysi 
      :mod (d / depletion 
            :example (a / and 
                  :op1 (t / thing 
                        :name (n2 / name 
                              :op1 "RNAi")) 
                  :op2 (b / blot-01 
                        :mod (w / world-region 
                              :name (n / name 
                                    :op1 "West") 
                              :wiki "Western_world")) 
                  :op3 (c / cause-01))))

# ::snt ( A ) Western blot analysis of ES cells transfected with control ( cont ) or p150CAF-1 ( p150 ) RNAi plasmid vectors .
# ::tok ( A ) Western blot analysis of ES cells transfected with control ( cont ) or p150CAF-1 ( p150 ) RNAi plasmid vectors .
# ::alignments 21-22|0.0.0 20-21|0.0.1.0+0.0.1+0.0 15-16|0.0.0.0 13-14|0.1.0.1 11-12|0.1.1 8-9|0.1.0 7-8|0.1.0.0 5-6|0.1 4-5|0 3-4|0.1.2.1+0.1.2.0.0+0.1.2.0+0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:34.751
(b / blot-01 
      :ARG0 (t / thing 
            :mod-of (p / plasmid 
                  :op1-of (o / or)) 
            :name (n / name 
                  :op1 "RNAi")) 
      :ARG1 (a / analyze-01 
            :ARG1 (c3 / cell 
                  :mod (e / e) 
                  :op1-of (c / cont)) 
            :ARG1-of (c2 / control-01) 
            :mod (w / world-region 
                  :name (n2 / name 
                        :op1 "West") 
                  :wiki "Western_world")))

# ::snt -actin was used as a loading control .
# ::tok -actin was used as a loading control .
# ::alignments 6-7|0.0 5-6|0.0.0 2-3|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:34.763
(u / use-01 
      :ARG2 (c / control-01 
            :ARG1 (l / load-01)))

# ::snt Amount of cells used in each lane is indicated .
# ::tok Amount of cells used in each lane is indicated .
# ::alignments 8-9|0 6-7|0.0.0.0.0 5-6|0.0.0.0.0.0 3-4|0.0.0.0 2-3|0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:34.789
(i / indicate-01 
      :ARG1 (a / amount-01 
            :ARG1 (c / cell 
                  :ARG1-of (u / use-01 
                        :ARG2 (l / lane-01 
                              :mod (e / each))))))

# ::snt p150CAF-1 knockdown does not significantly affect HP1 , histone H3 , or H3K9me3 levels .
# ::tok p150CAF-1 knockdown does not significantly affect HP1 , histone H3 , or H3K9me3 levels .
# ::alignments 13-14|0.1.3 12-13|0.1.2.0.0+0.1.2.0+0.1.2 11-12|0.1 9-10|0.1.1 8-9|0.1.1.0 6-7|0.1.0 5-6|0 4-5|0.2 3-4|0.3 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:35.244
(a / affect-01 
      :ARG0 (k / knockdown) 
      :ARG1 (o / or 
            :op1 (h3 / HP1) 
            :op2 (h / H3 
                  :mod (h2 / histone)) 
            :op3 (p / person 
                  :name (n / name 
                        :op1 "H3K9me3")) 
            :op4 (l / level)) 
      :ARG2 (s / significant-02) 
      :polarity -)

# ::snt ( B ) IF analysis .
# ::tok ( B ) IF analysis .
# ::alignments 4-5|0 3-4|0.0 1-2|0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:35.270
(a / analyze-01 
      :manner (c / cause-01 
            :ARG1 (l / location 
                  :name (n / name 
                        :op1 "B") 
                  :wiki -)))

# ::snt ES cells transfected with control ( cont ) or p150CAF-1 ( p150 ) siRNA vector were immunostained with p150CAF-1 antibody ( green ) and DAPI ( blue ) .
# ::tok ES cells transfected with control ( cont ) or p150CAF-1 ( p150 ) siRNA vector were immunostained with p150CAF-1 antibody ( green ) and DAPI ( blue ) .
# ::alignments 26-27|0.0.0.0.0 24-25|0.0.0.1.2.0.0+0.0.0.1.2.0+0.0.0.1.2 23-24|0.0.0.1 21-22|0.0.0.1.1 19-20|0.0.0.1.0 14-15|0.0 13-14|0 8-9|0.0.0 6-7|0.0.0.1.1.0 4-5|0.0.0.0 1-2|0.0.0.0.1 0-1|0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:35.397
(s / siRNA 
      :mod-of (v / vector 
            :op2-of (o / or 
                  :op1 (c2 / control-01 
                        :ARG0 (b / blue) 
                        :ARG1 (c3 / cell 
                              :mod (e / e))) 
                  :op3 (a / and 
                        :op1 (a2 / antibody) 
                        :op2 (g / green-02 
                              :ARG0 (c / cont)) 
                        :op3 (p / person 
                              :name (n / name 
                                    :op1 "DAPI"))))))

# ::snt Scale bar = 5 m .
# ::tok Scale bar = 5 m .
# ::alignments 4-5|0 3-4|0.0.0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:35.416
(m / m 
      :domain (b / bar-01 
            :ARG0 5 
            :ARG1 (s / scale)))

# ::snt Fluorescence was quantified along a line drawn across the nucleus and data were plotted , revealing efficient p150CAF-1 depletion by RNAi .
# ::tok Fluorescence was quantified along a line drawn across the nucleus and data were plotted , revealing efficient p150CAF-1 depletion by RNAi .
# ::alignments 20-21|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 18-19|0.2.0.0 16-17|0.2.0.0.0 15-16|0.2.0 13-14|0.2 11-12|0.2.1 10-11|0 9-10|0.0.0.0.1.0 7-8|0.0.0.0.1 6-7|0.0.0.0 5-6|0.0.0 3-4|0.0 2-3|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:35.846
(a / and 
      :location (a3 / along 
            :op1 (l / line 
                  :ARG1-of (d3 / draw-02 
                        :ARG0 (t / thing 
                              :name (n / name 
                                    :op1 "RNAi")) 
                        :location (a2 / across 
                              :op1 (n2 / nucleus))))) 
      :op1 (q / quantify-01 
            :ARG1 (f / fluorescence)) 
      :op2 (p / plot-01 
            :ARG0-of (r / reveal-01 
                  :ARG1 (d / depletion 
                        :ARG1-of (e / efficient-01))) 
            :ARG1 (d2 / data)))

# ::snt The apparent difference in the efficiency of CAF-1 knockdown revealed by Western blot and IF likely reflects the observation that the RNAi plasmid vector used in this study is efficient in 85 % of the transfected ES cell population , whereas 15 % of cells display no inhibition of the target gene ( see Materials and Methods ) .
# ::tok The apparent difference in the efficiency of CAF-1 knockdown revealed by Western blot and IF likely reflects the observation that the RNAi plasmid vector used in this study is efficient in 85 % of the transfected ES cell population , whereas 15 % of cells display no inhibition of the target gene ( see Materials and Methods ) .
# ::alignments 56-57|0.0.1 55-56|0.0 54-55|0.0.0.0 53-54|0.0.0 51-52|0.2.0.0.0.0.0.0.0.0.0.0.1 50-51|0.2.0.0.0.0.0.0.0.0.0.0.1.0 47-48|0.2.0.0.0.0.0.0.0.0.0.0 46-47|0.2.0.0.0.0.0.0.0.0.2 45-46|0.2.0.0.0.0.0.0.0.0.0.0.0 44-45|0.2.0.0.0.0.0.0.0.0.0.0.0.0.0 42-43|0.2.0.0.0.0.0.0.0.0.0.0.0.0 41-42|0.2.0.0.0.0.0.0.0.0.0.0.0.0.1 40-41|0.2.0.0.0.0.0.0.0.0.0.0.0.1 38-39|0.2.0.0.0.0.0.0.0.0.3 37-38|0.2.0.0.0.0.0.0.0.0.3.0 36-37|0.2.0.0.0.0.0.0.0.0.3.0.0 35-36|0.1 32-33|0.2.0.0.0.0.0.0.0.0.1 31-32|0.2.0.0.0.0.0.0.0.0.1.0 29-30|0.2.0.0.0.0.0.0.0.0 27-28|0.2.0.0.0.0.0 26-27|0.2.0.0.0.0.0.1 24-25|0.2.0.0.0.0.0.0 23-24|0.2.0.0.0.0.0.0.0 22-23|0.2.0.0.0.0.0.0.0.2 21-22|0.2.0.0.0.0.0.0.0.1.0.0+0.2.0.0.0.0.0.0.0.1.0+0.2.0.0.0.0.0.0.0.1 18-19|0.2.0.0.0.0.0.0.0.0.0.2 16-17|0.2.0.0.0.0.0.0.0.0.0 15-16|0.2.0.0.0.0.0.0.0.0.0.1 14-15|0 13-14|0.2 12-13|0.2.0.1 11-12|0.2.0.1.0.1+0.2.0.1.0.0.0+0.2.0.1.0.0+0.2.0.1.0 9-10|0.2.0 8-9|0.2.0.0 7-8|0.2.0.0.1.0.0+0.2.0.0.1.0+0.2.0.0.1 5-6|0.2.0.0.0 2-3|0.2.0.0.0.0 1-2|0.2.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:40.351
(c3 / cause-01 
      :ARG0 (a / and 
            :ARG1-of (s / see-01 
                  :ARG0 (m2 / material)) 
            :op1 (m / method)) 
      :ARG1 (t2 / transfect) 
      :op1-of (a2 / and 
            :ARG0-of (r2 / reveal-01 
                  :ARG1 (k / knockdown 
                        :ARG1-of (e3 / efficient-01 
                              :ARG1-of (d2 / differ-02 
                                    :ARG1-of (s2 / study-01 
                                          :ARG2-of (u / use-01 
                                                :ARG1 (v / vector 
                                                      :ARG1-of (e2 / efficient-01 
                                                            :ARG1-of (r / reflect-01 
                                                                  :ARG0 (i / inhibition 
                                                                        :ARG1-of (d / display-01 
                                                                              :ARG0 (p / percentage-entity 
                                                                                    :domain (c / cell) 
                                                                                    :value 15) 
                                                                              :op1-of (w / whereas)) 
                                                                        :poss (g / gene 
                                                                              :ARG1-of (t / target-01))) 
                                                                  :ARG1-of (l / likely-01) 
                                                                  :ARG2 (o / observation)) 
                                                            :ARG3 (p3 / percentage-entity 
                                                                  :value 85) 
                                                            :polarity - 
                                                            :time (p2 / population 
                                                                  :mod (c2 / cell 
                                                                        :mod (e / e)))) 
                                                      :mod (t4 / thing 
                                                            :name (n / name 
                                                                  :op1 "RNAi")) 
                                                      :mod (p4 / plasmid))) 
                                          :mod (t3 / this)) 
                                    :mod (a3 / apparent))) 
                        :mod (t5 / thing 
                              :name (n3 / name 
                                    :op1 "CAF-1"))) 
                  :ARG2 (b / blot-01 
                        :mod (w2 / world-region 
                              :name (n2 / name 
                                    :op1 "West") 
                              :wiki "Western_world")))))

# ::snt Click here for additional data file .
# ::tok Click here for additional data file .
# ::alignments 5-6|0.0 4-5|0.0.0 3-4|0.0.0.0 1-2|0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:40.367
(c / click-01 
      :ARG1 (f / file 
            :mod (d / data 
                  :mod (a / additional))) 
      :location (h / here))

# ::snt CAF-1-Depleted Embryonic Fibroblasts Active for DNA Replication Do Not Display an Altered Heterochromatin Nuclear Architecture .
# ::tok CAF-1-Depleted Embryonic Fibroblasts Active for DNA Replication Do Not Display an Altered Heterochromatin Nuclear Architecture .
# ::alignments 14-15|0.0.0.0.0 13-14|0.0.0.0.0.1 11-13|0.0.0.0.0.0.1.1+0.0.0.0.0.0.1.0+0.0.0.0.0.0.1+0.0.0.0.0.0 9-10|0.0.0.0 8-9|0.0.0.0.1 6-7|0.0.0.0.0.0.0 5-6|0.0.0.0.0.0.0.0 2-4|0.0.1+0+0.0+0.0.0 1-2|0.0.0.1 0-1|0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:40.799
(f / Fibroblasts 
      :op1-of (n3 / name 
            :name-of (t2 / thing 
                  :ARG0-of (d / display-01 
                        :ARG1 (a / architecture 
                              :mod (t / thing 
                                    :domain (r / replication 
                                          :mod (d2 / DNA)) 
                                    :name (n2 / name 
                                          :op1 (a2 / Altered) 
                                          :op2 (h / Heterochromatin))) 
                              :mod (n / nucleus)) 
                        :polarity -) 
                  :mod (e / embryonic) 
                  :quant (c / caf-1-deplet)) 
            :op2 (a3 / Active)))

# ::snt Immunodetection of p150CAF-1 ( green ) and BrdU ( red ) in MEFs transfected with control ( cont ) or p150CAF-1 RNAi vectors .
# ::tok Immunodetection of p150CAF-1 ( green ) and BrdU ( red ) in MEFs transfected with control ( cont ) or p150CAF-1 RNAi vectors .
# ::alignments 22-23|0.1.2 21-22|0.1.1.0.0+0.1.1.0+0.1.1 19-20|0.1 17-18|0.1.0.0.0 15-16|0.1.0 12-13|0.1.0.0 9-10|0.2 7-8|0.0.0.0+0.0.0+0.0 6-7|0 4-5|0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:40.925
(a / and 
      :op1 (p / person 
            :name (n2 / name 
                  :op1 "BrdU")) 
      :op1-of (o / or 
            :op2 (c2 / control-01 
                  :ARG1 (m / mef 
                        :op1-of (c / cont)) 
                  :ARG1-of (g / green-02)) 
            :op3 (t / thing 
                  :name (n / name 
                        :op1 "RNAi")) 
            :op4 (v / vector)) 
      :op2 (r / red))

# ::snt MEFs were pulse-labeled for 1 h with BrdU prior to fixation and IF analysis .
# ::tok MEFs were pulse-labeled for 1 h with BrdU prior to fixation and IF analysis .
# ::alignments 13-14|0.2 12-13|0 11-12|0.2.1 10-11|0.2.1.0 8-9|0.2.1.0.0 5-6|0.1 4-5|0.2.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:40.991
(c / cause-01 
      :ARG0 (m / mef) 
      :ARG1 (h / h) 
      :manner-of (a / analyze-01 
            :ARG0 1 
            :op2-of (a2 / and 
                  :op1 (f / fixation 
                        :op1-of (p / prior)))))

# ::snt The p150 + BrdU image shows the merge between p150CAF-1 and BrdU fluorescence .
# ::tok The p150 + BrdU image shows the merge between p150CAF-1 and BrdU fluorescence .
# ::alignments 12-13|0.2.0 10-11|0.2 7-8|0.1 5-6|0 4-5|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:41.013
(s / show-01 
      :ARG0 (i / image) 
      :ARG1 (m / merge-01) 
      :op1-of (a / and 
            :op2 (f / fluorescence)))

# ::snt DAPI staining is shown in the right-hand panel .
# ::tok DAPI staining is shown in the right-hand panel .
# ::alignments 7-8|0.1 6-7|0.1.0 3-4|0 1-2|0.0 0-1|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:41.038
(s / show-01 
      :ARG1 (s2 / stain-01 
            :ARG1 (p2 / person 
                  :name (n / name 
                        :op1 "DAPI"))) 
      :time (p / panel 
            :mod (r / right-hand)))

# ::snt The cytoplasmic CAF-1 IF pattern is non-specific .
# ::tok The cytoplasmic CAF-1 IF pattern is non-specific .
# ::alignments 4-5|0.0 3-4|0 2-3|0.1.0.0+0.1.0+0.1 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:41.063
(c / cause-01 
      :ARG1 (p / pattern 
            :mod (c2 / cytoplasmic)) 
      :mod (t / thing 
            :name (n / name 
                  :op1 "CAF-1")))

# ::snt Click here for additional data file .
# ::tok Click here for additional data file .
# ::alignments 5-6|0.0 4-5|0.0.0 3-4|0.0.0.0 1-2|0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:41.078
(c / click-01 
      :ARG1 (f / file 
            :mod (d / data 
                  :mod (a / additional))) 
      :location (h / here))

# ::snt We thank E. Heard and S. Khochbin for critical reading and suggestions ; S. Jounier and H. Humbertclaude for cell culture ; J. Mitja , S. Thessier , and J. C. Robillard for animal care ; M. Vernet for AT-1 cells ; K. Nacerddine for the PML antibody ; N. Gilbert and T. Bestor for probes ; G. Hamard for advice on blastocyst injection ; P. Le Baccon for help on image analysis ; and C. Mann , A. Sentenac , and E. Moustacchi for their support .
# ::tok We thank E. Heard and S. Khochbin for critical reading and suggestions ; S. Jounier and H. Humbertclaude for cell culture ; J. Mitja , S. Thessier , and J. C. Robillard for animal care ; M. Vernet for AT-1 cells ; K. Nacerddine for the PML antibody ; N. Gilbert and T. Bestor for probes ; G. Hamard for advice on blastocyst injection ; P. Le Baccon for help on image analysis ; and C. Mann , A. Sentenac , and E. Moustacchi for their support .
# ::alignments 86-87|0.3.3.0 82-84|0.3.3.1.1+0.3.3.1.0+0.3.3.1+0.3.3 81-82|0.4 78-80|0.1.1.0.1+0.1.1.0.0+0.1.1.0+0.1.1 76-77|0.4.5.1+0.4.5.0.0+0.4.5.0+0.4.5 74-75|0.1 72-73|0.8.0 71-72|0.8.0.0 69-70|0.8.0.1 66-68|0.3.2.0.1+0.3.2.0.0+0.3.2.0+0.3.2 63-64|0.8.1 62-63|0.8.1.1 60-61|0.8.1.0 57-59|0.3.1.0.1+0.3.1.0.0+0.3.1.0+0.3.1 55-56|0.7.0 52-54|0.8.2.1+0.8.2.0+0.8.2+0.8 51-52|0.1.0.1 50-51|0.1.0.2+0.1.0.0.0+0.1.0.0+0.1.0 47-48|0.8.0.1.0.0 46-47|0.8.0.1.0.1.0+0.8.0.1.0.1+0.8.0.1.0 42-44|0.4.4.0.1+0.4.4.0.0+0.4.4.0+0.4.4 40-41|0.4.3.1 36-38|0.4.3.0.1+0.4.3.0.0+0.4.3.0+0.4.3 34-35|0.7 33-34|0.7.1 30-32|0.6.0.1+0.6.0.0+0.6.0+0.6 28-29|0.4.2.1 25-27|0.5.0.1+0.5.0.0+0.5.0+0.5 22-24|0.4.2.0.1+0.4.2.0.0+0.4.2.0+0.4.2 20-21|0.2 19-20|0.2.0 16-18|0.0.0.1+0.0.0.0+0.0.0+0.0 15-16|0.4.1.1 13-15|0.4.1.0.1+0.4.1.0.0+0.4.1.0+0.4.1 12-13|0 11-12|0.4.0.0+0.4.0 10-11|0.3 9-10|0.4.1.1.1 8-9|0.4.1.1.0 5-7|0.3.0.0.1.0.0.1+0.3.0.0.1.0.0.0+0.3.0.0.1.0.0+0.3.0.0.1.0 4-5|0.3.0.0.1 2-4|0.3.0.1.1+0.3.0.1.0+0.3.0.1+0.3.0 1-2|0.3.0.0 0-1|0.3.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:54.256
(a10 / and 
      :op1 (p12 / person 
            :name (n14 / name 
                  :op1 "H." 
                  :op2 "Humbertclaude")) 
      :op1-of (a2 / and 
            :op2 (p7 / person 
                  :name (n7 / name 
                        :op1 "Gilbert") 
                  :op1-of (a5 / and) 
                  :wiki -) 
            :op3 (p2 / person 
                  :name (n2 / name 
                        :op1 "A." 
                        :op2 "Sentenac"))) 
      :op2 (c4 / culture 
            :mod (c5 / cell)) 
      :op2-of (a11 / and 
            :op1 (p15 / person 
                  :ARG2-of (t4 / thank-01 
                        :ARG0 (w / we) 
                        :ARG1 (a12 / and 
                              :op1 (p14 / person 
                                    :name (n16 / name 
                                          :op1 "S." 
                                          :op2 "Khochbin")))) 
                  :name (n17 / name 
                        :op1 "E." 
                        :op2 "Heard")) 
            :op3 (p4 / person 
                  :name (n5 / name 
                        :op1 "G." 
                        :op2 "Hamard")) 
            :op4 (t / thing 
                  :name (n4 / name 
                        :op1 (l / Le) 
                        :op2 (b / Baccon))) 
            :op5 (p / person 
                  :ARG1-of (s / support-01) 
                  :name (n / name 
                        :op1 "E." 
                        :op2 "Moustacchi"))) 
      :op2-of (a / and 
            :op1 (t3 / thing 
                  :ARG1-of (s2 / suggest-01)) 
            :op3 (p13 / person 
                  :name (n15 / name 
                        :op1 "S." 
                        :op2 "Jounier") 
                  :op2-of (a9 / and 
                        :ARG1-of (c6 / critical-02) 
                        :op1 (r2 / read-01))) 
            :op4 (p11 / person 
                  :name (n13 / name 
                        :op1 "J." 
                        :op2 "Mitja") 
                  :op1-of (a8 / and)) 
            :op5 (p9 / person 
                  :name (n10 / name 
                        :op1 "M." 
                        :op2 "Vernet") 
                  :purpose (c / cell)) 
            :op6 (p8 / person 
                  :name (n9 / name 
                        :op1 "K." 
                        :op2 "Nacerddine")) 
            :op7 (p3 / person 
                  :name (n3 / name 
                        :op1 "Mann") 
                  :wiki "Simon_Mann")) 
      :op3 (p10 / person 
            :name (n12 / name 
                  :op1 "S." 
                  :op2 "Thessier")) 
      :op4 (t2 / thing 
            :name (n11 / name 
                  :op1 (c3 / C.) 
                  :op2 (r / Robillard))) 
      :op5 (c2 / care-03 
            :ARG0 (p5 / probe) 
            :ARG1 (a7 / animal)) 
      :op6 (p6 / person 
            :ARG0-of (a3 / analyze-01 
                  :ARG1 (i / image) 
                  :ARG1-of (h / help-01 
                        :ARG2 (o / organization 
                              :mod-of (a6 / antibody) 
                              :name (n8 / name 
                                    :op1 "PML")))) 
            :ARG2-of (i2 / inject-01 
                  :ARG1-of (a4 / advise-01) 
                  :mod (b2 / blastocyst)) 
            :name (n6 / name 
                  :op1 "T." 
                  :op2 "Bestor")))

# ::snt CAF-1 - chromatin assembly factor 1 .
# ::tok CAF-1 - chromatin assembly factor 1 .
# ::alignments 5-6|0.2 4-5|0 3-4|0.0 2-3|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:54.271
(f / factor 
      :mod (a / assembly) 
      :mod (c / chromatin) 
      :quant 1)

# ::snt ChIP - chromatin immunoprecipitation .
# ::tok ChIP - chromatin immunoprecipitation .
# ::alignments 2-3|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:54.277
(c / chromatin 
      :degree (c2 / chip-01))

# ::snt E4 - embryonic day 4 .
# ::tok E4 - embryonic day 4 .
# ::alignments 4-5|0.0.0.0 3-4|0.0.0 2-3|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:54.291
(e2 / E4 
      :degree-of (e / embryonic 
            :mod-of (d / day 
                  :mod 4)))

# ::snt ES - embryonic stem .
# ::tok ES - embryonic stem .
# ::alignments 3-4|0.0.0 2-3|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:54.299
(e2 / e 
      :degree-of (e / embryonic 
            :mod-of (s / stem)))

# ::snt FISH - fluorescence in situ hybridization .
# ::tok FISH - fluorescence in situ hybridization .
# ::alignments 5-6|0.0 2-3|0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:54.314
(f2 / fish-01 
      :ARG1 (h / hybridization 
            :mod-of (f / fluorescence)))

# ::snt IAP - intracisternal A particle .
# ::tok IAP - intracisternal A particle .
# ::alignments 4-5|0 0-1|0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:54.325
(p / particle 
      :mod-of (o / organization 
            :name (n / name 
                  :op1 "IAP")))

# ::snt MEF - mouse embryonic fibroblast .
# ::tok MEF - mouse embryonic fibroblast .
# ::alignments 4-5|0.0.0 3-4|0.0.0.0 2-3|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:54.336
(m2 / MEF 
      :mod-of (m / mouse 
            :mod-of (f / fibroblast 
                  :mod (e / embryonic))))

# ::snt PCNA - proliferating cell nuclear antigen .
# ::tok PCNA - proliferating cell nuclear antigen .
# ::alignments 5-6|0 4-5|0.2 3-4|0.1 2-3|0.0 0-1|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:54.360
(a / antigen 
      :ARG1-of (p / proliferate-01 
            :ARG0 (o / organization 
                  :name (n2 / name 
                        :op1 "PCNA"))) 
      :mod (c / cell) 
      :mod (n / nucleus))

# ::snt PML - promyelocytic leukemia .
# ::tok PML - promyelocytic leukemia .
# ::alignments 3-4|0.2+0.0.0+0.0+0 0-1|0.1.0.0+0.1.0+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:54.374
(d / disease 
      :name (n / name 
            :op1 "Leukemia") 
      :poss (o / organization 
            :name (n2 / name 
                  :op1 "PML")) 
      :wiki "Leukemia")

# ::snt RNAi - RNA interference .
# ::tok RNAi - RNA interference .
# ::alignments 3-4|0.0.0 2-3|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:54.382
(r2 / RNAi 
      :mod-of (r / rna 
            :ARG1-of (i / interfere-01)))

# ::snt siRNA - short interfering RNA .
# ::tok siRNA - short interfering RNA .
# ::alignments 4-5|0.0.0 3-4|0.0 2-3|0.0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:54.397
(s2 / siRNA 
      :ARG2-of (i / interfere-01 
            :ARG1 (r / rna 
                  :mod (s / short))))

# ::snt Loss of p150CAF-1 Function Leads to Early Developmental Arrest and Alteration of Heterochromatin Organization .
# ::tok Loss of p150CAF-1 Function Leads to Early Developmental Arrest and Alteration of Heterochromatin Organization .
# ::alignments 12-14|0.1.0.0.0.0.1+0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 10-11|0.1.0.1 9-10|0.1.0 8-9|0.1.0.0 7-8|0.1.0.0.1 6-7|0.1 4-5|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:54.513
(l / lead-01 
      :ARG0 (l2 / los) 
      :ARG1 (e / early 
            :op1-of (a2 / and 
                  :op2 (a3 / arrest-01 
                        :ARG0 (o / organization 
                              :name (n / name 
                                    :op1 "Heterochromatin" 
                                    :op2 "Organization")) 
                        :ARG1 (d / developmental)) 
                  :op3 (a / alteration))))

# ::snt ( A ) Generation of Chaf1a + /  mice by homologous recombination in ES cells .
# ::tok ( A ) Generation of Chaf1a + /  mice by homologous recombination in ES cells .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:54.514
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt ( Top ) Scheme of the p150CAF1 protein indicating the interacting domains ( ID ) for HP1 and p60CAF-1 , and the acidic domain ( AD ) .
# ::tok ( Top ) Scheme of the p150CAF1 protein indicating the interacting domains ( ID ) for HP1 and p60CAF-1 , and the acidic domain ( AD ) .
# ::alignments 25-26|0.1.0.0.0 23-24|0.1.2 22-23|0.1.2.0 20-21|0.1 17-18|0.0.0 13-14|0.1.1 11-12|0.1.0 10-11|0.1.0.0 8-9|0 7-8|0.0.1 3-4|0.0 1-2|0.1.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:54.796
(i3 / indicate-01 
      :ARG0 (s / scheme-01 
            :ARG0 (a3 / and) 
            :ARG1 (p / protein)) 
      :ARG1 (a2 / and 
            :op1 (d2 / domain 
                  :ARG1-of (i2 / interact-01 
                        :ARG0 "AD" 
                        :ARG2 (t / top))) 
            :op2 (i / id) 
            :op3 (d / domain 
                  :mod (a / acidic))))

# ::snt ( Middle ) Structure of the murine Chaf1a gene .
# ::tok ( Middle ) Structure of the murine Chaf1a gene .
# ::alignments 8-9|0.0 7-8|0.0.0.0.0+0.0.0.0+0.0.0 6-7|0.0.1 3-4|0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:54.875
(s / structure-01 
      :ARG1 (g / gene 
            :mod (c / country 
                  :name (n / name 
                        :op1 "Chaf1a")) 
            :mod (m / murine)) 
      :op1-of "Middle_East")

# ::snt Blocks and lines represent exons and introns , respectively .
# ::tok Blocks and lines represent exons and introns , respectively .
# ::alignments 8-9|0.1.0 6-7|0.0.2 5-6|0.1 4-5|0.0.1 3-4|0 2-3|0.1.1 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:55.079
(r2 / represent-01 
      :ARG0 (a2 / and 
            :op1 (b / block-01) 
            :op2 (e / exon) 
            :op3 (i / intron)) 
      :ARG1 (a / and 
            :mod (r / respective) 
            :op1 (l / line)))

# ::snt A star indicates the translation initiation site .
# ::tok A star indicates the translation initiation site .
# ::alignments 6-7|0.1 5-6|0.1.0 4-5|0.1.1.0+0.1.1 2-3|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:55.108
(i2 / indicate-01 
      :ARG0 (s2 / star) 
      :ARG1 (s / site 
            :mod (i / initiation) 
            :mod (t / thing 
                  :ARG2-of (t2 / translate-01))))

# ::snt Below is shown the Chaf1a targeting vector , which includes genomic DNA homology regions ( 5 HR and 3 HR ) , the diphtheria toxin ( DT ) , and neomycin selection genes .
# ::tok Below is shown the Chaf1a targeting vector , which includes genomic DNA homology regions ( 5 HR and 3 HR ) , the diphtheria toxin ( DT ) , and neomycin selection genes .
# ::alignments 32-33|0.1.0.0.0.2 31-32|0.1.0.0.0.2.0 30-31|0.1.0.0.0.2.0.0 29-30|0.1.0.0 24-25|0.1.0.0.0.1 23-24|0.1.0.0.0.1.0 18-19|0.0 17-18|0.1.0.0.0 16-17|0.1.0.0.0.0.0.0+0.1.0.0.0.0.0+0.1.0.0.0.0 15-16|0.1.0.0.0.0.1 13-14|0.1.0.1 12-13|0.1.0.1.0 11-12|0.1.0.1.0.0 9-10|0.1.0 6-7|0.1 5-6|0.1.1 4-5|0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 2-3|0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:56.486
(s2 / show-01 
      :ARG0 3 
      :ARG1 (v / vector 
            :ARG0-of (i / include-01 
                  :ARG1 (a / and 
                        :op1 (a2 / and 
                              :op1 (o / organization 
                                    :name (n2 / name 
                                          :op1 "HR") 
                                    :quant 5) 
                              :op2 (t / toxin 
                                    :mod (d / diphtheria)) 
                              :op3 (g / gene 
                                    :ARG1-of (s / select-01 
                                          :ARG0 (n / neomycin))))) 
                  :ARG2 (r / region 
                        :mod (h / homology 
                              :mod (d2 / DNA)))) 
            :ARG1-of (t2 / target-01 
                  :ARG0 (c / country 
                        :name (n3 / name 
                              :op1 "Chaf1a")))) 
      :ARG2 (b / below))

# ::snt Recombined ( Rec ) ES cells and mice were identified by Southern blot using ScaI ( S ) and the indicated probe .
# ::tok Recombined ( Rec ) ES cells and mice were identified by Southern blot using ScaI ( S ) and the indicated probe .
# ::alignments 21-22|0.0 20-21|0 18-19|0.0.1 16-17|0.0.0.0+0.0.0 14-15|0.0.1.0.0.0.0+0.0.1.0.0.0+0.0.1.0.0 13-14|0.0.1.0 12-13|0.0.1.0.2.2 11-12|0.0.1.0.2.2.0.0.0+0.0.1.0.2.2.0.0+0.0.1.0.2.2.0 9-10|0.0.1.0.2 7-8|0.0.1.0.2.1.0 6-7|0.0.1.0.2.1 5-6|0.0.1.0.1 0-1|0.0.1.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:57.279
(i / indicate-01 
      :ARG1 (p / probe-01 
            :ARG0 (n / name 
                  :op1 "S-400") 
            :op1-of (a / and 
                  :ARG0-of (u / use-01 
                        :ARG1 (t / thing 
                              :name (n2 / name 
                                    :op1 "ScaI")) 
                        :ARG2 (c / cell) 
                        :purpose-of (i2 / identify-01 
                              :ARG0 (r / recombine-01) 
                              :ARG1 (a2 / and 
                                    :op1 (m / mouse)) 
                              :manner (b / blot-01 
                                    :ARG1 (t2 / thing 
                                          :name (n3 / name 
                                                :op1 "Southern"))))))))

# ::snt ( B ) Breeding strategy used for the production of E4 Chaf1a  /  embryos .
# ::tok ( B ) Breeding strategy used for the production of E4 Chaf1a  /  embryos .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:57.280
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Genotyping was performed by PCR using the three oligonucleotide primers indicated in ( A ) ( 1 , 2 , and 3 ) .
# ::tok Genotyping was performed by PCR using the three oligonucleotide primers indicated in ( A ) ( 1 , 2 , and 3 ) .
# ::alignments 21-22|0.0.0.0.0 20-21|0 18-19|0.0.1.1 16-17|0.0.1.2 10-11|0.0.0.0 9-10|0.0.0 7-8|0.0.0.1 5-6|0.0 2-3|0.0.1 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:57.440
(a / and 
      :op1 (u / use-01 
            :ARG1 (p / primer 
                  :ARG1-of (i / indicate-01 
                        :ARG0 3) 
                  :quant 3) 
            :manner-of (p2 / perform-02 
                  :ARG1 (g / genotyp) 
                  :ARG2 2 
                  :op1-of 1)))

# ::snt An example of the result of a genotyping experiment is shown .
# ::tok An example of the result of a genotyping experiment is shown .
# ::alignments 10-11|0 8-9|0.0 7-8|0.0.0 4-5|0.0.1 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:57.491
(s / show-01 
      :ARG0 (e / experiment-01 
            :ARG1 (g / genotyp) 
            :ARG1-of (r / result-01)) 
      :ARG1 (e2 / example))

# ::snt ( C ) Immunodetection of p150CAF-1 ( green ) and HP1 ( red ) in E4 embryos derived from Chaf1a + /  intercrosses .
# ::tok ( C ) Immunodetection of p150CAF-1 ( green ) and HP1 ( red ) in E4 embryos derived from Chaf1a + /  intercrosses .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:57.494
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Because Chaf1a + / + and Chaf1a + /  embryos both stain positively for the presence of p150CAF-1 , they are both designated as wild-type .
# ::tok Because Chaf1a + / + and Chaf1a + /  embryos both stain positively for the presence of p150CAF-1 , they are both designated as wild-type .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:57.496
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt p150CAF-1 expression , which indicates ongoing S phase , can be detected in most cells within the wild-type blastocyst ( upper panel ) .
# ::tok p150CAF-1 expression , which indicates ongoing S phase , can be detected in most cells within the wild-type blastocyst ( upper panel ) .
# ::alignments 21-22|0.1.1.1.0 20-21|0.1.1.1 18-19|0.0 14-15|0.1.2 13-14|0.1.2.0 11-12|0.1 9-10|0 7-8|0.1.1.0.0 6-7|0.1.1.0.0.0.0+0.1.1.0.0.0 5-6|0.1.0 4-5|0.1.1.0 1-2|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:57.689
(p2 / possible-01 
      :ARG0 (b / blastocyst) 
      :ARG1 (d / detect-01 
            :ARG0 (o / ongo) 
            :ARG1 (e / express-01 
                  :ARG0-of (i / indicate-01 
                        :ARG1 (p3 / phase 
                              :name (n / name 
                                    :op1 "S-400"))) 
                  :ARG1 (u / upper 
                        :mod-of (p / panel))) 
            :ARG2 (c / cell 
                  :quant (m / most))))

# ::snt The lower panel shows a 12-cell embryo labeling negatively for p150CAF-1 .
# ::tok The lower panel shows a 12-cell embryo labeling negatively for p150CAF-1 .
# ::alignments 8-9|0.1.0 7-8|0.1 6-7|0.1.1 3-4|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:57.717
(s / show-01 
      :ARG0 (p / panel 
            :ARG1-of (l2 / low-04)) 
      :ARG1 (l / label-01 
            :ARG0 (n / negatively) 
            :ARG1 (e / embryo)))

# ::snt Only nonspecific background labeling can be observed .
# ::tok Only nonspecific background labeling can be observed .
# ::alignments 6-7|0.0 4-5|0 3-4|0.0.0 2-3|0.0.0.0 1-2|0.0.0.2 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:57.738
(p / possible-01 
      :ARG1 (o / observe-01 
            :ARG1 (l / label-01 
                  :ARG1 (b / background) 
                  :mod (o2 / only) 
                  :mod (n / nonspecific))))

# ::snt In each panel , the right-hand image shows the merge between the HP1 fluorescence and DAPI-stained DNA in blue .
# ::tok In each panel , the right-hand image shows the merge between the HP1 fluorescence and DAPI-stained DNA in blue .
# ::alignments 18-19|0.1.0.1.0.0 16-17|0.1.0.1.0 15-16|0.1.0.1.0.1 14-15|0.1.0.1 13-14|0.1.0 12-13|0.1.0.0 9-10|0.1 7-8|0 6-7|0.0 5-6|0.0.0 2-3|0.2 1-2|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:57.978
(s / show-01 
      :ARG0 (i / image 
            :mod (r / right-hand)) 
      :ARG1 (m / merge-01 
            :ARG1 (f / fluorescence 
                  :mod (h / HP1) 
                  :op1-of (a / and 
                        :op2 (d / DNA 
                              :location (b / blue) 
                              :mod (d2 / dapi-stain))))) 
      :time (p / panel 
            :mod (e / each)))

# ::snt Pink color indicates the association of HP1 with DAPI-dense material .
# ::tok Pink color indicates the association of HP1 with DAPI-dense material .
# ::alignments 9-10|0.1.0.0 8-9|0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 6-7|0.1.0 4-5|0.1 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:58.064
(i / indicate-01 
      :ARG0 (c / color 
            :mod (p / pink-01)) 
      :ARG1 (a / associate-01 
            :ARG1 (h / HP1 
                  :source (m / material 
                        :mod (t / thing 
                              :name (n / name 
                                    :op1 "DAPI-dense"))))))

# ::snt The bottom of each panel shows the magnification of a nucleus selected from the above embryo ( white square ) .
# ::tok The bottom of each panel shows the magnification of a nucleus selected from the above embryo ( white square ) .
# ::alignments 18-19|0.3 17-18|0.3.0 15-16|0.1.0.0.0 14-15|0.2 11-12|0.1.0.0 10-11|0.1.0 7-8|0.1 5-6|0 4-5|0.0.0 3-4|0.0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:58.433
(s3 / show-01 
      :ARG0 (b / bottom 
            :poss (p / panel 
                  :mod (e2 / each))) 
      :ARG1 (m / magnification 
            :poss (n / nucleus 
                  :ARG1-of (s2 / select-01 
                        :ARG3 (e / embryo)))) 
      :ARG2 (a / above) 
      :op1-of (s / square 
            :mod (w / white)))

# ::snt The arrowhead indicates the typical heterochromatin foci revealed by DAPI and HP1 staining in wild-type embryos .
# ::tok The arrowhead indicates the typical heterochromatin foci revealed by DAPI and HP1 staining in wild-type embryos .
# ::alignments 15-16|0.1.2.1 12-13|0.0.0 10-11|0.1.2.0 9-10|0.1.2.0.0.0.0+0.1.2.0.0.0+0.1.2.0.0 7-8|0.1.2 6-7|0.1 5-6|0.1.0 4-5|0.1.1 2-3|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:58.684
(i / indicate-01 
      :ARG0 (a2 / arrowhead 
            :ARG0-of (s / stain-01)) 
      :ARG1 (f / focus-01 
            :ARG1 (h / heterochromatin) 
            :ARG1-of (t / typical-02) 
            :ARG1-of (r / reveal-01 
                  :ARG0 (a / and 
                        :op1 (p / person 
                              :name (n / name 
                                    :op1 "DAPI"))) 
                  :medium (e / embryo))))

# ::snt These foci are not visible in Chaf1a  /  embryos .
# ::tok These foci are not visible in Chaf1a  /  embryos .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:58.686
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt DAPI and HP1 staining are diffuse within the nucleus of p150CAF-1-depleted embryos , with enrichment at the nuclear periphery , revealing abnormal heterochromatin organization .
# ::tok DAPI and HP1 staining are diffuse within the nucleus of p150CAF-1-depleted embryos , with enrichment at the nuclear periphery , revealing abnormal heterochromatin organization .
# ::alignments 23-24|0.0 22-23|0.0.1 21-22|0 20-21|0.0.0 18-19|0.0.0.1.0 17-18|0.0.0.1.0.0 14-15|0.0.0.1 11-12|0.0.0.1.1 10-11|0.0.0.1.1.0 8-9|0.0.0.0.0.0.0 5-6|0.0.0.0.0.0 3-4|0.0.0.0 1-2|0.0.0.0.0 0-1|0.0.0.0.0.1.0.0+0.0.0.0.0.1.0+0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:59.096
(a / abnormal 
      :mod-of (o / organization 
            :ARG1-of (r / reveal-01 
                  :ARG1-of (s / stain-01 
                        :op2-of (a2 / and 
                              :ARG1-of (d / diffuse-01 
                                    :ARG2 (n2 / nucleus)) 
                              :op1 (p3 / person 
                                    :name (n3 / name 
                                          :op1 "DAPI")))) 
                  :ARG2-of (e / enrich-01 
                        :ARG0 (p / periphery 
                              :mod (n / nucleus)) 
                        :ARG1 (e2 / embryo 
                              :mod (p2 / p150caf-1-deplet)))) 
            :mod (h / heterochromatin)))

# ::snt Scale bars represent 10 m .
# ::tok Scale bars represent 10 m .
# ::alignments 4-5|0.1 3-4|0.1.0 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:59.168
(r / represent-01 
      :ARG0 (b / bar 
            :mod (s / scale)) 
      :ARG1 (m / m 
            :quant 10))

# ::snt ( E ) Wild-type embryos isolated at embryonic day 2 ( E2 , two cells ) , E2 .5 ( four cells ) , E3 ( eight cells ) , E3 .5 ( 16 cells ) , and E4 ( 32 cells ) are shown .
# ::tok ( E ) Wild-type embryos isolated at embryonic day 2 ( E2 , two cells ) , E2 .5 ( four cells ) , E3 ( eight cells ) , E3 .5 ( 16 cells ) , and E4 ( 32 cells ) are shown .
# ::alignments 44-45|0 41-42|0.2.0 40-41|0.1.0 37-38|0.0 34-35|0.4 33-34|0.0.1.1.3 27-28|0.0.1.1.0 26-27|0.0.1.1.2 21-22|0.5 20-21|0.2 14-15|0.1 13-14|0.3 9-10|0.6 8-9|0.0.1 7-8|0.0.1.0 5-6|0.0.1.1 4-5|0.0.1.1.1 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:59.498
(s / show-01 
      :ARG1 (a / and 
            :op1 (e3 / E) 
            :op2 (d / day 
                  :mod (e / embryonic) 
                  :time-of (i / isolate-01 
                        :ARG0 (c3 / cell) 
                        :ARG1 (e2 / embryo) 
                        :op1-of 8 
                        :op1-of 16))) 
      :op1-of (c5 / cell 
            :mod 32) 
      :op1-of (4 / 4 
            :mod-of (c / cell)) 
      :op1-of 2 
      :op1-of (c2 / cell) 
      :op1-of (c4 / cell) 
      :op1-of 2)

# ::snt Heterochromatin was monitored by DAPI staining ( upper panel ) and HP1 immunolabeling ( in red , lower panel ) .
# ::tok Heterochromatin was monitored by DAPI staining ( upper panel ) and HP1 immunolabeling ( in red , lower panel ) .
# ::alignments 18-19|0 17-18|0.0 15-16|0.0.1.1 12-13|0.0.1.0.1 11-12|0.0.1.0.1.0 10-11|0.0.1.0 8-9|0.0.0 7-8|0.0.0.0 5-6|0.0.1.0.0.0 4-5|0.0.1.0.0.1.0+0.0.1.0.0.1+0.0.1.0.0 2-3|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:59.730
(p / panel 
      :ARG1-of (l / low-04 
            :ARG0 (p2 / panel 
                  :mod (u / upper)) 
            :purpose-of (m / monitor-01 
                  :ARG0 (a / and 
                        :op1 (p3 / person 
                              :ARG0-of (s / stain-01) 
                              :name (n / name 
                                    :op1 "DAPI")) 
                        :op2 (i / immunolabel 
                              :mod (h / HP1))) 
                  :ARG1 (r / red))))

# ::snt ( F ) Magnification of a nucleus ( DAPI-stained ) representative of each stage .
# ::tok ( F ) Magnification of a nucleus ( DAPI-stained ) representative of each stage .
# ::alignments 13-14|0.0.0 12-13|0.0.0.0 10-11|0.0 8-9|0 6-7|0.0.2 3-4|0.0.1 1-2|0.0.0.1.1+0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:59.834
(d / dapi-stain 
      :ARG2-of (r / represent-01 
            :ARG1 (s / stage 
                  :mod (e / each) 
                  :poss-of (a / aircraft-type 
                        :name (n2 / name 
                              :op1 "F22") 
                        :wiki "Lockheed_Martin_F-22_Raptor")) 
            :ARG3 (m / magnification) 
            :mod (n / nucleus)))

# ::snt The right-hand panel shows the nucleus of an ES cell .
# ::tok The right-hand panel shows the nucleus of an ES cell .
# ::alignments 9-10|0.1.0 8-9|0.1.0.0 5-6|0.1 3-4|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:59.862
(s / show-01 
      :ARG0 (p / panel 
            :mod (r / right-hand)) 
      :ARG1 (n / nucleus 
            :poss (c / cell 
                  :location (e / e))))

# ::snt Scale bar represents 10 m .
# ::tok Scale bar represents 10 m .
# ::alignments 4-5|0.1 3-4|0.1.0 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:30:59.919
(r / represent-01 
      :ARG0 (b / bar-01 
            :ARG1 (s / scale)) 
      :ARG1 (m / m 
            :quant 10))

# ::snt Depletion of p150CAF-1 in ES Cells Results in a Severe Alteration of Heterochromatin Organization .
# ::tok Depletion of p150CAF-1 in ES Cells Results in a Severe Alteration of Heterochromatin Organization .
# ::alignments 12-14|0.0.0.0.0.0.1+0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 10-11|0.0.0.0 9-10|0.0.0 6-7|0.0 4-6|0.0.1.0.1+0.0.1.0.0+0.0.1.0+0.0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:00.013
(d / depletion 
      :ARG2-of (r / result-01 
            :ARG0 (s / severe 
                  :mod-of (a / alteration 
                        :mod (o / organization 
                              :name (n / name 
                                    :op1 "Heterochromatin" 
                                    :op2 "Organization")))) 
            :ARG1 (t / thing 
                  :name (n2 / name 
                        :op1 (e / ES) 
                        :op2 (c / Cells)))))

# ::snt ( A ) Strategy used to deplete p150CAF-1 by RNAi in ES cells .
# ::tok ( A ) Strategy used to deplete p150CAF-1 by RNAi in ES cells .
# ::alignments 12-13|0.1.1 11-12|0.1.1.0 9-10|0.1.0.0.0+0.1.0.0+0.1.0 6-7|0.1 4-5|0 3-4|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:00.049
(u / use-01 
      :ARG0 (s / strategy) 
      :ARG2 (d / deplete-01 
            :ARG0 (t / thing 
                  :name (n / name 
                        :op1 "RNAi")) 
            :ARG1 (c / cell 
                  :mod (e / e))))

# ::snt The siRNA expression vector includes a puromycin selection cassette ( Puro ) , the mouse H1 promoter , and the siRNA encoding sequence .
# ::tok The siRNA expression vector includes a puromycin selection cassette ( Puro ) , the mouse H1 promoter , and the siRNA encoding sequence .
# ::alignments 22-23|0.0.2 21-22|0.0.2.0 18-19|0.0 16-17|0.0.1 15-16|0.0.1.1 14-15|0.0.1.1.0 10-11|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 8-9|0.0.0 7-8|0.0.0.0 6-7|0.0.0.0.0 4-5|0 3-4|0.1 2-3|0.1.0 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:01.223
(i / include-01 
      :ARG1 (a / and 
            :op1 (c / cassette 
                  :ARG0-of (s2 / select-01 
                        :ARG1 (p2 / puromycin))) 
            :op2 (p / promote-01 
                  :ARG0 (t / thing 
                        :name (n / name 
                              :op1 "Puro")) 
                  :ARG1 (h / H1 
                        :mod (m / mouse))) 
            :op3 (s / sequence 
                  :ARG1-of (e / encode-01))) 
      :ARG2 (v / vector 
            :ARG0-of (e2 / express-01 
                  :ARG1 (s3 / siRNA))))

# ::snt ES cells were kept under puromycin selection during 48 h following transfection .
# ::tok ES cells were kept under puromycin selection during 48 h following transfection .
# ::alignments 11-12|0.2 10-11|0 9-10|0.0 8-9|0.0.0 6-7|0.1.0.0 5-6|0.1.0.0.0 3-4|0.1 1-2|0.1.0 0-1|0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:01.341
(f / follow-01 
      :ARG0 (h / h 
            :quant 48) 
      :ARG1 (k / keep-01 
            :ARG1 (c / cell 
                  :ARG0-of (s / select-01 
                        :ARG1 (p / puromycin)) 
                  :mod (e / e))) 
      :ARG2 (t / transfection))

# ::snt ( B ) Abnormal heterochromatin organization in p150CAF-1-depleted ES cells .
# ::tok ( B ) Abnormal heterochromatin organization in p150CAF-1-depleted ES cells .
# ::alignments 9-10|0.0.0 8-9|0.0.0.0 7-8|0.0.0.1 5-6|0.0 4-5|0.0.1 3-4|0 1-2|0.1.1+0.1.0.0+0.1.0+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:01.377
(a / abnormal 
      :mod-of (o / organization 
            :location (c / cell 
                  :mod (e / e) 
                  :mod (p / p150caf-1-deplet)) 
            :mod (h / heterochromatin)) 
      :mod-of (l / location 
            :name (n / name 
                  :op1 "B") 
            :wiki -))

# ::snt Immunodetection of p150CAF-1 ( green ) and HP1 ( red ) in ES cells transfected with control ( cont ) and p150CAF-1 siRNA .
# ::tok Immunodetection of p150CAF-1 ( green ) and HP1 ( red ) in ES cells transfected with control ( cont ) and p150CAF-1 siRNA .
# ::alignments 22-23|0.1.1 20-21|0.1 18-19|0.1.0.0.1 16-17|0.1.0 13-14|0.1.0.0 12-13|0.1.0.0.0 9-10|0.0 6-7|0 4-5|0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:01.473
(a2 / and 
      :op1 (r / red) 
      :op1-of (a / and 
            :op2 (c2 / control-01 
                  :ARG1 (c3 / cell 
                        :mod (e / e) 
                        :op1-of (c / cont)) 
                  :ARG1-of (g / green-02)) 
            :op3 (s / siRNA)))

# ::snt siRNA expression results in efficient p150CAF-1 depletion .
# ::tok siRNA expression results in efficient p150CAF-1 depletion .
# ::alignments 6-7|0.1 4-5|0.1.0 2-3|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:01.503
(r / result-01 
      :ARG1 (e2 / express-01) 
      :ARG2 (d / depletion 
            :ARG1-of (e / efficient-01)))

# ::snt The right-hand image shows the merge between HP1 fluorescence and DAPI-stained DNA in blue .
# ::tok The right-hand image shows the merge between HP1 fluorescence and DAPI-stained DNA in blue .
# ::alignments 13-14|0.1.0.1.0.0 11-12|0.1.0.1.0 10-11|0.1.0.1.0.1 9-10|0.1.0.1 8-9|0.1.0 7-8|0.1.0.0 5-6|0.1 3-4|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:01.639
(s / show-01 
      :ARG0 (i / image 
            :mod (r / right-hand)) 
      :ARG1 (m / merge-01 
            :ARG1 (f / fluorescence 
                  :mod (h / HP1) 
                  :op1-of (a / and 
                        :op2 (d / DNA 
                              :location (b / blue) 
                              :mod (d2 / dapi-stain))))))

# ::snt Scale bar = 10 m .
# ::tok Scale bar = 10 m .
# ::alignments 4-5|0 3-4|0.0.0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:01.666
(m / m 
      :domain (b / bar-01 
            :ARG0 10 
            :ARG1 (s / scale)))

# ::snt ( C ) Heterochromatin organization is not altered in p150CAF-1-depleted MEFs .
# ::tok ( C ) Heterochromatin organization is not altered in p150CAF-1-depleted MEFs .
# ::alignments 10-11|0.2 9-10|0.2.0 7-8|0 6-7|0.3 4-5|0.1 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:01.732
(a / alter-01 
      :ARG0 (c / C) 
      :ARG1 (o / organization) 
      :ARG2 (m / mef 
            :mod (p / p150caf-1-deplet)) 
      :polarity -)

# ::snt Immunodetection of p150CAF-1 ( green ) and HP1 ( red ) in MEFs transfected with control ( cont ) or p150CAF-1 siRNA .
# ::tok Immunodetection of p150CAF-1 ( green ) and HP1 ( red ) in MEFs transfected with control ( cont ) or p150CAF-1 siRNA .
# ::alignments 21-22|0.1.1 19-20|0.1 17-18|0.1.0.0.0 15-16|0.1.0 12-13|0.1.0.0 9-10|0.0 6-7|0 4-5|0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:01.810
(a / and 
      :op1 (r / red) 
      :op1-of (o / or 
            :op2 (c2 / control-01 
                  :ARG1 (m / mef 
                        :op1-of (c / cont)) 
                  :ARG1-of (g / green-02)) 
            :op3 (s / siRNA)))

# ::snt The right-hand image shows the merge between HP1 fluorescence and DAPI-stained DNA in blue .
# ::tok The right-hand image shows the merge between HP1 fluorescence and DAPI-stained DNA in blue .
# ::alignments 13-14|0.1.0.1.0.0 11-12|0.1.0.1.0 10-11|0.1.0.1.0.1 9-10|0.1.0.1 8-9|0.1.0 7-8|0.1.0.0 5-6|0.1 3-4|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:01.965
(s / show-01 
      :ARG0 (i / image 
            :mod (r / right-hand)) 
      :ARG1 (m / merge-01 
            :ARG1 (f / fluorescence 
                  :mod (h / HP1) 
                  :op1-of (a / and 
                        :op2 (d / DNA 
                              :location (b / blue) 
                              :mod (d2 / dapi-stain))))))

# ::snt ( D ) PML bodies are not altered in p150CAF-1-depleted ES cells .
# ::tok ( D ) PML bodies are not altered in p150CAF-1-depleted ES cells .
# ::alignments 11-12|0.0 10-11|0.0.0 9-10|0.0.1 7-8|0 6-7|0.3 4-5|0.1 3-4|0.1.0.0.0+0.1.0.0+0.1.0 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:02.243
(a / alter-01 
      :ARG0 (c / cell 
            :mod (e / e) 
            :mod (p / p150caf-1-deplet)) 
      :ARG1 (b / body 
            :mod (o / organization 
                  :name (n / name 
                        :op1 "PML"))) 
      :ARG2 (d / D) 
      :polarity -)

# ::snt Immunodetection of PML ( red ) in ES cells transfected with control ( cont ) or p150CAF-1 siRNA .
# ::tok Immunodetection of PML ( red ) in ES cells transfected with control ( cont ) or p150CAF-1 siRNA .
# ::alignments 17-18|0.1 15-16|0 13-14|0.0.1.1 11-12|0.0 8-9|0.0.1 7-8|0.0.1.0 4-5|0.1.0 2-3|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:02.292
(o / or 
      :op1 (c2 / control-01 
            :ARG0 (o2 / organization 
                  :name (n / name 
                        :op1 "PML")) 
            :ARG1 (c3 / cell 
                  :mod (e / e) 
                  :op1-of (c / cont))) 
      :op2 (s / siRNA 
            :poss-of (r / red)))

# ::snt The right-hand image shows the merge between PML fluorescence and DAPI-stained DNA in blue .
# ::tok The right-hand image shows the merge between PML fluorescence and DAPI-stained DNA in blue .
# ::alignments 13-14|0.1.0.1.0.0 11-12|0.1.0.1.0 10-11|0.1.0.1.0.1 9-10|0.1.0.1 8-9|0.1.0 7-8|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 5-6|0.1 3-4|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:02.430
(s / show-01 
      :ARG0 (i / image 
            :mod (r / right-hand)) 
      :ARG1 (m / merge-01 
            :ARG1 (f / fluorescence 
                  :mod (o / organization 
                        :name (n / name 
                              :op1 "PML")) 
                  :op1-of (a / and 
                        :op2 (d / DNA 
                              :location (b / blue) 
                              :mod (d2 / dapi-stain))))))

# ::snt p150CAF-1 Depletion and Loss of Heterochromatin Organization Are Compatible with Active DNA Replication in ES Cells .
# ::tok p150CAF-1 Depletion and Loss of Heterochromatin Organization Are Compatible with Active DNA Replication in ES Cells .
# ::alignments 14-16|0.0.5.0.1+0.0.5.0.0+0.0.5.0+0.0.5 12-13|0.0.4.0 11-12|0.0.4 10-11|0.0.3 8-9|0.0.0.0.0+0.0.0.0+0.0.0 7-8|0 5-7|0.0.1.0.0.1+0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 3-4|0.0.2 2-3|0.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:02.528
(b / be-01 
      :ARG1 (a2 / and 
            :domain-of (o / organization 
                  :name (n2 / name 
                        :op1 "Compatible")) 
            :op1 (d2 / depletion 
                  :op1 (o2 / organization 
                        :name (n3 / name 
                              :op1 "Heterochromatin" 
                              :op2 "Organization"))) 
            :op2 (l / los) 
            :op3 (a / active) 
            :op4 (d / DNA 
                  :mod-of (r / replication)) 
            :op5 (t / thing 
                  :name (n / name 
                        :op1 (e / ES) 
                        :op2 (c / Cells)))))

# ::snt ( A ) ES cells were transfected with p150CAF-1 or control siRNA vectors .
# ::tok ( A ) ES cells were transfected with p150CAF-1 or control siRNA vectors .
# ::alignments 12-13|0.0 11-12|0.0.0.0 10-11|0.0.0 9-10|0 4-5|0.0.0.1 3-4|0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:02.570
(o / or 
      :op1 (v / vector 
            :ARG2-of (c / control-01 
                  :ARG0 (s / siRNA) 
                  :ARG1 (c2 / cell 
                        :mod (e / e)))))

# ::snt After 3 d under puromycin selection , cells were pulse-labeled for 10 min with BrdU and immediately analyzed by IF .
# ::tok After 3 d under puromycin selection , cells were pulse-labeled for 10 min with BrdU and immediately analyzed by IF .
# ::alignments 19-20|0.0.0 17-18|0.0 16-17|0.0.2 15-16|0 12-13|0.0.0.0 11-12|0.1.0.0.0 7-8|0.0.1 5-6|0.1.0.0 4-5|0.1.0.0.1 2-3|0.1.0 1-2|0.1.0.1 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:02.689
(a2 / and 
      :op1 (a / analyze-01 
            :ARG0 (c / cause-01 
                  :ARG1 (m / min)) 
            :ARG1 (c2 / cell) 
            :time (i / immediate)) 
      :time (a3 / after 
            :op1 (d / d 
                  :ARG2-of (s / select-01 
                        :ARG0 10 
                        :ARG1 (p / puromycin)) 
                  :quant 3)))

# ::snt No significant difference in BrdU incorporation could be detected between control and p150CAF-1-depleted cells .
# ::tok No significant difference in BrdU incorporation could be detected between control and p150CAF-1-depleted cells .
# ::alignments 13-14|0.0.1.1 12-13|0.0.1.1.0 11-12|0.0.1 10-11|0.0.1.0 8-9|0.0 6-7|0 5-6|0.0.0.0 2-3|0.0.0 1-2|0.0.0.1 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:02.746
(p2 / possible-01 
      :ARG1 (d / detect-01 
            :ARG1 (d2 / differ-02 
                  :ARG1 (i / incorporation) 
                  :ARG1-of (s / significant-02)) 
            :op1-of (a / and 
                  :op2 (c2 / control-01) 
                  :op3 (c / cell 
                        :mod (p / p150caf-1-deplet))) 
            :polarity -))

# ::snt The right-hand image shows the merge between the p150CAF-1 and BrdU fluorescence .
# ::tok The right-hand image shows the merge between the p150CAF-1 and BrdU fluorescence .
# ::alignments 11-12|0.1.0 9-10|0.1.1 5-6|0.1 3-4|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:02.833
(s / show-01 
      :ARG0 (i / image 
            :mod (r / right-hand)) 
      :ARG1 (m / merge-01 
            :ARG0 (f / fluorescence) 
            :ARG1 (a / and)))

# ::snt Scale bar = 10 m .
# ::tok Scale bar = 10 m .
# ::alignments 4-5|0 3-4|0.0.0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:02.857
(m / m 
      :domain (b / bar-01 
            :ARG0 10 
            :ARG1 (s / scale)))

# ::snt ( B ) Immunodetection of PCNA ( red ) revealed no significant difference in the formation of replication foci between control and p150CAF-1-depleted ES cells .
# ::tok ( B ) Immunodetection of PCNA ( red ) revealed no significant difference in the formation of replication foci between control and p150CAF-1-depleted ES cells .
# ::alignments 24-25|0.1.0.1 23-24|0.1.0.1.0 22-23|0.1.0.1.0.0 21-22|0.1.0 20-21|0.1.0.0 18-19|0.1.2.1 17-18|0.1.2.1.0 15-16|0.1.2 12-13|0.1 11-12|0.1.1 10-11|0.2 9-10|0 7-8|0.1.0.0.0 5-6|0.0.0.0+0.0.0+0.0 1-2|0.1.2.0.1+0.1.2.0.0.0+0.1.2.0.0+0.1.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:03.080
(r2 / reveal-01 
      :ARG0 (o / organization 
            :name (n / name 
                  :op1 "PCNA")) 
      :ARG1 (d / differ-02 
            :ARG1 (a / and 
                  :op1 (c2 / control-01 
                        :ARG1 (r3 / red)) 
                  :op2 (c / cell 
                        :mod (e / e 
                              :mod (p / p150caf-1-deplet)))) 
            :ARG1-of (s / significant-02) 
            :prep-in (f2 / form-01 
                  :ARG0 (l / location 
                        :name (n2 / name 
                              :op1 "B") 
                        :wiki -) 
                  :ARG1 (f / focus-01 
                        :ARG1 (r / replication)))) 
      :polarity -)

# ::snt Immunodetection of p150CAF-1 is shown in green and the merging of p150CAF-1 and PCNA appears in yellow .
# ::tok Immunodetection of p150CAF-1 is shown in green and the merging of p150CAF-1 and PCNA appears in yellow .
# ::alignments 16-17|0.0.0.2 14-15|0.0.0 13-14|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 12-13|0.0.0.3 9-10|0.0.0.3.0 7-8|0.0 6-7|0.1 4-5|0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:03.174
(s / show-01 
      :ARG1 (a3 / and 
            :op1 (a / appear-02 
                  :ARG0 (o / organization 
                        :name (n / name 
                              :op1 "PCNA")) 
                  :ARG1 (i / Immunodetection) 
                  :ARG1-of (y / yellow-02) 
                  :op2-of (a2 / and 
                        :op1 (m / merge-01)))) 
      :ARG1-of (g / green-02))

# ::snt ( C ) Flow cytometry analysis showed a similar cell-cycle profile for control and p150CAF-1-depleted ES cells .
# ::tok ( C ) Flow cytometry analysis showed a similar cell-cycle profile for control and p150CAF-1-depleted ES cells .
# ::alignments 16-17|0.2.1 15-16|0.2.1.0 14-15|0.0.0 13-14|0.2 12-13|0.2.0 10-11|0.1 8-9|0.1.0 6-7|0 5-6|0.0 3-4|0.0.1.1+0.0.1 1-2|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:03.347
(s / show-01 
      :ARG0 (a2 / analyze-01 
            :ARG0 (p / p150caf-1-deplet) 
            :ARG1 (n / name 
                  :name-of (c3 / C) 
                  :op1 "Flow")) 
      :ARG1 (p2 / profile 
            :ARG1-of (r / resemble-01)) 
      :ARG3 (a / and 
            :op1 (c2 / control-01) 
            :op2 (c / cell 
                  :mod (e / e))))

# ::snt Results are presented as the percentage of cells in each phase of the cell cycle ( G1 , S , G2/M ) , as defined by BrdU incorporation and DNA content .
# ::tok Results are presented as the percentage of cells in each phase of the cell cycle ( G1 , S , G2/M ) , as defined by BrdU incorporation and DNA content .
# ::alignments 30-31|0.1.0.1 29-30|0.1.0.1.0 28-29|0.1.0 27-28|0.1.0.0 24-25|0.1 18-19|0.0.0.0+0.0.0 14-15|0.2.0.0.0 13-14|0.2.0.0.0.0 10-11|0.2.0.0 9-10|0.2.0.0.1 7-8|0.2.0 5-6|0.2 2-3|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:03.729
(p3 / present-01 
      :ARG1 (r / result-01 
            :ARG1 (n / name 
                  :op1 "S-400")) 
      :ARG1-of (d2 / define-01 
            :ARG0 (a / and 
                  :op1 (i / incorporation) 
                  :op2 (c / content 
                        :mod (d / DNA)))) 
      :ARG2 (p2 / percentage 
            :domain (c4 / cell 
                  :part-of (p / phase 
                        :mod (c2 / cycle-02 
                              :ARG1 (c3 / cell)) 
                        :mod (e / each)))))

# ::snt Data presented are the mean of three independent experiments ; error bars indicate the standard deviation .
# ::tok Data presented are the mean of three independent experiments ; error bars indicate the standard deviation .
# ::alignments 15-16|0.0.1.0.1 14-15|0.0.1.0.1.0 12-13|0.0.1.0 11-12|0.0.1.0.0 10-11|0.1.0.0 9-10|0.0.1 8-9|0.1 7-8|0.1.0.1+0.1.0 6-7|0.0.0.0 4-5|0 1-2|0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:03.852
(m / mean-01 
      :ARG0 (d3 / data 
            :ARG1-of (p / present-01 
                  :ARG0 3) 
            :domain-of (a / and 
                  :op1 (i / indicate-01 
                        :ARG0 (b / bar) 
                        :ARG1 (d / deviation 
                              :ARG1-of (s / standard-02))))) 
      :ARG1 (e2 / experiment-01 
            :ARG0-of (d2 / depend-01 
                  :ARG1 (e / error) 
                  :polarity -)))

# ::snt All experiments were performed 3 d after transfection of the siRNA vectors .
# ::tok All experiments were performed 3 d after transfection of the siRNA vectors .
# ::alignments 11-12|0.0.2.0 10-11|0.0.2 7-8|0.0.1.0 6-7|0.0.1 5-6|0.0.0 4-5|0.0.0.0 3-4|0.0 1-2|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:04.112
(e / experiment-01 
      :ARG2-of (p / perform-02 
            :ARG1 (d / d 
                  :quant 3) 
            :time (a / after 
                  :op1 (t / transfection)) 
            :time (s / siRNA 
                  :mod-of (v / vector))) 
      :quant (a2 / all))

# ::snt Depletion of p150CAF-1 Leads to Loss of Clustering , Altered Localization , and Decondensation of Pericentric Heterochromatin Domains .
# ::tok Depletion of p150CAF-1 Leads to Loss of Clustering , Altered Localization , and Decondensation of Pericentric Heterochromatin Domains .
# ::alignments 13-18|0.1.0.2.0.4+0.1.0.2.0.3+0.1.0.2.0.2+0.1.0.2.0.1+0.1.0.2.0.0+0.1.0.2.0+0.1.0.2 12-13|0.1.0 9-11|0.1.0.1.0.1+0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 7-8|0.1.0.0 5-6|0.1 3-4|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:04.178
(l3 / lead-01 
      :ARG0 (d / depletion) 
      :ARG4 (l2 / los 
            :op1-of (a / and 
                  :op2 (c / cluster-01) 
                  :op3 (t / thing 
                        :name (n2 / name 
                              :op1 (a2 / Altered) 
                              :op2 (l / Localization))) 
                  :op4 (o / organization 
                        :name (n / name 
                              :op1 "Decondensation" 
                              :op2 "of" 
                              :op3 "Pericentric" 
                              :op4 "Heterochromatin" 
                              :op5 "Domains")))))

# ::snt Distribution of pericentric ( red ) and centric ( green ) domains was analyzed in the interphase nuclei of mouse ES cells by DNA FISH , using major satellite ( pSAT ) [ 47 ] and minor satellite ( pMR150 ) [ 48 ] DNA probes , respectively .
# ::tok Distribution of pericentric ( red ) and centric ( green ) domains was analyzed in the interphase nuclei of mouse ES cells by DNA FISH , using major satellite ( pSAT ) [ 47 ] and minor satellite ( pMR150 ) [ 48 ] DNA probes , respectively .
# ::alignments 47-48|0.0 45-46|0.3.0.1.1.0.0.0 44-45|0.3.0.1.1.0.0 42-43|0.3.0.1.1.0.0.0.0 37-38|0.3.0.3 36-37|0.3.0.4 35-36|0.2 33-34|0.1.0 30-31|0.3.0.1.1.0.1.0 28-29|0.3.0.1.1 27-28|0.3.0.1.1.0 26-27|0.3.0.1 23-25|0.3.0.0.0.1+0.3.0.0.0.0+0.3.0.0.0+0.3.0.0 21-22|0.3.0.2.0 20-21|0.3.0.2.0.0 19-20|0.3.0.2.0.0.0 17-18|0.3.0.2 13-14|0.3.0 11-12|0.3 9-10|0.3.0.1.1.0.1 7-8|0.1 6-7|0 4-5|0.1.1 0-1|0.3.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:05.311
(a3 / and 
      :mod (r / respective) 
      :op1 (c2 / center-01 
            :ARG0 47 
            :ARG1 (r2 / red)) 
      :op1-of (a / and) 
      :op2 (d3 / domain 
            :ARG1-of (a2 / analyze-01 
                  :ARG0 (t / thing 
                        :name (n / name 
                              :op1 (d2 / DNA) 
                              :op2 (f / FISH))) 
                  :ARG2-of (u / use-01 
                        :ARG0 (d4 / distribution) 
                        :ARG1 (s2 / satellite 
                              :ARG1-of (m2 / major-02 
                                    :ARG0 (d / DNA 
                                          :mod-of (p / probe 
                                                :quant 48)) 
                                    :purpose-of (g / green-02 
                                          :ARG1 (p2 / pSAT))))) 
                  :location (n2 / nucleus 
                        :domain (c / cell 
                              :mod (e / e 
                                    :mod (m3 / mouse)))) 
                  :op1-of (s / satellite) 
                  :op1-of (m / minor))))

# ::snt ( A ) In ES cells expressing control ( cont ) siRNA , pericentric regions from several chromosomes associate in clusters ( red ) .
# ::tok ( A ) In ES cells expressing control ( cont ) siRNA , pericentric regions from several chromosomes associate in clusters ( red ) .
# ::alignments 22-23|0.1.0.0.1 20-21|0.1.0.0.2 18-19|0.1.0.0 17-18|0.1.0.0.0.0 16-17|0.1.0.0.0.0.0 14-15|0.1.0.0.0 11-12|0.1 9-10|0.1.0.0.3 7-8|0.1.0 6-7|0 5-6|0.0 4-5|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:05.606
(e / express-01 
      :ARG0 (c5 / cell 
            :mod (e2 / e)) 
      :ARG1 (s2 / siRNA 
            :ARG1-of (c4 / control-01 
                  :purpose-of (a / associate-01 
                        :ARG0 (r2 / region 
                              :source (c2 / chromosom 
                                    :quant (s / several))) 
                        :ARG1 (r / red) 
                        :ARG2 (c / cluster) 
                        :op1-of (c3 / cont)))))

# ::snt These chromocenters form foci as revealed by DAPI staining ( left-hand image ) , while centric regions ( green ) remain independent entities at the periphery of these domains .
# ::tok These chromocenters form foci as revealed by DAPI staining ( left-hand image ) , while centric regions ( green ) remain independent entities at the periphery of these domains .
# ::alignments 28-29|0.1.0.0.0 27-28|0.1.0.0.0.0 25-26|0.1.1 22-23|0.1.0 21-22|0.1.0.0.2+0.1.0.0 20-21|0.1 18-19|0 16-17|0.1.0.1 15-16|0.1.0.1.0 11-12|0.0.0 10-11|0.0 8-9|0.1.0.0.1 7-8|0.1.0.0.1.0.0.0+0.1.0.0.1.0.0+0.1.0.0.1.0 5-6|0.1.0.0.1.1 3-4|0.1.0.0.1.1.0 2-3|0.1.0.0.1.1.1 1-2|0.1.0.0.1.1.0.0 0-1|0.1.0.0.1.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:06.825
(g / green-02 
      :ARG0 (l / left-hand 
            :mod-of (i / image)) 
      :ARG1 (r / remain-01 
            :ARG1 (e / entity 
                  :ARG0-of (d2 / depend-01 
                        :ARG1 (d / domain 
                              :mod (t / this)) 
                        :ARG1-of (s / stain-01 
                              :ARG0 (p2 / person 
                                    :name (n / name 
                                          :op1 "DAPI")) 
                              :ARG0-of (r3 / reveal-01 
                                    :ARG1 (f / focus-01 
                                          :ARG1 (c2 / chromocenter 
                                                :mod (t2 / this))) 
                                    :condition-of (f2 / form))) 
                        :polarity -) 
                  :domain (r2 / region 
                        :ARG1-of (c / center-01))) 
            :ARG2 (p / periphery)))

# ::snt The right-hand image shows the merge between the pericentric and centric FISH signals .
# ::tok The right-hand image shows the merge between the pericentric and centric FISH signals .
# ::alignments 12-13|0.1.0.1 11-12|0.1.0.1.0.0.0+0.1.0.1.0.0+0.1.0.1.0 10-11|0.1.0.0 9-10|0.1.0 5-6|0.1 3-4|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:07.135
(s2 / show-01 
      :ARG0 (i / image 
            :mod (r / right-hand)) 
      :ARG1 (m / merge-01 
            :ARG1 (a / and 
                  :op1 (c / center-01) 
                  :op2 (s / signal 
                        :mod (t / thing 
                              :name (n / name 
                                    :op1 "FISH"))))))

# ::snt ( B ) The organization of pericentric domains was altered in cells expressing p150CAF-1 siRNA .
# ::tok ( B ) The organization of pericentric domains was altered in cells expressing p150CAF-1 siRNA .
# ::alignments 14-15|0.2.0.0 12-13|0.2.0 11-12|0.2 9-10|0 7-8|0.0.0 4-5|0.0 1-2|0.1.1+0.1.0.0+0.1.0+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:07.399
(a / alter-01 
      :ARG1 (o / organization 
            :quant-of (d / domain)) 
      :ARG2 (l / location 
            :name (n / name 
                  :op1 "B") 
            :wiki -) 
      :location (c / cell 
            :ARG0-of (e / express-01 
                  :ARG1 (s / siRNA))))

# ::snt Instead of forming well-defined chromocenters , pericentric domains were found either isolated or associated in heterogeneous aggregates of various sizes , often at the nuclear periphery .
# ::tok Instead of forming well-defined chromocenters , pericentric domains were found either isolated or associated in heterogeneous aggregates of various sizes , often at the nuclear periphery .
# ::alignments 25-26|0.2.0.1 24-25|0.2.0.1.0 21-22|0.1.0 19-20|0.2.2 18-19|0.2.2.1 16-17|0.2.2.0 15-16|0.2.2.0.0 13-14|0.2.1 12-13|0.2 11-12|0.2.0 10-11|0.2.0.0 9-10|0 7-8|0.0 4-5|0.1.1.0 3-4|0.1.1.0.0 2-3|0.1.1 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:08.205
(f / find-01 
      :ARG1 (d / domain) 
      :ARG1-of (i2 / instead-of-91 
            :ARG0 (o / often) 
            :ARG2 (f2 / form-01 
                  :ARG1 (c / chromocenter 
                        :mod (w / well-defin)))) 
      :ARG2 (o2 / or 
            :op1 (i / isolate-01 
                  :ARG1 (e / either) 
                  :time (p / periphery 
                        :mod (n / nucleus))) 
            :op2 (a2 / associate-01) 
            :op3 (s / size 
                  :ARG1-of (a / aggregate-01 
                        :mod (h / heterogeneou)) 
                  :mod (v / various))))

# ::snt Scale bar = 10 m .
# ::tok Scale bar = 10 m .
# ::alignments 4-5|0 3-4|0.0.0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:08.231
(m / m 
      :domain (b / bar-01 
            :ARG0 10 
            :ARG1 (s / scale)))

# ::snt ( C ) Control ES cells .
# ::tok ( C ) Control ES cells .
# ::alignments 5-6|0.1 3-4|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:08.254
(c2 / control-01 
      :ARG1 (c3 / C) 
      :purpose-of (c / cell))

# ::snt Fluorescence was quantified along a line randomly drawn across the nucleus in the merged image and data were plotted .
# ::tok Fluorescence was quantified along a line randomly drawn across the nucleus in the merged image and data were plotted .
# ::alignments 18-19|0.3 16-17|0.3.0 15-16|0 14-15|0.2 13-14|0.2.0 10-11|0.0.0.0.0.0 8-9|0.0.0.0.0 7-8|0.0.0.0 6-7|0.0.0.0.1 5-6|0.0.0 3-4|0.0 2-3|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:08.479
(a / and 
      :location (a3 / along 
            :op1 (l / line 
                  :ARG1-of (d2 / draw-02 
                        :location (a2 / across 
                              :op1 (n / nucleus)) 
                        :manner (r / random)))) 
      :op1 (q / quantify-01 
            :ARG1 (f / fluorescence)) 
      :op2 (i / image 
            :ARG1-of (m / merge-01)) 
      :op3 (p / plot-01 
            :ARG1 (d / data)))

# ::snt One can distinguish clear peaks corresponding to chromocenters ( red ) and the condensed minor satellites ( green ) .
# ::tok One can distinguish clear peaks corresponding to chromocenters ( red ) and the condensed minor satellites ( green ) .
# ::alignments 17-18|0.1.0.1 15-16|0.1 14-15|0.1.1 13-14|0.1.0 11-12|0 9-10|0.1.0.0 7-8|0.0 5-6|0.0.0 4-5|0.0.0.0 3-4|0.0.0.0.1 2-3|0.0.0.0.0 1-2|0.0.0.0.0.1 0-1|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:08.621
(a / and 
      :op1 (c2 / chromocenter 
            :ARG2-of (c3 / correspond-01 
                  :ARG1 (p / peak-01 
                        :ARG1-of (d / distinguish-01 
                              :ARG0 1 
                              :ARG1-of (p2 / possible-01)) 
                        :ARG1-of (c4 / clear-06)))) 
      :op2 (s / satellite 
            :ARG1-of (c / condense-01 
                  :ARG0 (r / red) 
                  :ARG1-of (g / green-02)) 
            :mod (m / minor)))

# ::snt ( D ) ES cells expressing p150CAF-1 siRNA .
# ::tok ( D ) ES cells expressing p150CAF-1 siRNA .
# ::alignments 7-8|0.1 5-6|0 4-5|0.3 3-4|0.0 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:08.665
(e / express-01 
      :ARG0 (e2 / e) 
      :ARG1 (s / siRNA) 
      :ARG2 (d / D) 
      :manner-of (c / cell))

# ::snt p150CAF-1 depletion led to a lower fluorescence intensity and a broader distribution of signals corresponding to DAPI ( blue ) and major satellite hybridization ( red , plot ) while the organization of the minor satellites remained unaffected .
# ::tok p150CAF-1 depletion led to a lower fluorescence intensity and a broader distribution of signals corresponding to DAPI ( blue ) and major satellite hybridization ( red , plot ) while the organization of the minor satellites remained unaffected .
# ::alignments 37-38|0.0.0.1.0.1.0.2.1+0.0.0.1.0.1.0.2 36-37|0.0.0.1.0.1.0 35-36|0.0.0.1.0.1.0.0 34-35|0.0.0.1.0.1.0.0.0 31-32|0.0.0.1.0.1 27-28|0.0.0.1.0.1.0.1.0 25-26|0.0.0.1.0.1.0.2.0 23-24|0.0.0 22-23|0.0.0.0 21-22|0.0 20-21|0.0.0.1 18-19|0 14-15|0.0.0.1.0.1.0.1 13-14|0.0.0.1.1.0 11-12|0.0.0.1.1 10-11|0.0.0.1.1.1 8-9|0.0.0.1.2 7-8|0.0.0.1.0.2 6-7|0.0.0.1.0.2.1 5-6|0.0.0.1.0.2.0 2-3|0.0.0.1.0 1-2|0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:09.182
(b / blue 
      :ARG0-of (m2 / major-02 
            :ARG1 (h / hybridization 
                  :mod (s2 / satellite) 
                  :op2-of (a2 / and 
                        :ARG2-of (l2 / lead-02 
                              :ARG0 (d2 / depletion) 
                              :ARG1 (o / organization 
                                    :ARG0-of (r / remain-01 
                                          :ARG1 (s / satellite 
                                                :mod (m / minor)) 
                                          :ARG1-of (c / correspond-01 
                                                :ARG1-of (p / plot-01)) 
                                          :ARG3 (a / affect-01 
                                                :ARG0 (r2 / red) 
                                                :polarity -))) 
                              :ARG4 (i / intensity 
                                    :ARG1-of (l / low-04) 
                                    :mod (f / fluorescence))) 
                        :op1 (d / distribute-01 
                              :ARG1 (s3 / signal) 
                              :ARG1-of (b2 / broad-02)) 
                        :op1-of (a3 / and)))))

# ::snt Insets in the right-hand images show a typical chromocenter in control cells ( C ) and a disrupted chromocenter in p150CAF-1-depleted cells ( D ) .
# ::tok Insets in the right-hand images show a typical chromocenter in control cells ( C ) and a disrupted chromocenter in p150CAF-1-depleted cells ( D ) .
# ::alignments 23-24|0.2.1.0.1 21-22|0.1.0.1 20-21|0.1.0.1.0 18-19|0.1.0 17-18|0.1.0.0 15-16|0.1 13-14|0.1.0.0.0 11-12|0.2.1 10-11|0.2.1.0 8-9|0.2 7-8|0.2.0 5-6|0 4-5|0.2.1.0.0 3-4|0.2.1.0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:10.004
(s / show-01 
      :ARG0 (i2 / inset) 
      :ARG1 (a / and 
            :op1 (c2 / chromocent 
                  :ARG1-of (d2 / disrupt-01 
                        :ARG0 (c3 / C)) 
                  :location (c / cell 
                        :mod (p / p150caf-1-deplet)))) 
      :ARG2 (c6 / chromocent 
            :ARG1-of (t / typical-02) 
            :location (c4 / cell 
                  :topic (c5 / control-01 
                        :ARG0 (i / image 
                              :mod (r / right-hand)) 
                        :ARG1 (d / D)))))

# ::snt Nucleosomal Organization Is Not Altered in p150CAF-1-Depleted ES Cells .
# ::tok Nucleosomal Organization Is Not Altered in p150CAF-1-Depleted ES Cells .
# ::alignments 7-9|0.1.2.1+0.1.2.0+0.1.2+0.1 6-7|0.1.1 4-5|0.1.0 3-4|0.0 2-3|0 0-2|0.1.0.0.0.1+0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:10.071
(b / be-01 
      :ARG1 - 
      :ARG2 (t / thing 
            :ARG1-of (a / alter-01 
                  :ARG0 (o / organization 
                        :name (n2 / name 
                              :op1 "Nucleosomal" 
                              :op2 "Organization"))) 
            :mod (p / p150caf-1-deplet) 
            :name (n / name 
                  :op1 (e / ES) 
                  :op2 (c / Cells))))

# ::snt Nuclei were prepared from ES cells transfected with control or p150CAF-1 siRNA vector .
# ::tok Nuclei were prepared from ES cells transfected with control or p150CAF-1 siRNA vector .
# ::alignments 12-13|0.0 11-12|0 9-10|0.0.0 8-9|0.0.0.0 5-6|0.0.0.0.0 4-5|0.0.0.0.0.0 2-3|0.0.0.0.0.1 0-1|0.0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:10.142
(s / siRNA 
      :mod-of (v / vector 
            :op2-of (o / or 
                  :op1 (c / control-01 
                        :ARG1 (c2 / cell 
                              :mod (e / e) 
                              :source-of (p / prepare-02 
                                    :ARG1 (n / nucleus)))))))

# ::snt Nuclei were digested with increasing amounts of DNase I or MNase .
# ::tok Nuclei were digested with increasing amounts of DNase I or MNase .
# ::alignments 10-11|0.1.0.0.1.0.0+0.1.0.0.1.0+0.1.0.0.1 9-10|0.1.0.0 8-9|0.1.0.0.0 5-6|0.1.0 4-5|0.1 2-3|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:10.225
(d / digest-01 
      :ARG1 (n2 / nucleus) 
      :ARG2 (i2 / increase-01 
            :ARG1 (a / amount 
                  :op1-of (o / or 
                        :op2 (i / i) 
                        :op3 (p / person 
                              :name (n / name 
                                    :op1 "MNase"))))))

# ::snt ( A ) After digestion with the indicated nucleases , total DNA was prepared and run onto an agarose gel which was stained with ethidium bromide to reveal bulk genomic DNA .
# ::tok ( A ) After digestion with the indicated nucleases , total DNA was prepared and run onto an agarose gel which was stained with ethidium bromide to reveal bulk genomic DNA .
# ::alignments 30-31|0.1.1.0.0.0.0.1 28-29|0.1.1.0.0.0.0.1.0 27-28|0.1.1.0.0.0.0 25-26|0.1.1.0.0.0.0.0 24-25|0.1.1.0.0.0.0.0.0 22-23|0.1.1.0.0.0 19-20|0.1.1.0.0 16-17|0.1.1.0 15-16|0.1.1 14-15|0.1 13-14|0.1.0 11-12|0.1.0.0 10-11|0.1.0.0.0 8-9|0.0 7-8|0 4-5|0.1.0.0.0.0 3-4|0.1.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:10.566
(i / indicate-01 
      :ARG1 (n / nucleas) 
      :op1-of (a / and 
            :op2 (p / prepare-02 
                  :ARG1 (d2 / DNA 
                        :ARG2-of (t / total-01 
                              :ARG1 (d3 / digestion 
                                    :op1-of (a2 / after))))) 
            :op3 (r2 / run-01 
                  :time (o / onto 
                        :op1 (g / gel 
                              :ARG0-of (s / stain-01 
                                    :ARG1 (r / reveal-01 
                                          :ARG0 (b2 / bromide 
                                                :mod (e / ethidium)) 
                                          :ARG1 (d / DNA 
                                                :ARG1-of (b / bulk-01)))))))))

# ::snt ( B ) The DNA was blotted onto a nylon membrane , which was then hybridized with the -32P-labeled pSAT major satellite repeat probe [ 47 ] .
# ::tok ( B ) The DNA was blotted onto a nylon membrane , which was then hybridized with the -32P-labeled pSAT major satellite repeat probe [ 47 ] .
# ::alignments 25-26|0.0.1 23-24|0.0.2 22-23|0.0.2.1 21-22|0.0.2.1.1 20-21|0.0.2.0.0 19-20|0.0.2.0 18-19|0 15-16|0.0.3.0.0 14-15|0.0.3.0.0.0 10-11|0.0.3.0 9-10|0.0.3.0.1 7-8|0.0.3 6-7|0.0 4-5|0.0.0 1-2|0.0.2.1.0.1+0.0.2.1.0.0.0+0.0.2.1.0.0+0.0.2.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:11.117
(- / -32p-label 
      :ARG0-of (b / blot-01 
            :ARG1 (d / DNA) 
            :ARG2 47 
            :ARG2-of (p / probe-01 
                  :ARG0 (p2 / pSAT 
                        :ARG1-of (m / major-02)) 
                  :ARG1 (r / repeat-01 
                        :ARG0 (l / location 
                              :name (n2 / name 
                                    :op1 "B") 
                              :wiki -) 
                        :ARG1 (s / satellite))) 
            :time (o / onto 
                  :op1 (m2 / membrane 
                        :ARG1-of (h / hybridize-01 
                              :time (t / then)) 
                        :mod (n / nylon)))))

# ::snt DNA CpG Methylation at Pericentric Heterochromatin Is Not Altered in p150CAF-1-Depleted ES Cells .
# ::tok DNA CpG Methylation at Pericentric Heterochromatin Is Not Altered in p150CAF-1-Depleted ES Cells .
# ::alignments 11-13|0.2.2.1+0.2.2.0+0.2.2+0.2 10-11|0.2.1 8-9|0.2.0 7-8|0.1 6-7|0 4-6|0.0.0.1+0.0.0.0+0.0.0+0.0 1-3|0.2.0.0.1.1+0.2.0.0.1.0+0.2.0.0.1+0.2.0.0 0-1|0.2.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:11.350
(b / be-01 
      :ARG0 (t2 / thing 
            :name (n2 / name 
                  :op1 (p2 / Pericentric) 
                  :op2 (h / Heterochromatin))) 
      :ARG1 - 
      :ARG2 (t / thing 
            :ARG2-of (a / alter-01 
                  :ARG1 (t3 / thing 
                        :mod (d / DNA) 
                        :name (n3 / name 
                              :op1 (c2 / CpG) 
                              :op2 (m / Methylation)))) 
            :mod (p / p150caf-1-deplet) 
            :name (n / name 
                  :op1 (e / ES) 
                  :op2 (c / Cells))))

# ::snt Total DNA was isolated from cells transfected with a control or the p150CAF-1 siRNA vector and digested with MaeII , whose recognition sequence is present in major satellite repeats .
# ::tok Total DNA was isolated from cells transfected with a control or the p150CAF-1 siRNA vector and digested with MaeII , whose recognition sequence is present in major satellite repeats .
# ::alignments 28-29|0.0.0 27-28|0.0.0.0 26-27|0.0.0.1 24-25|0.0.1 22-23|0.0 21-22|0 18-19|0.0.1.0.0.1.0+0.0.1.0.0.1+0.0.1.0.0 16-17|0.0.1.0 15-16|0.0.1.0.1 14-15|0.0.1.0.0.0.0.0 13-14|0.0.1.0.0.0.0.0.0 10-11|0.0.1.0.0.0.0 9-10|0.0.1.0.0.0 5-6|0.0.1.0.1.0.1 3-4|0.0.1.0.1.0 1-2|0.0.1.0.1.0.0 0-1|0.0.1.0.1.0.0.0.0+0.0.1.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:11.810
(r2 / recognize-01 
      :ARG1 (s2 / sequence 
            :ARG0-of (r / repeat-01 
                  :ARG1 (s / satellite) 
                  :ARG1-of (m / major-02)) 
            :domain-of (p / present 
                  :ARG0-of (d / digest-01 
                        :ARG1 (t / thing 
                              :ARG1-of (c / control-01 
                                    :op1-of (o / or 
                                          :op2 (v / vector 
                                                :mod (s3 / siRNA)))) 
                              :name (n / name 
                                    :op1 "MaeII")) 
                        :op2-of (a / and 
                              :op1 (i / isolate-01 
                                    :ARG1 (d2 / DNA 
                                          :name (n2 / name 
                                                :op1 "Total")) 
                                    :source (c2 / cell)))))))

# ::snt Digested DNA was run onto an agarose gel and analyzed by Southern blotting using the pSAT major satellite probe [ 47 ] .
# ::tok Digested DNA was run onto an agarose gel and analyzed by Southern blotting using the pSAT major satellite probe [ 47 ] .
# ::alignments 20-21|0.1.0.1 18-19|0.1.1.1 17-18|0.1.1.1.0 16-17|0.1.1.1.1 13-14|0.1.1 12-13|0.1.1.0 11-12|0.1.1.0.0.0.0+0.1.1.0.0.0+0.1.1.0.0 9-10|0.1 8-9|0 7-8|0.0.0.0 6-7|0.0.0.0.0 4-5|0.0.0 3-4|0.0 1-2|0.1.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:11.921
(a2 / and 
      :op1 (r / run-01 
            :time (o / onto 
                  :op1 (g / gel 
                        :mod (a3 / agarose)))) 
      :op2 (a / analyze-01 
            :ARG0 (d / DNA 
                  :ARG1-of (d2 / digest-01) 
                  :quant 47) 
            :manner (u / use-01 
                  :ARG0 (b / blot-01 
                        :ARG1 (t / thing 
                              :name (n / name 
                                    :op1 "Southern"))) 
                  :ARG1 (p / probe-01 
                        :ARG0 (s / satellite) 
                        :ARG1-of (m / major-02)))))

# ::snt Alteration of Epigenetic Marking at Pericentric Heterochromatin in p150CAF-1-Depleted Cells .
# ::tok Alteration of Epigenetic Marking at Pericentric Heterochromatin in p150CAF-1-Depleted Cells .
# ::alignments 9-10|0.0.0 8-9|0.0.0.0 5-7|0.0.1.0.1+0.0.1.0.0+0.0.1.0+0.0.1 3-4|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:11.946
(a / alteration 
      :ARG1-of (m / mark-01 
            :ARG2 (c / cell 
                  :mod (p / p150caf-1-deplet)) 
            :location (c2 / country 
                  :name (n / name 
                        :op1 "Pericentric" 
                        :op2 "Heterochromatin"))))

# ::snt ( A ) p150CAF-1 depletion leads to reduced H4K20me3 and H3K9me3 at pericentric heterochromatin .
# ::tok ( A ) p150CAF-1 depletion leads to reduced H4K20me3 and H3K9me3 at pericentric heterochromatin .
# ::alignments 13-14|0.1 10-11|0.2.1 9-10|0.2 8-9|0.2.0 7-8|0.2.0.0 5-6|0 4-5|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:12.089
(l / lead-03 
      :ARG0 (d / depletion) 
      :ARG1 (h / heterochromatin) 
      :ARG2 (a / and 
            :op1 (h3 / H4K20me3 
                  :ARG1-of (r / reduce-01)) 
            :op2 (h2 / H3K9me3)))

# ::snt Enrichment of histone marks at major satellite repeats was determined by ChIP from control ( cont ) and p150CAF-1 ( p150 ) siRNA-expressing ES cells .
# ::tok Enrichment of histone marks at major satellite repeats was determined by ChIP from control ( cont ) and p150CAF-1 ( p150 ) siRNA-expressing ES cells .
# ::alignments 24-25|0.2.0 23-24|0.2.0.0 20-21|0.2.1.0 17-18|0.2.1 15-16|0.0.0.2 13-14|0.2 11-12|0.0 9-10|0 7-8|0.0.0 6-7|0.0.0.0 5-6|0.0.0.1 3-4|0.0.0.3+0.0.0.3.0 2-3|0.0.0.3.0.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:12.298
(d / determined-02 
      :ARG0 (c4 / chip-01 
            :ARG1 (r / repeat-01 
                  :ARG1 (s / satellite) 
                  :ARG1-of (m / major-02) 
                  :op1-of (c2 / cont) 
                  :purpose-of (m2 / mark-01 
                        :ARG0 (t / thing 
                              :mod (h / histone))))) 
      :ARG1 (e2 / enrichment) 
      :ARG2 (c3 / control-01 
            :ARG1 (c / cell 
                  :mod (e / e)) 
            :op1-of (a / and 
                  :op2 (p / p150))))

# ::snt DNA prepared from the input and the antibody-bound fraction were run onto an agarose gel and analyzed by Southern blot with the pSAT major satellite repeat probe [ 47 ] .
# ::tok DNA prepared from the input and the antibody-bound fraction were run onto an agarose gel and analyzed by Southern blot with the pSAT major satellite repeat probe [ 47 ] .
# ::alignments 28-29|0.1.1.1 26-27|0.1.0.1 25-26|0.1.0.1.0 24-25|0.1.0.1.0.0 23-24|0.1.0.1.1 19-20|0.1.0 18-19|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 16-17|0.1 15-16|0 14-15|0.0.0.0 11-12|0.0.0 10-11|0.0 8-9|0.1.1.0.0.1 5-6|0.1.1.0.0 4-5|0.1.1.0.0.0 1-2|0.1.1.0 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:12.663
(a2 / and 
      :op1 (r2 / run-01 
            :time (o / onto 
                  :op1 (g / gel))) 
      :op2 (a / analyze-01 
            :ARG0 (b / blot-01 
                  :ARG1 (t / thing 
                        :name (n / name 
                              :op1 "Southern")) 
                  :ARG2 (p / probe-01 
                        :ARG1 (r / repeat-01 
                              :ARG1 (s / satellite)) 
                        :ARG1-of (m / major-02))) 
            :ARG1 (d / DNA 
                  :ARG1-of (p2 / prepare-02 
                        :ARG0 (a3 / and 
                              :op1 (i / input) 
                              :op2 (f / fraction))) 
                  :quant 47)))

# ::snt ( B ) Hybridization signals were quantified using an Instant Imager .
# ::tok ( B ) Hybridization signals were quantified using an Instant Imager .
# ::alignments 9-11|0.0.1.0.1+0.0.1.0.0+0.0.1.0+0.0.1 7-8|0.0 6-7|0 4-5|0.0.0 3-4|0.0.0.0 1-2|0.0.2.1+0.0.2.0.0+0.0.2.0+0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:12.993
(q / quantify-01 
      :ARG1 (u / use-01 
            :ARG0 (s / signal 
                  :mod (h / hybridization)) 
            :ARG1 (t / thing 
                  :name (n / name 
                        :op1 (i / Instant) 
                        :op2 (i2 / Imager))) 
            :ARG2 (l / location 
                  :name (n2 / name 
                        :op1 "B") 
                  :wiki -)))

# ::snt After autoradiography , the membrane was stripped and rehybridized with a minor satellite probe [ 49 ] .
# ::tok After autoradiography , the membrane was stripped and rehybridized with a minor satellite probe [ 49 ] .
# ::alignments 15-16|0.2.0.0 13-14|0.0 12-13|0.0.0 11-12|0.0.1 7-8|0 6-7|0.1 4-5|0.1.0 1-2|0.2.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:13.065
(a / and 
      :ARG1-of (p / probe-01 
            :ARG0 (s / satellite) 
            :mod (m / minor)) 
      :op1 (s2 / strip-01 
            :ARG1 (m2 / membrane)) 
      :time (a3 / after 
            :op1 (a2 / autoradiography 
                  :mod 49)))

# ::snt After quantification , the membrane was stripped and rehybridized with an IAP LTR probe [ 50 ] .
# ::tok After quantification , the membrane was stripped and rehybridized with an IAP LTR probe [ 50 ] .
# ::alignments 15-16|0.1.0.0 13-14|0.0.0 11-13|0.0.0.0.0.1+0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 7-8|0 6-7|0.0 4-5|0.0.1 1-2|0.1.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:13.155
(a / and 
      :op1 (s / strip-01 
            :ARG0 (p / probe-01 
                  :ARG0 (t / thing 
                        :name (n / name 
                              :op1 (i / IAP) 
                              :op2 (l / LTR)))) 
            :ARG1 (m / membrane)) 
      :time (a2 / after 
            :op1 (q / quantification 
                  :mod-of 50)))

# ::snt Results are presented as the amount of DNA immunoprecipitated from p150CAF-1-depleted ES cells divided by the DNA obtained from control cells .
# ::tok Results are presented as the amount of DNA immunoprecipitated from p150CAF-1-depleted ES cells divided by the DNA obtained from control cells .
# ::alignments 20-21|0.1.0 19-20|0.1.0.0 17-18|0.1 16-17|0 13-14|0.0 12-13|0.0.0 11-12|0.0.0.0 10-11|0.0.0.1 7-8|0.1.0.0.0 5-6|0.1.0.0.0.0 2-3|0.1.0.0.0.0.0 0-1|0.1.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:13.326
(d / DNA 
      :ARG0-of (d2 / divide-02 
            :ARG1 (c3 / cell 
                  :mod (e / e) 
                  :mod (p / p150caf-1-deplet))) 
      :ARG1-of (o / obtain-01 
            :source (c / cell 
                  :topic (c2 / control-01 
                        :ARG1 (d3 / DNA 
                              :quant (a / amount 
                                    :ARG2-of (p2 / present-01 
                                          :ARG1 (r / result-01))))))))

# ::snt The figure shows the mean value and standard deviation of three independent ChIP experiments .
# ::tok The figure shows the mean value and standard deviation of three independent ChIP experiments .
# ::alignments 13-14|0.1.1 12-13|0.1.1.0 11-12|0.1.1.1.0+0.1.1.1 10-11|0.0.0.0.0 8-9|0.1.0 7-8|0.1.0.0 6-7|0.1 5-6|0.0.0 4-5|0.0.0.0 2-3|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:13.447
(s2 / show-01 
      :ARG0 (f / figure 
            :ARG1-of (v / value-01 
                  :ARG1-of (m / mean-01 
                        :ARG0 3))) 
      :ARG1 (a / and 
            :op1 (d2 / deviation 
                  :ARG1-of (s / standard-02)) 
            :op2 (e / experiment-01 
                  :ARG1 (c / chip-01) 
                  :ARG1-of (d / depend-01 
                        :polarity -))))

# ::snt ( C and D ) H3K9me3 and H4K20me3 fluorescence patterns are severely altered in p150CAF-1-depleted ES cells .
# ::tok ( C and D ) H3K9me3 and H4K20me3 fluorescence patterns are severely altered in p150CAF-1-depleted ES cells .
# ::alignments 16-17|0.2.0 15-16|0.2.0.0 14-15|0.2.0.1 12-13|0.2 11-12|0.2.2 9-10|0.2.1.0 8-9|0.2.1.0.0 6-7|0.2.1 3-4|0.1 2-3|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:13.561
(a3 / and 
      :op1 (c2 / C) 
      :op2 (d / D) 
      :op3 (a / alter-01 
            :ARG0 (c / cell 
                  :mod (e / e) 
                  :mod (p / p150caf-1-deplet)) 
            :ARG1 (a2 / and 
                  :op1 (p2 / pattern-01 
                        :mod (f / fluorescence))) 
            :manner (s / severe)))

# ::snt Immunodetection of H3K9me3 ( C , green ) , H4K20me3 ( D , green ) , and HP1 ( red ) in control and p150CAF-1 siRNA-expressing ES cells .
# ::tok Immunodetection of H3K9me3 ( C , green ) , H4K20me3 ( D , green ) , and HP1 ( red ) in control and p150CAF-1 siRNA-expressing ES cells .
# ::alignments 27-28|0.2 26-27|0.2.0 25-26|0.2.1 23-24|0 22-23|0.1 19-20|0.0.3 16-17|0.0 13-14|0.0.0.0 11-12|0.0.2 9-10|0.0.1 6-7|0.0.0 4-5|0.1.0 2-3|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:13.678
(a / and 
      :op1 (a2 / and 
            :op1 (g2 / green-02 
                  :ARG1 (g / green-02 
                        :ARG1 (h2 / H3K9me3))) 
            :op2 (h / H4K20me3) 
            :op3 (d / D) 
            :op4 (r / red)) 
      :op2 (c2 / control-01 
            :ARG1 (c3 / C)) 
      :op3 (c / cell 
            :mod (e / e) 
            :mod (s / sirna-express)))

# ::snt Merging of HP1 with H3K9me3 ( C ) and H4K20me3 ( D ) is shown in yellow .
# ::tok Merging of HP1 with H3K9me3 ( C ) and H4K20me3 ( D ) is shown in yellow .
# ::alignments 16-17|0.0 14-15|0 11-12|0.1.0 9-10|0.1.2.0 8-9|0.1.2 6-7|0.2 4-5|0.1.1 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:13.769
(s / show-01 
      :ARG0 (y / yellow) 
      :ARG1 (m / merge-01 
            :ARG0 (d / D) 
            :ARG1 (h2 / H3K9me3) 
            :ARG2 (a / and 
                  :op1 (h / H4K20me3))) 
      :ARG2 (c / C))

# ::snt Scale bars represent 10 m .
# ::tok Scale bars represent 10 m .
# ::alignments 4-5|0.1 3-4|0.1.0 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:13.843
(r / represent-01 
      :ARG0 (b / bar 
            :mod (s / scale)) 
      :ARG1 (m / m 
            :quant 10))

# ::snt $ Current address : Unit de Gntique Fonctionnelle de la Souris , Centre National de la Recherche Scientifique URA 2578 , Institut Pasteur , Paris , France .
# ::tok $ Current address : Unit de Gntique Fonctionnelle de la Souris , Centre National de la Recherche Scientifique URA 2578 , Institut Pasteur , Paris , France .
# ::alignments 26-27|0.0.1.1.0.1.1+0.0.1.1.0.1.0.0+0.0.1.1.0.1.0+0.0.1.1.0.1 24-25|0.0.3+0.0.2.0+0.0.2+0.0 21-23|0.0.1.0.0.1+0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 19-20|0.0.1.1.1+0.0.1.1 12-19|0.0.1.1.0.0.6+0.0.1.1.0.0.5+0.0.1.1.0.0.4+0.0.1.1.0.0.3+0.0.1.1.0.0.2+0.0.1.1.0.0.1+0.0.1.1.0.0.0+0.0.1.1.0.0+0.0.1.1.0 4-11|0.0.0.0.6+0.0.0.0.5+0.0.0.0.4+0.0.0.0.3+0.0.0.0.2+0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 2-3|0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:13.957
(a / address 
      :poss-of (c2 / city 
            :location-of (o2 / organization 
                  :name (n5 / name 
                        :op1 "Unit" 
                        :op2 "de" 
                        :op3 "Gntique" 
                        :op4 "Fonctionnelle" 
                        :op5 "de" 
                        :op6 "la" 
                        :op7 "Souris")) 
            :mod-of (c3 / current 
                  :poss (p / person 
                        :name (n3 / name 
                              :op1 "Institut" 
                              :op2 "Pasteur")) 
                  :poss (d / date-entity 
                        :time-of (o / organization 
                              :name (n4 / name 
                                    :op1 "Centre" 
                                    :op2 "National" 
                                    :op3 "de" 
                                    :op4 "la" 
                                    :op5 "Recherche" 
                                    :op6 "Scientifique" 
                                    :op7 "URA") 
                              :part-of (c / country 
                                    :name (n / name 
                                          :op1 "France") 
                                    :wiki "France")) 
                        :year 2578)) 
            :name (n2 / name 
                  :op1 "Paris") 
            :wiki "Paris"))

# ::snt Competing interests .
# ::tok Competing interests .
# ::alignments 1-2|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:13.966
(c / compete-01 
      :topic-of (i / interest))

# ::snt The authors have declared that no competing interests exist .
# ::tok The authors have declared that no competing interests exist .
# ::alignments 8-9|0.1 7-8|0.1.0 6-7|0.1.0.0 5-6|0.1.1 3-4|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:14.008
(d / declare-01 
      :ARG0 (a / author-01) 
      :ARG1 (e / exist-01 
            :ARG1 (i / interest 
                  :ARG1-of (c / compete-02)) 
            :polarity -))

# ::snt A previous version of this article appeared as an Early Online Release on September 11 , 2006 ( doi : 10.1371 / journal.pgen .0020181 .
# ::tok A previous version of this article appeared as an Early Online Release on September 11 , 2006 ( doi : 10.1371 / journal.pgen .0020181 .
# ::alignments 21-22|0.0.2 20-21|0.0.3+0.0.1+0.0.0+0.0 18-19|0.2.0 13-17|0.2.2.2+0.2.2.1+0.2.2.0+0.2.2 11-12|0.2 10-11|0.2.1 9-10|0.2.1.0 6-7|0 5-6|0.1 4-5|0.1.0 2-3|0.1.1 1-2|0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:14.295
(a / appear-01 
      :ARG0 (d / date-entity 
            :day 71 
            :month 13 
            :op1-of (s / slash) 
            :year 10) 
      :ARG1 (a2 / article 
            :mod (t / this) 
            :mod (v / version 
                  :time (p / previous))) 
      :ARG2 (r / release-01 
            :ARG0 (d2 / doi) 
            :ARG1 (o / online 
                  :mod (e / early)) 
            :time (d3 / date-entity 
                  :day 11 
                  :month 9 
                  :year 2006)))

# ::snt eor ) .
# ::tok eor ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:14.298
(a / amr-empty)

# ::snt Author contributions .
# ::tok Author contributions .
# ::alignments 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:14.303
(c / contribute-01 
      :ARG1-of (a / author-01))

# ::snt MH , SB , AVP , JPQ , GA , and MG conceived and designed the experiments .
# ::tok MH , SB , AVP , JPQ , GA , and MG conceived and designed the experiments .
# ::alignments 16-17|0.3.0 14-15|0.3 13-14|0 12-13|0.3.1.0 11-12|0.2.0.0+0.2.0+0.2 10-11|0.3.1 8-9|0.1.1+0.1.0.0+0.1.0+0.1 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:14.405
(a / and 
      :op1 (s / sb) 
      :op2 (g / government-organization 
            :name (n2 / name 
                  :op1 "GA") 
            :wiki "Virginia_General_Assembly") 
      :op3 (o / organization 
            :name (n / name 
                  :op1 "MG")) 
      :op4 (d / design-01 
            :ARG1 (e / experiment-01) 
            :op1-of (a2 / and 
                  :ARG0-of (c / conceive-01))))

# ::snt MH , SB , AVP , and PH performed the experiments .
# ::tok MH , SB , AVP , and PH performed the experiments .
# ::alignments 10-11|0.0.0 8-9|0.0 7-8|0.2 6-7|0 2-3|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:14.424
(a / and 
      :ARG0-of (p / perform-02 
            :ARG1 (e / experiment-01)) 
      :op1 (s / sb) 
      :op2 (p2 / ph))

# ::snt MH , SB , AVP , and JPQ analyzed the data .
# ::tok MH , SB , AVP , and JPQ analyzed the data .
# ::alignments 10-11|0.1 8-9|0 6-7|0.0 2-3|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:14.441
(a / analyze-01 
      :ARG0 (a2 / and 
            :op1 (s / sb)) 
      :ARG1 (d / data))

# ::snt MG wrote the paper .
# ::tok MG wrote the paper .
# ::alignments 3-4|0.1 1-2|0 0-1|0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:14.456
(w / write-01 
      :ARG0 (o / organization 
            :name (n / name 
                  :op1 "MG")) 
      :ARG1 (p / paper))

# ::snt Funding .
# ::tok Funding .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:14.458
(f / fund-01)

# ::snt This study was funded by grants from the Association Pour la Recherche Sur le Cancer and the Fondation Pour la Recherche Medicale to MG , and grants from a Collaborative Programme Curie Institute/Commissariat  l'Energie Atomique to MG and GA. .
# ::tok This study was funded by grants from the Association Pour la Recherche Sur le Cancer and the Fondation Pour la Recherche Medicale to MG , and grants from a Collaborative Programme Curie Institute/Commissariat  l'Energie Atomique to MG and GA. .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:14.462
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt GA 's team is labelized by la Ligue Contre le Cancer , and part of the Epigenome Network .
# ::tok GA 's team is labelized by la Ligue Contre le Cancer , and part of the Epigenome Network .
# ::alignments 17-18|0.1.0+0.1 12-13|0 8-11|0.0.1.2+0.0.1.1+0.0.1.0+0.0.1+0.0 6-8|0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 2-3|0.0.2.0.0 0-1|0.0.2.0.1+0.0.2.1+0.0.2+0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:14.524
(a / and 
      :op1 (o / organization 
            :mod (p / person 
                  :name (n3 / name 
                        :op1 "la" 
                        :op2 "Ligue")) 
            :name (n2 / name 
                  :op1 "Contre" 
                  :op2 "le" 
                  :op3 "Cancer") 
            :name (n4 / name 
                  :name-of (g / government-organization 
                        :poss-of (t / team) 
                        :wiki "Virginia_General_Assembly") 
                  :op1 "GA")) 
      :op2 (n / network 
            :wiki "American_Broadcasting_Company"))

# ::snt AVP has been supported by the Curie Institute and the Fondation Franco Norvgienne ; MH by the CEA , the Curie Institute , and the Canceropole IdF .
# ::tok AVP has been supported by the Curie Institute and the Fondation Franco Norvgienne ; MH by the CEA , the Curie Institute , and the Canceropole IdF .
# ::alignments 25-27|0.3.0.1+0.3.0.0+0.3.0+0.3 23-24|0 20-22|0.2.0.1+0.2.0.0+0.2.0+0.2 17-18|0.1.0.0+0.1.0+0.1 13-14|0.0.0.0 10-13|0.0.2.0.2+0.0.2.0.1+0.0.2.0.0+0.0.2.0+0.0.2 8-9|0.0 6-8|0.0.1.0.1+0.0.1.0.0+0.0.1.0+0.0.1 3-4|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:31:15.349
(a / and 
      :op1 (a3 / and 
            :ARG0-of (s / support-01 
                  :op1-of (a2 / and)) 
            :op1 (o5 / organization 
                  :name (n5 / name 
                        :op1 "Curie" 
                        :op2 "Institute")) 
            :op2 (o4 / organization 
                  :name (n4 / name 
                        :op1 "Fondation" 
                        :op2 "Franco" 
                        :op3 "Norvgienne"))) 
      :op2 (o3 / organization 
            :name (n3 / name 
                  :op1 "CEA")) 
      :op3 (o2 / organization 
            :name (n2 / name 
                  :op1 "Curie" 
                  :op2 "Institute")) 
      :op4 (o / organization 
            :name (n / name 
                  :op1 "Canceropole" 
                  :op2 "IdF")))

